{
    "meta": {
        "total_records": 2643,
        "timestamp": "2026-06-02T18:33:08Z"
    },
    "data": [
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "escherichia coli lysate",
            "active_substance": "escherichia coli lysate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001263/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "02/06/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001263-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "poractant alfa",
            "active_substance": "poractant alfa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002478/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002478-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lactitol",
            "active_substance": "lactitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001819/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001819-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tranexamic acid",
            "active_substance": "tranexamic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003006/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/02/2026",
            "last_updated_date": "22/05/2026",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003006-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "progesterone",
            "active_substance": "progesterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002540/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002540-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "silver sulfadiazine",
            "active_substance": "silver sulfadiazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002702/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002702-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "terizidone",
            "active_substance": "terizidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002904/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002904-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "allergen for therapy: dermatophagoides pteronyssinus / dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)",
            "active_substance": "Dermatophagoides pteronyssinus;Dermatophagoides farina",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010582/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "epinephrine (except for nasal use)",
            "active_substance": "epinephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001232/202507",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001232-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "choline salicylate, cetalkonium chloride",
            "active_substance": "choline salicylate;cetalkonium chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000626/202508",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000626-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "piretanide / ramipril, piretanide",
            "active_substance": "piretanide;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002434/202508",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002434-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "buclizine / codeine / paracetamol, caffeine / codeine / paracetamol",
            "active_substance": "buclizine;codeine;paracetamol;Caffeine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000448/202508",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000448-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pethidine",
            "active_substance": "pethidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002357/202508",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/05/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002357-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "povidone, polyvinyl alcohol / povidone",
            "active_substance": "povidone;polyvinyl alcohol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002475/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002475-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "albendazole",
            "active_substance": "albendazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000073/202507",
            "regulatory_outcome": "Variation",
            "first_published_date": "15/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000073-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "losartan",
            "active_substance": "losartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001912/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001912-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "biperiden",
            "active_substance": "biperiden",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000415/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clonidine",
            "active_substance": "clonidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000813/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000813-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nifedipine",
            "active_substance": "nifedipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002156/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002156-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "meclozine",
            "active_substance": "meclozine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001945/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001945-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "raltitrexed",
            "active_substance": "raltitrexed",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002605/202509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002605-202509"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hexoprenaline sulfate",
            "active_substance": "hexoprenaline sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003170/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003170-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metronidazole / miconazole, chlorquinaldol / metronidazole",
            "active_substance": "Metronidazole;chlorquinaldol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002042/202507",
            "regulatory_outcome": "Variation",
            "first_published_date": "16/02/2026",
            "last_updated_date": "07/04/2026",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002042-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ropinirole",
            "active_substance": "ropinirole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002661/202507",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/04/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "captopril",
            "active_substance": "captopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000535/202504",
            "regulatory_outcome": "Variation",
            "first_published_date": "25/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000535-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cisatracurium",
            "active_substance": "cisatracurium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000777/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "24/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000777-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flutrimazole",
            "active_substance": "flutrimazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001456/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "24/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001456-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "copper chloride dihydrate / manganese chloride tetrahydrate / potassium iodide / sodium fluoride / sodium selenite anhydrous / zinc chloride",
            "active_substance": "copper chloride dihydrate;Manganese chloride tetrahydrate;potassium iodide;sodium fluoride (18F);sodium selenite anhydrous;zinc chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010803/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "24/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010803-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "human plasma protease C1 inhibitor (nationally authorised products)",
            "active_substance": "human plasma protease C1 inhibitor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010163/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "24/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bethanechol",
            "active_substance": "bethanechol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000402/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "20/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000402-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "etodolac",
            "active_substance": "etodolac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001324/202505",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001324-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diclofenac / misoprostol",
            "active_substance": "diclofenac;misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001040/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nicardipine",
            "active_substance": "nicardipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002149/202505",
            "regulatory_outcome": "Variation",
            "first_published_date": "18/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002149-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydrocortisone / natamycin / neomycine sulphate",
            "active_substance": "hydrocortisone;natamycin;neomycin sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001672/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "18/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001672-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ziprasidone",
            "active_substance": "ziprasidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003146/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "18/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003146-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fosphenytoin",
            "active_substance": "fosphenytoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001476/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "18/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001476-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pitavastatin",
            "active_substance": "pitavastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010502/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "iodine (123i) iobenguane",
            "active_substance": "iodine (123i) iobenguane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001763/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001763-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ioversol",
            "active_substance": "ioversol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001775/202506",
            "regulatory_outcome": "Variation",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001775-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "glyceryl trinitrate",
            "active_substance": "glyceryl trinitrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001552/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001552-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "beclometasone / formoterol",
            "active_substance": "beclometasone;formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010068/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lamivudine",
            "active_substance": "lamivudine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001824/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001824-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amoxicillin / clarithromycin / pantoprazole",
            "active_substance": "amoxicillin;clarithromycin;pantoprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002286/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002286-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cetylpyridinium / lysozyme, lysozyme / pyridoxine",
            "active_substance": "cetylpyridinium / lysozyme;lysozyme / pyridoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000640/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000640-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "octenidine",
            "active_substance": "octenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010748/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010748-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "anastrozole",
            "active_substance": "anastrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000210/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 / poliovirus type 3 vaccine (oral, live, attenuated),poliovirus type 1 (oral, live, attenuated) vaccine, poliovirus type 2 (oral, live, attenuated) vaccine, poliovirus type 3 (oral, live, attenuated) vaccine",
            "active_substance": "poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated);poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine;poliovirus type 1 (oral, live, attenuated) vaccine;poliovirus type 2 (oral, live, attenuated) vaccine;poliovirus type 3 (oral, live, attenuated) vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010801/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010801-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ademetionine",
            "active_substance": "ademetionine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000061/202508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000061-202508"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dimetindene / phenylephrine",
            "active_substance": "dimetindene;phenylephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001102/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001102-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methadone",
            "active_substance": "methadone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002004/202505",
            "regulatory_outcome": "Variation",
            "first_published_date": "11/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002004-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sulprostone",
            "active_substance": "sulprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002828/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002828-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "benzylpenicillin, benzathine benzylpenicillin, benzathine benzylpenicillin / lidocaine, procaine benzylpenicillin, benzathine benzylpenicillin / procaine benzylpenicillin",
            "active_substance": "benzylpenicillin;benzathine benzylpenicillin;lidocaine;procaine benzylpenicillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000383/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000383-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diphtheria / tetanus / pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)",
            "active_substance": "diptheria;tetanus;pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed);pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001126/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001126-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pneumococcal polysaccharide vaccine",
            "active_substance": "pneumococcal polysaccharide vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002453/202505",
            "regulatory_outcome": "Variation",
            "first_published_date": "10/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002453-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "caffeine / codeine / paracetamol / propyphenazone, acetylsalicylic acid / caffeine / codeine / paracetamol",
            "active_substance": "Caffeine;codeine;paracetamol;propyphenazone, acetylsalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002312/202506",
            "regulatory_outcome": "Variation",
            "first_published_date": "10/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002312-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gabapentin",
            "active_substance": "gabapentin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001499/202502",
            "regulatory_outcome": "Variation",
            "first_published_date": "26/11/2025",
            "last_updated_date": "09/03/2026",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cefixime",
            "active_substance": "cefixime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000594/202506",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000594-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tamoxifen",
            "active_substance": "tamoxifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002846/202504",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002846-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levomethadone",
            "active_substance": "levomethadone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001855/202505",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/03/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001855-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "simvastatin",
            "active_substance": "simvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002709/202504",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002709-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ethinylestradiol / etonogestrel",
            "active_substance": "ethinylestradiol;etonogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001307/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "20/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001307-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amlodipine / irbesartan",
            "active_substance": "amlodipine;irbesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010876/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010876-202506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "itopride",
            "active_substance": "itopride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010606/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010606-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nitrous oxide / oxygen",
            "active_substance": "nitrous oxide;oxygen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010572/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "alfacalcidol",
            "active_substance": "alfacalcidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000080/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000080-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "magnesium sulfate",
            "active_substance": "magnesium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009225/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009225-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mitoxantrone",
            "active_substance": "mitoxantrone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002076/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clonazepam",
            "active_substance": "clonazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000812/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000812-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rifabutin",
            "active_substance": "rifabutin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002639/202507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002639-202507"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ganciclovir",
            "active_substance": "ganciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001516/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol (gastrointestinal indication)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "testosterone (topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002908/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "chlorhexidine",
            "active_substance": "chlorhexidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000662/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/02/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000662-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "valsartan, hydrochlorothiazide / valsartan",
            "active_substance": "valsartan;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010396/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "30/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cefaclor",
            "active_substance": "cefaclor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000583/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "30/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000583-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cytarabine",
            "active_substance": "cytarabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000911/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000911-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "isradipine",
            "active_substance": "isradipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001797/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "29/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001797-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "torasemide",
            "active_substance": "torasemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002998/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "29/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002998-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "linezolid",
            "active_substance": "linezolid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001888/202504",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001888-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dienogest \r\nethinylestradiol (prolonged-release tablet)",
            "active_substance": "Dienogest;ethinylestradiol (prolonged-release tablet)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00011084/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00011084-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "formoterol",
            "active_substance": "formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001469/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001469-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/202505",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hyoscine butylbromide\r\nparacetamol",
            "active_substance": "hyoscine butylbromide;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002303/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002303-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metolazone",
            "active_substance": "metolazone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002037/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002037-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sulpiride\r\nlevosulpiride",
            "active_substance": "sulpiride;levosulpiride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001859/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001859-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nefopam",
            "active_substance": "nefopam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002131/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadobenic acid",
            "active_substance": "gadobenic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001500/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "zotepine",
            "active_substance": "zotepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003154/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003154-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadoxetic acid disodium",
            "active_substance": "gadoxetic acid disodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001509/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadopentetic acid",
            "active_substance": "gadopentetic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001504/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadodiamide",
            "active_substance": "gadodiamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001503/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "26/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001503-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadobutrol",
            "active_substance": "Gadobutrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001502/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "26/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "indobufen",
            "active_substance": "indobufen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001736/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001736-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nicergoline",
            "active_substance": "nicergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002150/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002150-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": " levonorgestrel",
            "active_substance": "levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010827/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010827-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "benzoyl peroxide\r\nclindamycin phosphate",
            "active_substance": "benzoyl peroxide;clindamycin phosphate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000796/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000796-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levofloxacin/dexamethasone (ocular use)",
            "active_substance": "levofloxacin/dexamethasone (ocular use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010881/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010881-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "azelaic acid",
            "active_substance": "azelaic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000276/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000276-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "solifenacin",
            "active_substance": "solifenacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002769/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002769-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadoteric acid",
            "active_substance": "gadoteric acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001505/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001505-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fotemustine",
            "active_substance": "fotemustine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001477/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001477-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ticlopidine",
            "active_substance": "ticlopidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002952/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002952-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "magnesium pidolate",
            "active_substance": "magnesium pidolate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010041/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010041-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sertaconazole",
            "active_substance": "sertaconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002694/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002694-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadoteric acid (IV and intravascular formulations)",
            "active_substance": "gadoteric acid (IV and intravascular formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001506/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "20/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "somatostatin",
            "active_substance": "somatostatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002771/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002771-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bifonazole",
            "active_substance": "bifonazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000411/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000411-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fusidic acid (systemic use)",
            "active_substance": "fusidic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010226/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diphtheria / tetanus vaccines (adsorbed), diphtheria vaccines (adsorbed)",
            "active_substance": "diphtheria;tetanus vaccine;diphtheria vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001128/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rifaximin",
            "active_substance": "rifaximin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002642/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002642-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mebendazole",
            "active_substance": "Mebendazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001939/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001939-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fenticonazole",
            "active_substance": "fenticonazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001371/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001371-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lodoxamide",
            "active_substance": "lodoxamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001898/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001898-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "misoprostol (gynaecological indication - labour induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clotiazepam",
            "active_substance": "clotiazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000827/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000827-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ciprofloxacin / dexamethasone (ear drops, suspension)",
            "active_substance": "ciprofloxacin;dexamethasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010012/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010012-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ceftriaxone sodium / lidocaine hydrochloride",
            "active_substance": "ceftriaxone sodium;lidocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000614/202505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000614-202505"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "carmellose (eye preparation)",
            "active_substance": "carmellose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000562/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000562-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "etamsylate",
            "active_substance": "Etamsylate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001294/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001294-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "calcipotriol",
            "active_substance": "calcipotriol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000492/202506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000492-202506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cefditoren",
            "active_substance": "cefditoren",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000592/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "15/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000592-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "codeine / paracetamol",
            "active_substance": "codeine;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000851/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "14/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000851-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clomipramine",
            "active_substance": "clomipramine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000811/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000811-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "piritramide",
            "active_substance": "piritramide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002437/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/01/2026",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002437-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clozapine",
            "active_substance": "clozapine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000836/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/01/2026",
            "last_updated_date": "08/01/2026",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000836-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "varicella vaccine (live)",
            "active_substance": "varicella vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010473/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-202503-0"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "varicella vaccine (live)",
            "active_substance": "varicella vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010473/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "selegiline",
            "active_substance": "selegiline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002688/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002688-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Rocuronium",
            "active_substance": "rocuronium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002656/202502",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rifampicin",
            "active_substance": "rifampicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002640/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002640-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metoprolol",
            "active_substance": "metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002039/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002039-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "prazepam",
            "active_substance": "prazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002502/202503",
            "regulatory_outcome": "Variation",
            "first_published_date": "18/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002502-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amlodipine / atorvastatin",
            "active_substance": "amlodipine;atorvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000177/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "11/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000177-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "caspofungin",
            "active_substance": "caspofungin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000576/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "03/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000576-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tibolone",
            "active_substance": "tibolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002947/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002947-202412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "propylthiouracil",
            "active_substance": "propylthiouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002558/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "02/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002558-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "carvedilol / ivabradine",
            "active_substance": "carvedilol;ivabradine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010883/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010883-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "vancomycin",
            "active_substance": "vancomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003097/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "01/12/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003097-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "reboxetine",
            "active_substance": "reboxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002615/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2025",
            "last_updated_date": "28/11/2025",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002615-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ofloxacin (systemic use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002203/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ivermectin (systemic use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010377/202504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-202504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "codeine",
            "active_substance": "codeine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000843/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000843-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Rosuvastatin / Omega-3-acid ethyl esters",
            "active_substance": "rosuvastatin;omega-3-acid ethyl esters 90",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010915/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "26/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010915-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "atenolol",
            "active_substance": "atenolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000259/202502",
            "regulatory_outcome": "Variation",
            "first_published_date": "26/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000259-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dorzolamide",
            "active_substance": "dorzolamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003168/202502",
            "regulatory_outcome": "Variation",
            "first_published_date": "26/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "prednisone",
            "active_substance": "prednisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002510/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002510-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "trimethoprim",
            "active_substance": "trimethoprim",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003045/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003045-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sodium citrate / sodium lauryl sulfoacetate, sodium citrate / sodium lauryl sulfoacetate / sorbitol",
            "active_substance": "sodium citrate / sodium lauryl sulfoacetate, sodium citrate / sodium lauryl sulfoacetate / sorbitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002735/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "18/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002735-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "estradiol (17-beta) / progesterone",
            "active_substance": "17 beta-estradiol;progesterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009145/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009145-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "botulinum toxin a (except for centrally authorised products)",
            "active_substance": "botulinum toxin a (except for centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000426/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000426-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "alprazolam",
            "active_substance": "alprazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000109/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clobetasol",
            "active_substance": "clobetasol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000799/202502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000799-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cyamemazine",
            "active_substance": "cyamemazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000886/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000886-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ethyl loflazepate",
            "active_substance": "ethyl loflazepate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001317/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001317-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fomepizole",
            "active_substance": "Fomepizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001466/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001466-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diazepam",
            "active_substance": "diazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001029/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001029-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "erythromycin (systemic use)",
            "active_substance": "erythromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010808/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010808-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hepatitis B vaccine (rDNA)",
            "active_substance": "hepatitis B vaccine (rDNA)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001597/202502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001597-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bupropion",
            "active_substance": "bupropion",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000461/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "03/11/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "niflumic acid",
            "active_substance": "niflumic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002157/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "urokinase",
            "active_substance": "urokinase",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003083/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003083-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ethinylestradiol",
            "active_substance": "ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001306/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001306-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Mannitol (all indications apart from cystic fibrosis)",
            "active_substance": "mannitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010005/202502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010005-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "thiamazole",
            "active_substance": "thiamazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002922/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002922-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "trandolapril / verapamil",
            "active_substance": "trandolapril;verapamil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003005/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003005-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "doxycycline",
            "active_substance": "doxycycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001173/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001173-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "milrinone",
            "active_substance": "milrinone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002064/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "glipizide",
            "active_substance": "glipizide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001535/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "30/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dermatan sulfate",
            "active_substance": "dermatan sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000957/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "30/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000957-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "testosterone (all formulations apart from topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010631/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010631-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dexketoprofen / tramadol",
            "active_substance": "dexketoprofen;tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010468/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "23/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010468-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "active_substance": "botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009084/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "23/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ciclosporin (systemic use)",
            "active_substance": "ciclosporin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000745/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "23/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "disodium hydrogen phosphate / sodium dihydrogen phosphate, phosphate sodium",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002737/202501",
            "regulatory_outcome": "Variation",
            "first_published_date": "23/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002737-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bisoprolol / hydrochlorothiazide",
            "active_substance": "bisoprolol;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000420/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Sevoflurane",
            "active_substance": "sevoflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002698/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002698-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "potassium para-aminobenzoate",
            "active_substance": "potassium para-aminobenzoate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010130/202502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010130-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pimozide",
            "active_substance": "pimozide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002413/202502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002413-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "warfarin",
            "active_substance": "warfarin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003129/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003129-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydroxyethyl starch / sodium chloride",
            "active_substance": "hydroxyethyl starch;sodium chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/202503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202503"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mesterolone",
            "active_substance": "mesterolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010551/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010551-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "xipamide, triamterene / xipamide",
            "active_substance": "xipamide;triamterene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003133/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003133-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lorazepam",
            "active_substance": "lorazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001909/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-202501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/202502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202502"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tofisopam",
            "active_substance": "tofisopam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002982/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002982-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cyclophosphamide",
            "active_substance": "cyclophosphamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000901/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000901-202501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "interferon gamma",
            "active_substance": "Interferon gamma",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001760/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "02/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001760-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diamorphine",
            "active_substance": "Diamorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001028/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "02/10/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001028-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "timolol (systemic use)",
            "active_substance": "timolol (systemic use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010432/202410",
            "regulatory_outcome": "Variation",
            "first_published_date": "30/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010432-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "omega-3-acid ethyl esters 90",
            "active_substance": "omega-3-acid ethyl esters 90",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010312/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flumazenil",
            "active_substance": "flumazenil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001413/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "23/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001413-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "haloperidol",
            "active_substance": "haloperidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001587/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "23/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001587-202501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "phosphocreatine",
            "active_substance": "phosphocreatine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002398/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002398-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "cyanocobalamin / diclofenac / pyridoxine / thiamine",
            "active_substance": "cyanocobalamin;diclofenac;pyridoxine;thiamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001041/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001041-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "acetylsalicylic acid / bisoprolol",
            "active_substance": "acetylsalicylic acid / bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010287/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "11/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "botulinum toxin a - haemagglutinin complex",
            "active_substance": "botulinum toxin a - haemagglutinin complex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000427/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "myristalkonium, benzalkonium (vaginal use only)",
            "active_substance": "myristalkonium, benzalkonium (vaginal use only)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010987/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010987-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flunitrazepam",
            "active_substance": "flunitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001418/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydromorphone",
            "active_substance": "hydromorphone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001686/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "human alfa1-proteinase inhibitor (apart from the centrally authorised product)",
            "active_substance": "human alfa1-proteinase inhibitor (apart from the centrally authorised product)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000108/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "varicella-zoster immunoglobuline",
            "active_substance": "varicella-zoster immunoglobuline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010266/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010266-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "typhoid vaccine (live, attenuated)",
            "active_substance": "typhoid vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003067/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003067-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cefotaxime",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000599/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000599-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nitric oxide",
            "active_substance": "nitric oxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002172/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002172-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amino acid combinations / glucose / triglyceride combinations",
            "active_substance": "amino acid combinations;glucose;triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010190/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "phenylephrine (ophthalmic formulations)",
            "active_substance": "phenylephrine (ophthalmic formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010402/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010402-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metamizole sodium / triacetonamine tosilate",
            "active_substance": "metamizole sodium;triacetonamine tosilate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001999/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001999-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lidocaine / phenazone",
            "active_substance": "lidocaine;phenazone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002359/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "08/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002359-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tapentadol",
            "active_substance": "tapentadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002849/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bendamustine hydrochloride",
            "active_substance": "bendamustine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003162/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "08/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "roxithromycin",
            "active_substance": "roxithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002669/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pirenoxine",
            "active_substance": "pirenoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002431/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002431-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tizanidine",
            "active_substance": "tizanidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002977/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002977-202412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "anthrax vaccine",
            "active_substance": "anthrax vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010771/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010771-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "alitretinoin (oral use)",
            "active_substance": "alitretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010710/202501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202501"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nicotine",
            "active_substance": "nicotine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002153/202412",
            "regulatory_outcome": "Variation",
            "first_published_date": "03/09/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002153-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levosimendan",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA00001858202409",
            "regulatory_outcome": "Variation",
            "first_published_date": "21/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa00001858202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "domperidone",
            "active_substance": "domperidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001158/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "20/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "isoniazid",
            "active_substance": "isoniazid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001789/202411",
            "regulatory_outcome": "Variation",
            "first_published_date": "13/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001789-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Miconazole, hydrocortisone / miconazole nitrate, miconazole nitrate / zinc oxide",
            "active_substance": "Miconazole;hydrocortisone;miconazole nitrate;zinc oxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002052/202410",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002052-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methocarbamol / paracetamol",
            "active_substance": "methocarbamol;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002013/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002013-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methylphenidate",
            "active_substance": "methylphenidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002024/202410",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dexketoprofen",
            "active_substance": "dexketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000997/202410",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000997-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clotrimazole / dexamethasone",
            "active_substance": "clotrimazole;dexamethasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000830/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000830-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clotrimazole / hydrocortisone",
            "active_substance": "clotrimazole;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000831/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/08/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000831-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "rabbit anti-human thymocyte immunoglobulin",
            "active_substance": "rabbit anti-human thymocyte immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010184/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/02/2025",
            "last_updated_date": "01/08/2025",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010184-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clotrimazole / metronidazole",
            "active_substance": "clotrimazole;Metronidazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000832/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000832-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "benzydamine",
            "active_substance": "benzydamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000375/202410",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lornoxicam",
            "active_substance": "lornoxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001911/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "29/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001911-202412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "ketamine",
            "active_substance": "ketamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001804/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "neomycin sulfate / nystatin / polymyxin b sulfate",
            "active_substance": "neomycin sulfate;nystatin;polymyxin b sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002139/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002139-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metoclopramide",
            "active_substance": "metoclopramide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002036/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methocarbamol",
            "active_substance": "methocarbamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002011/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002011-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "paracetamol / pseudoephedrine hydrochloride / triprolidine hydrochloride",
            "active_substance": "paracetamol;pseudoephedrine hydrocholoride;triprolidine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010270/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010270-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "acetylsalicylic acid / caffeine / paracetamol",
            "active_substance": "acetylsalicylic acid;Caffeine;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002291/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002291-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "natamycin",
            "active_substance": "natamycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003179/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003179-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metamizole sodium / pitofenone hydrochloride",
            "active_substance": "metamizole sodium;pitofenone hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002443/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002443-202412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "ceftobiprole",
            "active_substance": "ceftobiprole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010734/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010734-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "cinolazepam",
            "active_substance": "cinolazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000769/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000769-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "antazoline / tetryzoline",
            "active_substance": "antazoline;tetryzoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000219/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000219-202412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "dextromethorphan hydrobromide / paracetamol / promethazine hydrochloride",
            "active_substance": "dextromethorphan hydrobromide;paracetamol;promethazine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002300/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002300-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "chlorphenamine / dextromethorphan hydrobromide/ paracetamol",
            "active_substance": "chlorphenamine;dextromethorphan hydrobromide;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000699/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000699-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "dextromethorphan / paracetamol / phenylephrine",
            "active_substance": "dextromethorphan;paracetamol;phenylephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009247/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009247-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "dextromethorphan hydrobromide / pseudoephedrine hydrochloride / triprolidine hydrochloride",
            "active_substance": "dextromethorphan hydrobromide;pseudoephedrine hydrocholoride;triprolidine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001021/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001021-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "urea hydrogen peroxide",
            "active_substance": "urea hydrogen peroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009326/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009326-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "mexazolam",
            "active_substance": "mexazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002047/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002047-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dextromethorphan hydrobromide / diphenhydramine hydrochloride / levomenthol",
            "active_substance": "dextromethorphan hydrobromide;diphenhydramine hydrochloride;Levomenthol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001013/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001013-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "oxygen",
            "active_substance": "oxygen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002257/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002257-202412"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dihydroxyaluminum sodium carbonate, dihydroxyaluminum sodium carbonate / dimeticone",
            "active_substance": "dihydroxyaluminum sodium carbonate;dimeticone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001098/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001098-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cyanocobalamin / folic acid / pyridoxine",
            "active_substance": "cyanocobalamin;folic acid;pyridoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000893/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000893-202411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acrivastine, acrivastine / pseudoephedrine",
            "active_substance": "acrivastine;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000054/202412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000054-202412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "diphenhydramine / paracetamol",
            "active_substance": "diphenhydramine;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001110/202411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001110-202411"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sumatriptan, naproxen / sumatriptan",
            "active_substance": "sumatriptan;naproxen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002832/202409",
            "regulatory_outcome": "Variation",
            "first_published_date": "08/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002832-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diclofenac (systemic formulations)",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001048/202409",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/07/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "etonogestrel",
            "active_substance": "etonogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001331/202409",
            "regulatory_outcome": "Variation",
            "first_published_date": "13/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "azelastine / fluticasone",
            "active_substance": "azelastine;fluticasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010067/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "meropenem",
            "active_substance": "Meropenem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001989/202408",
            "regulatory_outcome": "Variation",
            "first_published_date": "11/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fluticasone / salmeterol (for nationally authorised products)",
            "active_substance": "fluticasone;salmeterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001455/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001455-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "colecalciferol, colecalciferol / calcium, ergocalciferol, ergocalciferol / calcium",
            "active_substance": "colecalciferol;calcium;ergocalciferol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010386/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010386-202410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "ascorbic acid / magnesium aspartate / leucine L / lysine L / phenylalanine L / valine L",
            "active_substance": "ascorbic acid;magnesium aspartate;leucine L;lysine L;phenylalanine L;valine L",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010988/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010988-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "letrozole",
            "active_substance": "letrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001842/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-202410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "clindamycin",
            "active_substance": "clindamycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000795/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-202410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydrocortisone (systemic formulations except for products indicated in adrenal insufficiency in a modified release tablet formulation and except for centrally authorised products for adrenal insufficiency, paediatric use only)",
            "active_substance": "hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010855/202408",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010855-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Alfentanil",
            "active_substance": "alfentanil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000082/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "02/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "oxcarbazepine",
            "active_substance": "oxcarbazepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002235/202408",
            "regulatory_outcome": "Variation",
            "first_published_date": "02/06/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "anastrozole",
            "active_substance": "anastrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000210/202408",
            "regulatory_outcome": "Variation",
            "first_published_date": "28/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "chlorocresol / chlorhexidine / hexamidine",
            "active_substance": "chlorocresol (4-chloro-3-methylphenol);hexamidine;chlorhexidine digluconate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001603/202408",
            "regulatory_outcome": "Variation",
            "first_published_date": "28/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001603-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "phloroglucinol, phloroglucinol / trimethylphloroglucinol",
            "active_substance": "phloroglucinol;trimethylphloroglucinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010355/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pramiracetam",
            "active_substance": "pramiracetam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002492/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002492-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hexaminolevulinate hydrochloride",
            "active_substance": "hexaminolevulinate hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001606/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001606-202409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "trifarotene",
            "active_substance": "trifarotene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010929/202410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010929-202410"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "carmustine (implant)",
            "active_substance": "carmustine (implant)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010348/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-202409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "naphazoline, naphazoline, zinc sulphate",
            "active_substance": "naphazoline;zinc sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010571/202407",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010571-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "zidovudine",
            "active_substance": "zidovudine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003143/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003143-202409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "rilmenidine",
            "active_substance": "rilmenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002643/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "betamethasone / tetryzoline",
            "active_substance": "betamethasone;tetryzoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010072/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010072-202409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "opium",
            "active_substance": "opium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010670/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-202409"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "magnesium sulfate / sodium sulfate / potassium sulfate",
            "active_substance": "magnesium sulfate;sodium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/202408",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-202408"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "everolimus (indicated for rejection of transplanted organs)",
            "active_substance": "everolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010269/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cinchocaine hydrochloride / hydrocortisone",
            "active_substance": "cinchocaine hydrochloride;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000761/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000761-202408"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "thiocolchicoside, paracetamol / thiocolchicoside",
            "active_substance": "thiocolchicoside;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010464/202407",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/05/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010464-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sotalol",
            "active_substance": "sotalol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002774/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002774-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "acenocoumarol",
            "active_substance": "acenocoumarol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000027/202407",
            "regulatory_outcome": "Variation",
            "first_published_date": "16/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000027-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "thallium [201TL]",
            "active_substance": "thallium [201TL]",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002920/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002920-202408"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "busulfan",
            "active_substance": "busulfan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000464/202407",
            "regulatory_outcome": "Variation",
            "first_published_date": "15/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000464-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ciclesonide",
            "active_substance": "ciclesonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000742/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-202408"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/202409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "hydrocortisone (all formulations apart from systemic use)",
            "active_substance": "hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010856/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010856-202408"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "tiagabine",
            "active_substance": "tiagabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002942/202406",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/04/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "benperidol",
            "active_substance": "benperidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000329/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "20/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000329-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "budesonide / salmeterol",
            "active_substance": "Budesonide;salmeterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010511/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010511-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tiapride",
            "active_substance": "tiapride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002944/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "montelukast",
            "active_substance": "montelukast",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002087/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-202407"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "neomycin / triamcinolone",
            "active_substance": "neomycin;triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000081/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000081-202408"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "bibrocathol",
            "active_substance": "bibrocathol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000406/202408",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000406-202408"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "lactobacillus all subspecies and combinations of subspecies",
            "active_substance": "lactobacillus all subspecies and combinations of subspecies",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010598/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010598-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "oxycodone hydrochloride / paracetamol",
            "active_substance": "oxycodone hydrochloride;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002256/202407",
            "regulatory_outcome": "Variation",
            "first_published_date": "13/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002256-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "bismuth subcitrate potassium / metronidazole / tetracycline",
            "active_substance": "bismuth subcitrate potassium;Metronidazole;tetracycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010199/202405",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "iobitridol",
            "active_substance": "iobitridol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001761/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001761-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "aciclovir",
            "active_substance": "aciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000048/202406",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "phenylpropanolamine",
            "active_substance": "phenylpropanolamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010483/202406",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010483-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "tianeptine",
            "active_substance": "tianeptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002943/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/03/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "propranolol (except for centrally authorised product)",
            "active_substance": "propranolol (except for centrally authorised product)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000434/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000434-202407-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "brivudine",
            "active_substance": "brivudine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000434/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000434-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "clebopride",
            "active_substance": "clebopride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000789/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000789-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "dexchlorpheniramine",
            "active_substance": "dexchlorpheniramine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000989/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "nilutamide",
            "active_substance": "nilutamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002163/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002163-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "human plasma proteins with no less than 95% albumin",
            "active_substance": "human plasma proteins with no less than 95% albumin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010605/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010605-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "anti-t lymphocyte immunoglobulin for human use, rabbit",
            "active_substance": "anti-t lymphocyte immunoglobulin for human use, rabbit",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010252/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010252-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nimesulide (systemic formulations)",
            "active_substance": "nimesulide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009236/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "benzalkonium chloride / ethyl alcohol, benzalkonium chloride / isopropyl alcohol",
            "active_substance": "benzalkonium chloride;ethyl alcohol;isopropyl alcohol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000342/202407",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000342-202407"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "hydrochlorothiazide / zofenopril",
            "active_substance": "hydrochlorothiazide;zofenopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003148/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003148-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "oxaliplatin",
            "active_substance": "oxaliplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002229/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amlodipine besilate / ramipril, amlodipine / hydrochlorothiazide / ramipril, hydrochlorothiazide / ramipril",
            "active_substance": "amlodipine besilate;amlodipine;hydrochlorothiazide;hydrochlorothiazide;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010774/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010774-202403"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "biclotymol",
            "active_substance": "biclotymol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000408/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/02/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000408-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "olodaterol / tiotropium",
            "active_substance": "olodaterol;tiotropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010489/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "29/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "promethazine",
            "active_substance": "promethazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002545/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002545-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "nebivolol",
            "active_substance": "nebivolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002129/202403",
            "regulatory_outcome": "Variation",
            "first_published_date": "23/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002129-202403"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "tolperisone",
            "active_substance": "tolperisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002991/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "23/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002991-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "flunarizine",
            "active_substance": "flunarizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001416/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "23/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "enalapril maleate / lercanidipine",
            "active_substance": "enalapril maleate;lercanidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001215/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001215-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "buspirone",
            "active_substance": "buspirone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000463/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000463-202404"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "loteprednol",
            "active_substance": "loteprednol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001913/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001913-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)",
            "active_substance": "ambrosia artemisii folia",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010693/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acemetacin",
            "active_substance": "acemetacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000026/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000026-202405"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "active_substance": "fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001370/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "21/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202404"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ranitidine",
            "active_substance": "ranitidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002610/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "metyrapone",
            "active_substance": "metyrapone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002046/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "20/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002046-202406"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "praziquantel",
            "active_substance": "praziquantel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002503/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "20/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002503-202404"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "loperamide, loperamide / simethicone",
            "active_substance": "loperamide;simethicone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010665/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010665-202405"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "deoxycholic acid",
            "active_substance": "Deoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010525/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "metformin",
            "active_substance": "metformin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002001/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "17/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "tafluprost",
            "active_substance": "tafluprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002843/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "daunorubicin",
            "active_substance": "daunorubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000936/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000936-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ferucarbotran",
            "active_substance": "Ferucarbotran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001382/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001382-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "indocyanine green",
            "active_substance": "indocyanine green",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001737/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001737-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "yohimbine",
            "active_substance": "yohimbine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003136/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003136-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alginic acid / aluminium oxide hydrated / sodium hydrogen carbonate, alginic acid / aluminium hydroxide / calcium carbonate / sodium carbonate",
            "active_substance": "alginic acid;aluminium oxide hydrated;aluminium hydroxide;calcium carbonate;sodium carbonate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000123/202406",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000123-202406"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "iodine (131i) iobenguane",
            "active_substance": "Iodine (131I) iobenguane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001764/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001764-202405"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "bilastine",
            "active_substance": "bilastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003163/202403",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003163-202403"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "chlorphenamine maleate / paracetamol",
            "active_substance": "chlorphenamine maleate;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000703/202403",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000703-202403"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "lanthanum",
            "active_substance": "lanthanum",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003175/202403",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003175-202403"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "oxycodone",
            "active_substance": "oxycodone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002254/202404",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/01/2025",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin / fluocinolone acetonide",
            "active_substance": "ciprofloxacin;Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000772/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000772-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ofloxacin (topical use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002204/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "02/12/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergotamine",
            "active_substance": "dihydroergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001075/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "29/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "chlorprothixene",
            "active_substance": "chlorprothixene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000717/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "29/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000717-202403"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/202405",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202405"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bupivacaine, bupivacaine / epinephrine",
            "active_substance": "bupivacaine;bupivacaine / epinephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010335/202404",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010335-202404"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carteolol",
            "active_substance": "carteolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000574/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000574-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mesalazine",
            "active_substance": "Mesalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001990/202402",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "zofenopril",
            "active_substance": "zofenopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003147/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003147-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "terazosin",
            "active_substance": "terazosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002895/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002895-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amiodarone",
            "active_substance": "amiodarone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000166/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "21/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levonorgestrel / ethinylestradiol, ethinylestradiol (combination pack)",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "13/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "liothyronine",
            "active_substance": "liothyronine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001890/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001890-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "zoledronic acid",
            "active_substance": "zoledronic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003149/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003149-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "barnidipine",
            "active_substance": "barnidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000300/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000300-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (IV use)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000007/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nitrazepam",
            "active_substance": "nitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002170/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002170-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "highly refined fish oil, glycerol, purified egg phosphatide",
            "active_substance": "highly refined fish oil;glycerol;purified egg phosphatide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010802/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010802-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide",
            "active_substance": "calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009162/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009162-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "metamizole",
            "active_substance": "metamizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001997/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/11/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fluprednidene",
            "active_substance": "fluprednidene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010097/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010097-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "erythromycin (topical use)",
            "active_substance": "erythromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010809/202403",
            "regulatory_outcome": "",
            "first_published_date": "31/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010809-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fluprednidene / gentamicin",
            "active_substance": "fluprednidene;gentamicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010098/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010098-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "human anti-d immunoglobulin",
            "active_substance": "human anti-d immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001614/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001614-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fluorodopa (18F)",
            "active_substance": "fluorodopa (18F)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010002/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "31/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010002-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amantadine",
            "active_substance": "amantadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000126/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000126-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "valproic acid, sodium valproate, valproate pivoxil, valproate semisodium, valpromide, valproate bismuth, calcium valproate, valproate magnesium",
            "active_substance": "valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpromide;valproate bismuth;calcium valproate;valproate magnesium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003090/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "28/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide",
            "active_substance": "amitriptyline;amitriptylinoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010374/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "28/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010374-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "macrogol 3350 combinations (oral use)",
            "active_substance": "Macrogol 3350",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010705/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "25/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010705-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "amitriptyline / perphenazine",
            "active_substance": "amitriptyline;perphenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000170/202401",
            "regulatory_outcome": "Variation",
            "first_published_date": "25/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "allopurinol",
            "active_substance": "allopurinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000095/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "galantamine",
            "active_substance": "galantamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001512/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001512-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "protirelin",
            "active_substance": "protirelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009273/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009273-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Amlodipine\r\nLosartan",
            "active_substance": "amlodipine;losartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010512/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010512-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cilazapril, cilazapril / hydrochlorothiazide",
            "active_substance": "cilazapril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000749/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "human coagulation factor VIII (inhibitor bypassing fraction)",
            "active_substance": "human coagulation factor VIII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009174/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ferric carboxymaltose (parenteral use)",
            "active_substance": "ferric carboxymaltose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010865/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010865-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pentoxyverine",
            "active_substance": "pentoxyverine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002345/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002345-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rupatadine",
            "active_substance": "rupatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002673/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "iron dextran",
            "active_substance": "iron dextran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010696/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010696-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "iron sucrose (parenteral use)",
            "active_substance": "iron sucrose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010864/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010864-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "aprotinin",
            "active_substance": "aprotinin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000230/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ferric derisomaltose (parenteral use)",
            "active_substance": "ferric derisomaltose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010866/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "08/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010866-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dorzolamide / timolol",
            "active_substance": "dorzolamide;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001166/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001166-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sodium iron gluconate (parenteral use)",
            "active_substance": "sodium iron gluconate (parenteral preparations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010867/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010867-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "chlormadinone acetate / ethinylestradiol",
            "active_substance": "chlormadinone acetate;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000679/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000679-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sterculia, frangula / sterculia",
            "active_substance": "sterculia, frangula;sterculia",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010428/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010428-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "chlormadinone",
            "active_substance": "chlormadinone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000677/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000677-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ondansetron",
            "active_substance": "ondansetron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002217/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nomegestrol",
            "active_substance": "nomegestrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002181/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flubendazole",
            "active_substance": "flubendazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001400/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001400-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/202403",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202403"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ampicillin / sulbactam",
            "active_substance": "ampicillin;sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000197/202402",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "03/10/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-202402"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bendroflumethiazide, bendroflumethiazide / potassium chloride",
            "active_substance": "bendroflumethiazide;potassium chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010583/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/10/2024",
            "last_updated_date": "01/10/2024",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010583-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cefpodoxim",
            "active_substance": "cefpodoxim",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000604/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "25/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000604-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "meropenem",
            "active_substance": "Meropenem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001989/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-202108"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dexpanthenol",
            "active_substance": "dexpanthenol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000999/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000999-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cyproheptadine",
            "active_substance": "cyproheptadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000902/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "13/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levodropropizine",
            "active_substance": "levodropropizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001853/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001853-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "betahistine",
            "active_substance": "betahistine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000389/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000389-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dydrogesterone-estradiol",
            "active_substance": "dydrogesterone-estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA-00001276-202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001276-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "doxazosin",
            "active_substance": "doxazosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001169/232312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001169-232312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lormetazepam",
            "active_substance": "lormetazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001910/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pseudoephedrine / triprolidine",
            "active_substance": "pseudoephedrine;triprolidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003047/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ketotifen (oral formulations)",
            "active_substance": "ketotifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001813/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "azelastine",
            "active_substance": "azelastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000277/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "calcium carbonate / famotidine / magnesium hydroxide",
            "active_substance": "calcium carbonate;Famotidine;magnesium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001351/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001351-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ketoprofen / sucralfate",
            "active_substance": "ketoprofen;sucralfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002797/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "10/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002797-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydrochlorothiazide / spironolactone",
            "active_substance": "hydrochlorothiazide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001662/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "povidone iodinated",
            "active_substance": "povidone iodinated",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002487/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002487-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hepatitis A vaccines (inactivated, adsorbed)",
            "active_substance": "hepatitis A vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001596/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001596-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "caffeine / drotaverine hydrochloride / metamizole sodium",
            "active_substance": "Caffeine;drotaverine hydrochloride;metamizole sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001996/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001996-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "celecoxib",
            "active_substance": "celecoxib",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000616/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "altizide / spironolactone",
            "active_substance": "altizide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002781/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "balsalazide",
            "active_substance": "balsalazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009074/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009074-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "salicylic acid (topical use)",
            "active_substance": "salicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002680/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002680-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dapoxetine",
            "active_substance": "dapoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000928/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "alitretinoin (oral use)",
            "active_substance": "alitretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010710/202401",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202401"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Codeine/ibuprofen",
            "active_substance": "codeine;Ibuprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000850/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000850-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "atomoxetine",
            "active_substance": "atomoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000262/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "03/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000262-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "glatiramer",
            "active_substance": "glatiramer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001529/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "02/09/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methylprednisolone",
            "active_substance": "methylprednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002026/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydroxycarbamide (except for centrally authorised product)",
            "active_substance": "hydroxycarbamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009182/202312",
            "regulatory_outcome": "Variation",
            "first_published_date": "27/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydrochlorothiazide / nebivolol",
            "active_substance": "hydrochlorothiazide;nebivolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001658/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "23/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001658-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "atorvastatin",
            "active_substance": "atorvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010347/202310",
            "regulatory_outcome": "Variation",
            "first_published_date": "13/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010347-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Minoxidil (topical formulation)",
            "active_substance": "minoxidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002067/202310",
            "regulatory_outcome": "Variation",
            "first_published_date": "13/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "09/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nimodipine",
            "active_substance": "nimodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002166/202311",
            "regulatory_outcome": "Variation",
            "first_published_date": "07/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002166-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ceftazidime",
            "active_substance": "ceftazidime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000608/202310",
            "regulatory_outcome": "Variation",
            "first_published_date": "02/08/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000608-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lisinopril / torasemide",
            "active_substance": "lisinopril;torasemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010685/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010685-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)",
            "active_substance": "diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001124/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nabilone",
            "active_substance": "nabilone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002100/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002100-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Ethanol extracts of: Iberis amara L., planta tota recens / Angelica archangelica L., radix / Matricaria recutita L., flos / Carum carvi L., fructus / Silybum marianum (L.) Gaertn., fructus / Melissa officinalis L., folium / Mentha piperita L., folium / Chelidonium majus L., herba / Glycyrrhiza glabra L., radix",
            "active_substance": "iberis amara L., planta tota recens;angelica archangelica L., radix;matricaria recutita L., flos;carum carvi L., fructus;silybum marianum (L.) gaertn., fructus;melissa officinalis L., folium;mentha piperita L., folium;chelidonium majus L., herba;glycyrrhiza glabra L., radix",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010800/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010800-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levofloxacin (intravenous and oral use)",
            "active_substance": "levofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010767/202310",
            "regulatory_outcome": "Variation",
            "first_published_date": "16/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010767-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flupentixol / melitracene",
            "active_substance": "flupentixol;melitracene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001445/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001445-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tafluprost / timolol",
            "active_substance": "tafluprost;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010324/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010324-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flupentixol",
            "active_substance": "flupentixol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001444/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001444-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "sulfasalazine",
            "active_substance": "sulfasalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002816/202312",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002816-202312"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "baclofen (oral use, for muscle spasticity indication)",
            "active_substance": "baclofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000294/202309",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/202310",
            "regulatory_outcome": "Variation",
            "first_published_date": "12/07/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diclofenac (topical formulations)",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010342/202309",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/07/2024",
            "last_updated_date": "05/07/2024",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010342-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "adapalene / benzoyl peroxide",
            "active_substance": "adapalene;benzoyl peroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000059/202309",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/07/2024",
            "last_updated_date": "05/07/2024",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "tetrabenazine",
            "active_substance": "tetrabenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002911/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bromocriptine",
            "active_substance": "bromocriptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000438/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000438-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Etifoxine",
            "active_substance": "etifoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001321/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "18/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "methacholine",
            "active_substance": "methacholine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010891/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "18/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010891-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "citric acid / potassium salts, potassium citrate",
            "active_substance": "citric acid;potassium salts;potassium citrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000783/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "18/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000783-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "flutamide",
            "active_substance": "flutamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001453/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001453-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hydroxyzine, hydroxyzine combination",
            "active_substance": "hydroxyzine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001696/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ascorbic acid / chlorphenamine maleate / paracetamol",
            "active_substance": "ascorbic acid;chlorphenamine maleate;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000696/202311",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000696-202311"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ramipril",
            "active_substance": "ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002607/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002607-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lithium",
            "active_substance": "lithium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001897/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "11/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001897-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "naproxen",
            "active_substance": "naproxen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002125/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "11/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002125-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003043/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "vincristine",
            "active_substance": "vincristine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003121/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003121-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "naloxone / oxycodone",
            "active_substance": "naloxone;oxycodone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002114/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/06/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002114-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dexibuprofen",
            "active_substance": "dexibuprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000996/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "30/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000996-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "human von willebrand factor",
            "active_substance": "human von willebrand factor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001642/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "desflurane",
            "active_substance": "desflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000958/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "21/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000958-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levofloxacin (ocular use)",
            "active_substance": "levofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010768/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010768-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "prulifloxacin",
            "active_substance": "prulifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002569/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "acetylcysteine",
            "active_substance": "acetylcysteine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000034/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000034-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rubidium (82Rb) chloride",
            "active_substance": "rubidium (82Rb) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010806/202310",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202310"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "paracetamol/tramadol",
            "active_substance": "paracetamol;tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002310/202308",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002310-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "quetiapine",
            "active_substance": "quetiapine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002589/202307",
            "regulatory_outcome": "Variation",
            "first_published_date": "03/05/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002589-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mirtazapine",
            "active_substance": "mirtazapine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002068/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002068-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "inosine pranobex",
            "active_substance": "inosine pranobex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010425/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010425-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "human plasma protease C1 inhibitor (nationally authorised products)",
            "active_substance": "human plasma protease C1 inhibitor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010163/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rosuvastatin/ perindopril /indapamide",
            "active_substance": "rosuvastatin;perindopril;Indapamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010752/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "19/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010752-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dienogest / estradiol (contraception indication)",
            "active_substance": "Dienogest;estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010444/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010444-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ipratropium / xylometazoline",
            "active_substance": "ipratropium;xylometazoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009201/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "17/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009201-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "modafinil",
            "active_substance": "modafinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010242/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "zolpidem",
            "active_substance": "zolpidem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003151/202308",
            "regulatory_outcome": "",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003151-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bromazepam",
            "active_substance": "bromazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000435/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000435-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pefloxacin",
            "active_substance": "pefloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002322/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002322-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "phenytoin",
            "active_substance": "phenytoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002392/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002392-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "trazodone",
            "active_substance": "trazodone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003012/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003012-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "suxamethonium",
            "active_substance": "suxamethonium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002834/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002834-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/202309",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202309"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "prednisolone",
            "active_substance": "prednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002506/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002506-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "colchicine",
            "active_substance": "colchicine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000858/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000858-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levocetirizine",
            "active_substance": "levocetirizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001850/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001850-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "diclofenac / misoprostol",
            "active_substance": "diclofenac;misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001040/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "xylometazoline",
            "active_substance": "xylometazoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003134/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003134-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pimecrolimus",
            "active_substance": "pimecrolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002411/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "aztreonam (parenteral use)",
            "active_substance": "aztreonam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010178/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010178-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "paracetamol / pseudoephedrine",
            "active_substance": "paracetamol;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002307/202306",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002307-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/202307",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "rizatriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002655/202306",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002655-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ibutilide",
            "active_substance": "ibutilide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001713/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001713-202212"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "felodipine",
            "active_substance": "felodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001356/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001356-202212"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "rosuvastatin",
            "active_substance": "rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002664/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002664-202211"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003002/202306",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003002-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "oxycodone hydrochloride / paracetamol",
            "active_substance": "oxycodone hydrochloride;paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002256/202307",
            "regulatory_outcome": "Variation",
            "first_published_date": "03/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002256-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nimesulide (topical formulations)",
            "active_substance": "nimesulide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002165/202306",
            "regulatory_outcome": "Variation",
            "first_published_date": "02/04/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002165-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "Dienogest;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001057/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "26/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001057-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010378/202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "25/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010378-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fenofibrate",
            "active_substance": "fenofibrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001362/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001362-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cyproterone",
            "active_substance": "cyproterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000905/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000905-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lanreotide",
            "active_substance": "lanreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001826/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "estradiol, estradiol /prednisolone (only cream/balm/emulsion for application in the female genital area)",
            "active_substance": "estradiol;prednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010441/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "25/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010441-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "misoprostol (gynaecological indication - termination of pregnancy)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010354/202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "21/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mifepristone",
            "active_substance": "mifepristone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002060/202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "15/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002060-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "ezetimibe;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010271/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "14/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010271-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "cyproterone / ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000906/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000906-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "oxytocin (systemic use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010913/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010913-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Ribavirin (oral formulations)",
            "active_substance": "ribavirin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010007/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "08/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010007-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "indometacin",
            "active_substance": "indometacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001738/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "08/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001738-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "niclosamide",
            "active_substance": "niclosamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002151/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002151-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "donepezil / memantine",
            "active_substance": "donepezil;memantine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00011039/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00011039-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Anastrozole",
            "active_substance": "anastrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000210/202308",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202308"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadopentetic acid",
            "active_substance": "gadopentetic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001504/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "06/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadoteric acid (IV and intravascular formulations)",
            "active_substance": "gadoteric acid (IV and intravascular formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001506/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "04/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nalbuphine",
            "active_substance": "nalbuphine",
            "related_medicines": "",
            "procedure_number": "PSUSA-00002110-202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "01/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002110-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ceftriaxone",
            "active_substance": "ceftriaxone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000613/202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "01/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000613-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadobenic acid",
            "active_substance": "gadobenic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001500/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "01/03/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "moxifloxacin (systemic use)",
            "active_substance": "moxifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009231/202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009231-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Gadobutrol",
            "active_substance": "Gadobutrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001502/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadoxetic acid disodium",
            "active_substance": "gadoxetic acid disodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001509/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gadoteridol",
            "active_substance": "gadoteridol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001507/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "octreotide",
            "active_substance": "octreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002201/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002201-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "phentermine;topiramate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010956/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010956-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pseudoephedrine, acetylsalicylic acid / pseudoephedrine",
            "active_substance": "pseudoephedrine;acetylsalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010667/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010667-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "almotriptan",
            "active_substance": "almotriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000101/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000101-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Ferucarbotran",
            "active_substance": "Ferucarbotran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001382/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001382-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)",
            "active_substance": "hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001594/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001594-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol (gastrointestinal indication)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "allergen for therapy: betula verrucosa (sublingual use)",
            "active_substance": "allergen for therapy: betula verrucosa (sublingual use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010815/202307",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "09/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202307"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "epirubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001234/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "08/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001234-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "active_substance": "fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001370/202304",
            "regulatory_outcome": "",
            "first_published_date": "06/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "gentamicin (systemic use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009159/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "01/02/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009159-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "racecadotril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002602/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "30/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002602-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "aceclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000022/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "25/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000022-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "piroxicam",
            "active_substance": "piroxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002438/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002438-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "clarithromycin",
            "active_substance": "clarithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000788/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000788-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "venlafaxine",
            "active_substance": "venlafaxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003104/202305",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003104-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "pravastatin",
            "active_substance": "pravastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002500/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "24/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002500-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "mometasone",
            "active_substance": "mometasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002085/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "24/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002085-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "nortriptyline",
            "active_substance": "nortriptyline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002192/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "19/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002192-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Zuclopenthixol",
            "active_substance": "zuclopenthixol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003155/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "16/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003155-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "patent blue V sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002320/202304v",
            "regulatory_outcome": "",
            "first_published_date": "16/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002320-202304v"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "chlorpromazine",
            "active_substance": "chlorpromazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000715/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000715-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "15/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "norfloxacin",
            "active_substance": "norfloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002190/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002190-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ebastine",
            "active_substance": "ebastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001191/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "12/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001191-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "pelargonium sidoides dc and-or pelargonium reniforme curt-radix",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002329/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002329-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "aciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000048/202306",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-202306"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Thiamphenicol",
            "active_substance": "thiamphenicol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002925/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002925-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Irinotecan (except for liposomal formulations)",
            "active_substance": "irinotecan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001783/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001783-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "azithromycin (ocular use formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010492/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010492-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Azithromycin (systemic use formulations)",
            "active_substance": "azithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010491/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "11/01/2024",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010491-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "fluconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001404/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001404-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "doxylamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001174/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001174-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "piribedil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002436/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002436-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "lavender oil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010810/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "22/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010810-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "furosemide-spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001493/202303",
            "regulatory_outcome": "Variation",
            "first_published_date": "22/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001493-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002254/202304",
            "regulatory_outcome": "Variation",
            "first_published_date": "21/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus), ibuprofen / caffeine",
            "active_substance": "Ibuprofen;ibuprofen lysine;Caffeine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010649/202302",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/11/2023",
            "last_updated_date": "11/12/2023",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010649-202302"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ofloxacin (systemic use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002203/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "Dronabinol;cannabidiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010844/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010844-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "rifamyciun",
            "related_medicines": "",
            "procedure_number": "PSUSA-00002641-202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "07/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002641-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cytarabine",
            "active_substance": "cytarabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000911/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000911-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "porfimer",
            "active_substance": "porfimer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010332/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010332-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ivabradine / metoprolol",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "06/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Tretinoin (topical formulations)",
            "active_substance": "tretinoin;tetrabenazine (ADV6979)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003016/202208",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003016-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tapentadol",
            "active_substance": "tapentadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002849/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "ceftobiprole",
            "active_substance": "ceftobiprole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010734/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010734-202111"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "xylometazoline",
            "active_substance": "xylometazoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003134/202005",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003134-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acarbose",
            "active_substance": "acarbose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000017/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000017-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acarbose",
            "active_substance": "acarbose",
            "related_medicines": "",
            "procedure_number": "PSUSA/0000017/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0000017-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acebutolol",
            "active_substance": "acebutolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000018/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000018-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "aceclofenac",
            "active_substance": "aceclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000022/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000022-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "aceclofenac",
            "active_substance": "aceclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000022/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000022-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acenocoumarol",
            "active_substance": "acenocoumarol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000027/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000027-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acemetacin",
            "active_substance": "acemetacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000026/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000026-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetyl salicylic acid / atorvastatin / ramipril",
            "active_substance": "acetyl salicylic acid;atorvastatin;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010280/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010280-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetyl salicylic acid / atorvastatin / ramipril",
            "active_substance": "acetyl salicylic acid;atorvastatin;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010280/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010280-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylcysteine",
            "active_substance": "acetylcysteine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000034/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000034-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylcysteine",
            "active_substance": "acetylcysteine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000034/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000034-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylsalicylic acid / bisoprolol",
            "active_substance": "acetylsalicylic acid;bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010287/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylsalicylic acid / bisoprolol",
            "active_substance": "acetylsalicylic acid;bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010287/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylsalicylic acid / bisoprolol",
            "active_substance": "acetylsalicylic acid;bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010287/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylsalicylic acid / bisoprolol",
            "active_substance": "acetylsalicylic acid;bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010287/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010287-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acetylsalicylic acid",
            "active_substance": "acetylsalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000039/201902",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000039-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "(18f) fludeoxyglucose",
            "active_substance": "fludeoxyglucose (18F)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001437/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001437-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "1-propanol / 2-propanol / lactic acid",
            "active_substance": "1-propanol;2-propanol;lactic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010414/201909",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010414-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "acetylsalicylic acid",
            "active_substance": "acetylsalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000039/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000039-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aciclovir / hydrocortisone",
            "active_substance": "aciclovir;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009004/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009004-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aciclovir / hydrocortisone",
            "active_substance": "aciclovir;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009004/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009004-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aciclovir",
            "active_substance": "aciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA 00000048/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aciclovir",
            "active_substance": "aciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000048/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000048-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acipimox",
            "active_substance": "acipimox",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000050/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000050-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acipimox",
            "active_substance": "acipimox",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000050/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000050-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acipimox",
            "active_substance": "acipimox",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000050/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000050-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/201810",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/201510",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Adapalene / benzoyl peroxide",
            "active_substance": "adapalene;benzoyl peroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000059/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Adapalene / benzoyl peroxide",
            "active_substance": "adapalene;benzoyl peroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000059/201709",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Adapalene / benzoyl peroxide",
            "active_substance": "adapalene;benzoyl peroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000059/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000059-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Adapalene",
            "active_substance": "adapalene",
            "related_medicines": "",
            "procedure_number": "PSUSA/0058/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0058-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Adenosine",
            "active_substance": "adenosine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000062/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000062-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ajmaline",
            "active_substance": "ajmaline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000072/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000072-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / sodium chloride / sodium glycerophosphate hydrated / soya bean oil / taurine / threonine / tryptophan / tyrosine / valine / potassium acetate / calcium chloride dihydrate / magnesium acetate tetrahydrate / olive oil",
            "active_substance": "alanine;arginine;aspartic acid;cysteine;glucose anhydrous;glutamic acid;glycine;histidine;isoleucine;leucine;lysine;methionine;ornithine;phenylalanine;proline;serine;sodium chloride;sodium glycerophosphate hydrated;soya bean oil;taurine;threonine;tryptophan;tyrosine;valine;potassium acetate;calcium chloride dihydrate;magnesium acetate tetrahydrate;olive oil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010190/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / sodium chloride / sodium glycerophosphate hydrated / soya bean oil / taurine / threonine / tryptophan / tyrosine / valine / potassium acetate / calcium chloride dihydrate / magnesium acetate tetrahydrate / olive oil",
            "active_substance": "alanine;arginine;aspartic acid;cysteine;glucose anhydrous;glutamic acid;glycine;histidine;isoleucine;leucine;lysine;methionine;ornithine;phenylalanine;proline;serine;sodium chloride;sodium glycerophosphate hydrated;soya bean oil;taurine;threonine;tryptophan;tyrosine;valine;potassium acetate;calcium chloride dihydrate;magnesium acetate tetrahydrate;olive oil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010190/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Albendazole",
            "active_substance": "albendazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000073/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000073-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aldesleukin",
            "active_substance": "aldesleukin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000076/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000076-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alendronate / alfacalcidol",
            "active_substance": "alendronate;alfacalcidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010308/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010308-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alendronate",
            "active_substance": "alendronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000078/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000078-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alendronate",
            "active_substance": "alendronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000078/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000078-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alfacalcidol",
            "active_substance": "alfacalcidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000080/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000080-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "1-propanol / 2-propanol / orthophenylphenol",
            "active_substance": "1-propanol;2-propanol;orthophenylphenol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010406/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010406-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "13C-methacetin",
            "active_substance": "methacetin (13C)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010846/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010846-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "13C-methacetin",
            "active_substance": "methacetin (13C)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010846/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010846-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (i.v. application)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000007/202012",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (i.v. application)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000007/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (i.v. application)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000007/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000007-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (topical application)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010000/201901",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 Fluorouracil (topical application)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010000/201412",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (topical application)",
            "active_substance": "5 fluorouracil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010000/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil / salicylic acid",
            "active_substance": "5 fluorouracil;salicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000008/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000008-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil / salicylic acid",
            "active_substance": "5 fluorouracil;salicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000008/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000008-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil / salicylic acid",
            "active_substance": "5 fluorouracil;salicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000008/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000008-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "allopurinol",
            "active_substance": "allopurinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000095/201612",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "allopurinol",
            "active_substance": "allopurinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000095/202012",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "allopurinol",
            "active_substance": "allopurinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000095/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "allopurinol",
            "active_substance": "allopurinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000095/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000095-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "almagate",
            "active_substance": "almagate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000097/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000097-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "almotriptan",
            "active_substance": "almotriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000101/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000101-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "almotriptan",
            "active_substance": "almotriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000101/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000101-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alpha-1-antitrypsin",
            "active_substance": "alpha-1-antitrypsin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000108/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alprazolam",
            "active_substance": "alprazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000109/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alprazolam",
            "active_substance": "alprazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000109/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (erectile dysfunction)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000110/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000110-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (erectile dysfunction)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000110/201601",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000110-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (indicated in peripheral arterial occlusive diseases)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000111/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000111-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (patency of the ductus arteriosus)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010021/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010021-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (patency of the ductus arteriosus)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010021/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010021-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (patency of the ductus arteriosus)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010021/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010021-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alteplase",
            "active_substance": "alteplase",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000112/201705",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000112-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "altizide / spironolactone",
            "active_substance": "altizide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002781/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "altizide / spironolactone",
            "active_substance": "altizide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002781/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "altizide / spironolactone",
            "active_substance": "altizide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002781/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002781-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amantadine",
            "active_substance": "amantadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000126/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000126-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010693/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambroxol / clenbuterol",
            "active_substance": "ambroxol;clenbuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000131/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000131-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambroxol / clenbuterol",
            "active_substance": "ambroxol;clenbuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000131/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000131-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambroxol",
            "active_substance": "ambroxol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000130/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000130-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambroxol",
            "active_substance": "ambroxol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000130/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000130-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amfepramone",
            "active_substance": "amfepramone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000138/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000138-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amikacin",
            "active_substance": "amikacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000143/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000143-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amino acid combinations (only combinations of pure amino acids or combination of amino acids with mineral compounds/electrolytes, i.v. application)",
            "active_substance": "amino acid combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010187/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010187-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta",
            "active_substance": "amino acid combinations;glucose;triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010190/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta",
            "active_substance": "amino acid combinations;glucose;triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010190/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amino acid combinations / glucose / triglyceride combinations / with or without electrolytes / mineral compounds - only for the drug Numeta",
            "active_substance": "amino acid combinations;glucose;triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010190/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010190-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amino acid combinations / glucose / triglyceride combinations",
            "active_substance": "amino acid combinations;glucose;triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010565/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010565-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amino acid combinations/ glucose/ with or without electrolytes / mineral compounds",
            "active_substance": "amino acid combinations;glucose;triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010566/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010566-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "aminosalicylate sodium",
            "active_substance": "aminosalicylate sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000165/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000165-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "aminosalicylate sodium",
            "active_substance": "aminosalicylate sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000165/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000165-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amiodarone",
            "active_substance": "amiodarone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000166/202012",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amiodarone",
            "active_substance": "amiodarone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000166/201412",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amiodarone",
            "active_substance": "amiodarone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000166/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000166-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amisulpride",
            "active_substance": "amisulpride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000167/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amisulpride",
            "active_substance": "amisulpride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000167/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amisulpride",
            "active_substance": "amisulpride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000167/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amisulpride",
            "active_substance": "amitriptyline;perphenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000170/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amisulpride",
            "active_substance": "amitriptyline;perphenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000170/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline hydrochloride / chlordiazepoxide",
            "active_substance": "amitriptyline hydrochloride;chlordiazepoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000171/201602",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline hydrochloride / chlordiazepoxide",
            "active_substance": "amitriptyline hydrochloride;chlordiazepoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000171/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline hydrochloride / chlordiazepoxide",
            "active_substance": "amitriptyline hydrochloride;chlordiazepoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000171/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline hydrochloride / chlordiazepoxide",
            "active_substance": "amitriptyline hydrochloride;chlordiazepoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000171/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline hydrochloride / chlordiazepoxide",
            "active_substance": "amitriptyline hydrochloride;chlordiazepoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000171/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline hydrochloride / chlordiazepoxide",
            "active_substance": "amitriptyline hydrochloride;chlordiazepoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000171/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000171-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide",
            "active_substance": "amitriptyline;amitriptylinoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010374/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010374-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide",
            "active_substance": "amitriptyline;amitriptylinoxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010374/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010374-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline / perphenazine",
            "active_substance": "amitriptyline;perphenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000170/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000170-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amitriptyline",
            "active_substance": "amitriptyline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000168/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000168-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "AmitriptylineAmlodipine / atorvastatin / perindopril",
            "active_substance": "amlodipine;atorvastatin;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010431/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010431-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alfentanil",
            "active_substance": "alfentanil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000082/202109",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alfentanil",
            "active_substance": "alfentanil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000082/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alfentanil",
            "active_substance": "alfentanil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000082/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alfuzosin",
            "active_substance": "alfuzosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000084/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000084-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alitretinoin (oral use)",
            "active_substance": "alitretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010710/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alitretinoin (oral use)",
            "active_substance": "alitretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010710/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alitretinoin (oral use)",
            "active_substance": "alitretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010710/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alizapride",
            "active_substance": "alizapride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000091/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000091-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "alizapride",
            "active_substance": "alizapride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000082/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000082-201509-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for diagnostic - skin prick test containing only Phleum Pratense (product authorised via mutually recognition procedure)",
            "active_substance": "Phleum pratense",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010466/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010466-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010693/201904",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Ambrosia Artemisiifolia (302) (sublingual use, products authorised via decentralised procedure)",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010693/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010693-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: betula verrucosa (sublingual tablet)",
            "active_substance": "Betula verrucosa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010815/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: betula verrucosa (sublingual tablet)",
            "active_substance": "Betula verrucosa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010815/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)",
            "active_substance": "Dactylis glomerata L.;Phleum pratense L.;Anthoxanthum odoratum L.;Poa pratensis L.;Lolium perenne L.",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010465/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010465-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis",
            "active_substance": "Dactylis glomerata L.;Phleum pratense L.;Anthoxanthum odoratum L.;Poa pratensis L.;Lolium perenne L.",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010465/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010465-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Dermatophagoides pteronyssinus / Dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)",
            "active_substance": "Dermatophagoides pteronyssinus;Dermatophagoides farina",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010582/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Dermatophagoides pteronyssinus / Dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)",
            "active_substance": "Dermatophagoides pteronyssinus;Dermatophagoides farina",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010582/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Dermatophagoides pteronyssinus / Dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)",
            "active_substance": "Dermatophagoides pteronyssinus;Dermatophagoides farina",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010582/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Phleum Pratense (oromucosal use, product authorised via mutually recognition procedure)",
            "active_substance": "Phleum pratense L.",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010475/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010475-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Phleum Pratense (oromucosal use, product authorised via mutually recognition procedure)",
            "active_substance": "Phleum pratense L.",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010475/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010475-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / atorvastatine",
            "active_substance": "amlodipine;atorvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000177/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000177-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / indapamide, amlodipine / indapamide / perindopril",
            "active_substance": "amlodipine;Indapamide;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010358/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010358-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / losartan",
            "active_substance": "amlodipine;losartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010512/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010512-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / perindopril",
            "active_substance": "amlodipine;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000179/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000179-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / perindopril",
            "active_substance": "amlodipine;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000179/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000179-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / rosuvastatin, perindopril / amlodipine / rosuvastatin",
            "active_substance": "amlodipine;perindopril;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010434/202107",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010434-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / rosuvastatin",
            "active_substance": "amlodipine;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010434/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010434-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine besilate / ramipril, amlodipine / hydrochlorothiazide / ramipril, hydrochlorothiazide / ramipril",
            "active_substance": "amlodipine besilate;amlodipine;hydrochlorothiazide;hydrochlorothiazide;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010774/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010774-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine besilate / ramipril",
            "active_substance": "amlodipine besilate;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000181/201503",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000181-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine besilate / ramipril",
            "active_substance": "amlodipine besilate;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000181/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000181-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine besilate / hydrochlorothiazide / olmesartan medoxomil",
            "active_substance": "amlodipine besilate;hydrochlorothiazide;olmesartan medoxomil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002210/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002210-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine lisinopril",
            "active_substance": "amlodipine;lisinopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010192/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010192-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / candesartan",
            "active_substance": "amlodipine;Candesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010191/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010191-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / olmesartan",
            "active_substance": "amlodipine;olmesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002208/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002208-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine",
            "active_substance": "amlodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000174/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000174-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine",
            "active_substance": "amlodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000174/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000174-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amorolfine",
            "active_substance": "amorolfine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000185/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000185-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amoxicillin / clavulanate",
            "active_substance": "amoxicillin;clavulanate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000188/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000188-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amoxicillin",
            "active_substance": "amoxicillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000187/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000187-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ampicillin / sulbactam",
            "active_substance": "ampicillin;sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000197/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ampicillin / sulbactam",
            "active_substance": "ampicillin;sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000197/201502",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ampicillin / sulbactam",
            "active_substance": "ampicillin;sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000197/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000197-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amsacrine",
            "active_substance": "amsacrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000199/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000199-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Anastrozole",
            "active_substance": "anastrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000210/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Androstanolone",
            "active_substance": "androstanolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000212/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000212-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aniracetam",
            "active_substance": "aniracetam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010790/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010790-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Anthrax vaccine",
            "active_substance": "anthrax vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010771/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010771-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Anthrax vaccine",
            "active_substance": "anthrax vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010771/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010771-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Anti-T lymphocyte immunoglobulin for human use, horse",
            "active_substance": "anti-T lymphocyte immunoglobulin for human use, horse",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010433/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010433-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Antithrombin iii",
            "active_substance": "antithrombin iii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003159/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Antithrombin iii",
            "active_substance": "antithrombin iii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003159/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Antithrombin iii",
            "active_substance": "antithrombin iii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003159/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Antithrombin iii",
            "active_substance": "antithrombin iii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003159/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003159-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Apomorphine",
            "active_substance": "apomorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000227/201505",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Apomorphine",
            "active_substance": "apomorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000227/201511",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Apomorphine",
            "active_substance": "apomorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000227/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Apomorphine",
            "active_substance": "apomorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000227/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aprotinin / calcium chloride / human factor XIII / ...",
            "active_substance": "aprotinin;calcium chloride;human factor XIII;human fibrinogen;human thrombin, aprotinin;fibrinogen;fibronectin;human coagulation factor XIII;plasma protein fraction;plasminogen;thrombin, aprotinin;human fibrinogen;thrombin;calcium chloride, aprotinin;calcium chloride;factor XIII;human thrombin;human clottable protein containing mainly fibrinogen and fibronectin, calcium chloride;human fibrinogen;bovine aprotinin, calcium chloride;bovine aprotinin, human fibrinogen;calcium chloride dihydrate;plasma fibronectin;bovine aprotinin;human coagulation factor XIII, human fibrinogen;calcium chloride dihydrate;plasma protein fraction;fibronectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010346/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010346-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aprotinin",
            "active_substance": "aprotinin",
            "related_medicines": "",
            "procedure_number": "PSUSA-00000230-201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aprotinin",
            "active_substance": "aprotinin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000230/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Argatroban",
            "active_substance": "argatroban",
            "related_medicines": "",
            "procedure_number": "PSUSA/ 00009057/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009057-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Argatroban",
            "active_substance": "argatroban",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009057/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009057-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Argatroban",
            "active_substance": "argatroban",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009057/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009057-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Argipressin",
            "active_substance": "argipressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010749/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010749-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Artemether / lumefantrin (apart from the dispersible tablet)",
            "active_substance": "artemether;lumefantrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000236/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000236-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Artemether / lumefantrin (dispersible tablet)",
            "active_substance": "artemether;lumefantrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009060/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009060-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Artemether / lumefantrin (dispersible tablet)",
            "active_substance": "artemether;lumefantrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/0009060/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0009060-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Artemether-lumefantrin (apart from the dispersible tablet)",
            "active_substance": "artemether;lumefantrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000236/201910",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000236-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ascorbic acid / paracetamol / pheniramine maleate",
            "active_substance": "ascorbic acid;paracetamol;pheniramine maleate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002368/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002368-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ascorbic acid / paracetamol / phenylephrine hydrochloride",
            "active_substance": "ascorbic acid;paracetamol;phenylephrine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000255/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000255-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Asparaginase, crisantaspase (nationally authorised products)",
            "active_substance": "asparaginase;crisantaspase",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003161/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003161-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Asparaginase, crisantaspase, pegaspargase (nationally authorised products)",
            "active_substance": "asparaginase;crisantaspase;pegaspargase",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003161/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003161-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Asparaginase",
            "active_substance": "asparaginase",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003161/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003161-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atenolol / chlortalidone",
            "active_substance": "atenolol;chlortalidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000260/201409",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000260-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atenolol / chlortalidone",
            "active_substance": "atenolol;chlortalidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000260/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000260-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atomoxetine",
            "active_substance": "atomoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000262/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000262-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atomoxetine",
            "active_substance": "atomoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000262/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000262-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atorvastatin / perindopril",
            "active_substance": "atorvastatin;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010679/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010679-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atorvastatin / ezetimibe",
            "active_substance": "atorvastatin;ezetimibe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010385/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010385-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atorvastatin",
            "active_substance": "atorvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010347/201710",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010347-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atovaquone / proguanil",
            "active_substance": "atovaquone;proguanil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000266/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000266-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atovaquone",
            "active_substance": "atovaquone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000265/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000265-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azathioprine",
            "active_substance": "azathioprine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000275/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000275-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azelastin",
            "active_substance": "azelastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000277/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azelastin",
            "active_substance": "azelastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000277/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azelastine / fluticasone",
            "active_substance": "azelastine;fluticasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010067/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azelastine / fluticasone",
            "active_substance": "azelastine;fluticasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010067/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azelastine / fluticasone",
            "active_substance": "azelastine;fluticasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010067/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010067-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azelastine",
            "active_substance": "azelastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000277/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000277-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azithromycin (ocular use formulations)",
            "active_substance": "azithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010492/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010492-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azithromycin (systemic use formulations)",
            "active_substance": "azithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010491/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010491-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azithromycin",
            "active_substance": "azithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010491/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010491-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Azithromycin",
            "active_substance": "azithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010492/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010492-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aztreonam",
            "active_substance": "aztreonam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010178/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010178-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bacillus clausii multi-antibioresistant spores",
            "active_substance": "bacillus clausii multi-antibioresistant spores",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000284/201611",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000284-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bacillus clausii multi-antibioresistant spores",
            "active_substance": "bacillus clausii multi-antibioresistant spores",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000284/201911",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000284-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Baclofen (intrathecal)",
            "active_substance": "baclofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000293/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000293-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Baclofen (oral)",
            "active_substance": "baclofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000294/202009",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Baclofen (oral)",
            "active_substance": "baclofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000294/201609",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Baclofen (oral)",
            "active_substance": "baclofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000294/201809",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000294-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Baclofen",
            "active_substance": "baclofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000293/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000293-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus mitis / streptococcus pneumoniae / streptococcus pyogenes, bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus pneumoniae / streptococcus pyogenes, streptococcus pneumoniae / streptococcus aga",
            "active_substance": "bacterial lysate of haemophilus influenzae;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus mitis;streptococcus pneumoniae;streptococcus pyogenes;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus aga",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002786/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002786-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus mitis / streptococcus pneumoniae / streptococcus pyogenes, bacterial lysate of haemophilus influenzae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus pneumoniae / streptococcus pyogenes",
            "active_substance": "bacterial lysate of haemophilus influenzae;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus mitis;streptococcus pneumoniae;streptococcus pyogenes;klebsiella pneumoniae;moraxella catarrhalis;staphylococcus aureus;streptococcus pneumoniae;streptococcus aga",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002786/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002786-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bambuterol",
            "active_substance": "bambuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000295/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000295-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "BCG (bacillus calmette-guérin) for immunotherapy",
            "active_substance": "bacillus calmette-guérin (BCG)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000303/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000303-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "BCG vaccine (freeze-dried)",
            "active_substance": "bacillus calmette-guérin (BCG)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000304/201803",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000304-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beclometasone / formoterol (inhalative application)",
            "active_substance": "beclometasone;formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010068/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beclometasone / formoterol (inhalative application)",
            "active_substance": "beclometasone;formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010068/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beclometasone / salbutamol",
            "active_substance": "beclometasone;salbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000309/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000309-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beclometasone",
            "active_substance": "beclometasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000306/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000306-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bemetizide / triamterene",
            "active_substance": "beclometasone;triamterene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009076/201506",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009076-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bemiparin",
            "active_substance": "bemiparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000312/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000312-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bemiparin",
            "active_substance": "bemiparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000312/201904",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000312-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benazepril / hydrochlorothiazide",
            "active_substance": "benazepril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000314/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000314-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benazepril / hydrochlorothiazide",
            "active_substance": "hydrochlorothiazide;benazepril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000314/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000314-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bendamustine hydrochloride",
            "active_substance": "bendamustine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003162/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benazepril",
            "active_substance": "benazepril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000313/202011",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000313-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benazepril",
            "active_substance": "benazepril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000313/201511",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000313-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bendamustine hydrochloride",
            "active_substance": "bendamustine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003162/201601",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bendamustine hydrochloride",
            "active_substance": "bendamustine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003162/201701",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bendamustine hydrochloride",
            "active_substance": "bendamustine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003162/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bendroflumethiazide, bendroflumethiazide/potassium chloride",
            "active_substance": "bendroflumethiazide;potassium chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA-00010583-201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010583-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzydamine",
            "active_substance": "benzydamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000375/201510",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benserazide / levodopa",
            "active_substance": "benserazide;levodopa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000330/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000330-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzalkonium chloride / chlorhexidine digluconate",
            "active_substance": "benzalkonium chloride;chlorhexidine digluconate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010070/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010070-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzalkonium chloride / chlorhexidine digluconate",
            "active_substance": "benzalkonium chloride;chlorhexidine digluconate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010070/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010070-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzydamine / cetylpyridine",
            "active_substance": "benzydamine;cetylpyridine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000378/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000378-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzydamine",
            "active_substance": "benzydamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000375/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzydamine",
            "active_substance": "benzydamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000375/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000375-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzyl nicotinate / camphor / dimethyl sulfoxide / nonivamide / turpentine oil",
            "active_substance": "benzyl nicotinate;camphor;Dimethyl sulfoxide;nonivamide;turpentine oil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010584/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010584-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benzylpenicillin",
            "active_substance": "benzylpenicillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000383/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000383-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beractant",
            "active_substance": "beractant",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000384/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000384-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beractant",
            "active_substance": "beractant",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000384/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000384-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beta-alanine",
            "active_substance": "beta-alanine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010510/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010510-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beta-alanine",
            "active_substance": "beta-alanine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010510/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010510-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betahistine",
            "active_substance": "betahistine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000389/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000389-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betahistine",
            "active_substance": "betahistine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000389/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000389-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betahistine",
            "active_substance": "betahistine",
            "related_medicines": "",
            "procedure_number": "PSUSA/0000389/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0000389-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betamethasone / tetryzoline",
            "active_substance": "betamethasone;tetryzoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010072/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010072-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betamethasone / tetryzoline",
            "active_substance": "betamethasone;tetryzoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010072/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010072-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betamethasone",
            "active_substance": "betamethasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000391/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000391-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betamethasone dipropionate clotrimazole",
            "active_substance": "betamethasone dipropionate clotrimazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000394/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000394-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betamethasone valerate / clioquinol",
            "active_substance": "betamethasone valerate;clioquinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000398/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000398-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betamethasone valerate / fusidic acid",
            "active_substance": "betamethasone valerate;fusidic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000399/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000399-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betaxolol",
            "active_substance": "betaxolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000401/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000401-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bethanechol",
            "active_substance": "bethanechol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000402/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000402-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betula verrucosa",
            "active_substance": "Betula verrucosa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010815/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bezafibrate",
            "active_substance": "bezafibrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000405/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000405-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bicalutamide",
            "active_substance": "bicalutamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000407/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000407-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bilastine",
            "active_substance": "bilastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003163/201603",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003163-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bilastine",
            "active_substance": "bilastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003163/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003163-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Biotin",
            "active_substance": "biotin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000414/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000414-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Biperiden",
            "active_substance": "biperiden",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000415/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Biperiden",
            "active_substance": "biperiden",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000415/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bismuth subcitrate potassium / metronidazole / tetracycline",
            "active_substance": "bismuth subcitrate potassium;Metronidazole;tetracycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010199/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bismuth subcitrate potassium / metronidazole / tetracycline",
            "active_substance": "bismuth subcitrate potassium;Metronidazole;tetracycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010199/201505",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bismuth subcitrate potassium / metronidazole / tetracycline",
            "active_substance": "bismuth subcitrate potassium;Metronidazole;tetracycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010199/201705",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bismuth subcitrate potassium / metronidazole / tetracycline",
            "active_substance": "bismuth subcitrate potassium;Metronidazole;tetracycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010199/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bismuth subcitrate potassium / metronidazole / tetracycline",
            "active_substance": "bismuth subcitrate potassium;Metronidazole;tetracycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010199/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010199-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bisoprolol",
            "active_substance": "bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000419/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000419-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bisoprolol / hydrochlorothiazide",
            "active_substance": "bisoprolol;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000420/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bisoprolol / hydrochlorothiazide",
            "active_substance": "bisoprolol;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000420/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bisoprolol / hydrochlorothiazide",
            "active_substance": "bisoprolol;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000420/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000420-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bisoprolol / perindopril",
            "active_substance": "bisoprolol;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010462/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010462-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bisoprolol",
            "active_substance": "bisoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000419/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000419-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bivalrudin",
            "active_substance": "bivalrudin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000421/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000421-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "active_substance": "botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009084/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "active_substance": "botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009084/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum toxin a - haemagglutinin complex",
            "active_substance": "botulinum toxin a - haemagglutinin complex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000427/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum toxin a - haemagglutinin complex",
            "active_substance": "botulinum toxin a - haemagglutinin complex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000427/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum toxin a",
            "active_substance": "botulinum toxin a",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000426/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000426-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bovine lung phospholipid",
            "active_substance": "bovine lung phospholipid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010791/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010791-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brimonidine (except for the centrally authorised product)",
            "active_substance": "brimonidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000430/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000430-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brimonidine (except for the centrally authorised product)",
            "active_substance": "brimonidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000430/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000430-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brimonidine / timolol",
            "active_substance": "brimonidine;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000431/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000431-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brimonidine / timolol",
            "active_substance": "brimonidine;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000431/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000431-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brivudine",
            "active_substance": "brivudine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000434/201907",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000434-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromazepam",
            "active_substance": "bromazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000435/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000435-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromazepam",
            "active_substance": "bromazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000435/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000435-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromhexine",
            "active_substance": "bromhexine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000437/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000437-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromocriptine",
            "active_substance": "bromocriptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000438/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000438-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromocriptine",
            "active_substance": "bromocriptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000438/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000438-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromperidol",
            "active_substance": "bromperidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000439/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000439-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brotizolam",
            "active_substance": "brotizolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000444/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000444-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brotizolam",
            "active_substance": "brotizolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000444/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000444-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Budesonide / formoterol (apart from centrally authorised products)",
            "active_substance": "Budesonide;formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000450/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000450-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Budesonide / salmeterol",
            "active_substance": "Budesonide;salmeterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010511/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010511-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Budesonide",
            "active_substance": "Budesonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000449/201604",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000449-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Budesonide",
            "active_substance": "Budesonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000449/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000449-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Buprenorphine",
            "active_substance": "buprenorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000459/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000459-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bupropion",
            "active_substance": "bupropion",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000461/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bupropion",
            "active_substance": "bupropion",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000461/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Buserelin",
            "active_substance": "buserelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000462/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000462-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Buserelin",
            "active_substance": "buserelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000462/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000462-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Buspirone",
            "active_substance": "buspirone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000463/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000463-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Busulfan",
            "active_substance": "busulfan",
            "related_medicines": "",
            "procedure_number": "PSUSA/0464/201907",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0464-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Butoconazole",
            "active_substance": "butoconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000471/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000471-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Butoconazole",
            "active_substance": "butoconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000471/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000471-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cabergoline",
            "active_substance": "cabergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000477/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cabergoline",
            "active_substance": "cabergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000477/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cabergoline",
            "active_substance": "cabergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000477/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine (apnea)",
            "active_substance": "Caffeine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000482/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000482-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine / drotaverine hydrochloride / metamizol sodium",
            "active_substance": "Caffeine;drotaverine hydrochloride;metamizol sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001996/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001996-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine / drotaverine hydrochloride / metamizol sodium",
            "active_substance": "Caffeine;drotaverine hydrochloride;metamizol sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001996/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001996-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine / ergotamine",
            "active_substance": "Caffeine;ergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000485/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine / ergotamine",
            "active_substance": "Caffeine;ergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000485/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine / ergotamine",
            "active_substance": "Caffeine;ergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000485/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcifediol",
            "active_substance": "calcifediol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000491/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000491-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitonin salmon, synthetic analogue of eel calcitonin",
            "active_substance": "calcitonin salmon;synthetic analogue of eel calcitonin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000494/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000494-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitonin salmon, synthetic analogue of eel calcitonin",
            "active_substance": "calcitonin salmon;synthetic analogue of eel calcitonin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000494/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000494-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitonin salmon, synthetic analogue of eel calcitonin",
            "active_substance": "calcitonin salmon;synthetic analogue of eel calcitonin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000494/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000494-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitriol",
            "active_substance": "calcitriol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000495/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000495-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitriol",
            "active_substance": "calcitriol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000495/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000495-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitriol",
            "active_substance": "calcitriol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000495/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000495-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitriol",
            "active_substance": "calcium carbonate;Famotidine;magnesium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001351/201409",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001351-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcitriol",
            "active_substance": "calcium carbonate;Famotidine;magnesium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001351/201709",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001351-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide",
            "active_substance": "calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/0009162202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0009162202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide",
            "active_substance": "calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009162/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009162-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcium chloride / glutamic acid / glutathione / histidine / lactobionic acid / magnesium chloride / mannitol / potassium chloride / sodium hydroxide",
            "active_substance": "calcium chloride;glutamic acid;Glutathione;histidine;lactobionic acid;magnesium chloride;mannitol;potassium chloride;sodium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009162/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009162-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcium salts / colecalciferol",
            "active_substance": "colecalciferol;calcium salts",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010386/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010386-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcium salts / colecalciferol",
            "active_substance": "colecalciferol;calcium salts",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010386/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010386-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Camellia sinensis, Leaf, Dry extract refined (derived from Camellia sinensis, L. O.KUNTZE) (topical use)",
            "active_substance": "camellia sinensis",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010569/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010569-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Candesartan, candesartan / hydrochlorothiazide",
            "active_substance": "hydrochlorothiazide;Candesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000527/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000527-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Captopril / hydrochlorothiazide",
            "active_substance": "captopril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000536/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000536-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carbomers",
            "active_substance": "carbomers",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000557/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000557-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Captopril / hydrochlorothiazide",
            "active_substance": "captopril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000536/201604",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000536-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Captopril",
            "active_substance": "captopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000535/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000535-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Captopril",
            "active_substance": "captopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000535/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000535-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carboplatin",
            "active_substance": "carboplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000559/201601",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000559-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbamazepine",
            "active_substance": "carbamazepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000539/202012",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000539-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbetocin",
            "active_substance": "carbetocin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000546/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000546-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbidopa / levodopa",
            "active_substance": "carbidopa;levodopa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000548/201910",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000548-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carboplatin",
            "active_substance": "carboplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000559/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000559-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbidopa / levodopa (except for centrally authorised product)",
            "active_substance": "carbidopa;levodopa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000548/201610",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000548-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carboprost",
            "active_substance": "carboprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000560/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000560-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carboprost",
            "active_substance": "carboprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000560/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000560-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carmustine",
            "active_substance": "carmustine (implant)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010348/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carmustine",
            "active_substance": "carmustine (implant)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010348/201809",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carmustine",
            "active_substance": "carmustine (implant)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010348/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010348-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carmustine (powder and solvent for solution for infusion)",
            "active_substance": "carmustine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010349/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010349-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "carmustine (powder and solvent for solution for infusion)",
            "active_substance": "carmustine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010349/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010349-202104"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Carrageenin / titanium dioxide / zinc oxide, carrageenin / lidocaine / titanium dioxide / zinc oxide, titanium dioxide / zinc oxide / tetracaine hydrochloride",
            "active_substance": "carrageenin;titanium dioxide;lidocaine;zinc oxide;tetracaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001869/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001869-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dacarbazine",
            "active_substance": "dacarbazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000919/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000919-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dalteparin sodium",
            "active_substance": "dalteparin sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000922/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000922-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dalteparin sodium",
            "active_substance": "dalteparin sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000922/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000922-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Danaparoid",
            "active_substance": "danaparoid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000923/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000923-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dapoxetine",
            "active_substance": "dapoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000928/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dapoxetine",
            "active_substance": "dapoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000928/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dapoxetine",
            "active_substance": "dapoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000928/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000928-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Daunorubicin",
            "active_substance": "daunorubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000936/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000936-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Daunorubicin",
            "active_substance": "daunorubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000936/201506",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000936-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Daunorubicin",
            "active_substance": "daunorubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/0000936/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0000936-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Delapril / manidipine, delapril / indapamide",
            "active_substance": "delapril;manidipine;Indapamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010496/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010496-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Delapril",
            "active_substance": "delapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000946/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000946-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Demeclocycline / triamcinolone",
            "active_substance": "triamcinolone;demeclocycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010415/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010415-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Deoxycholic acid",
            "active_substance": "Deoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010525/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Deoxycholic acid",
            "active_substance": "Deoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010525/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Deoxycholic acid",
            "active_substance": "Deoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010525/201710",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Deoxycholic acid",
            "active_substance": "Deoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010525/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Deoxycholic acid",
            "active_substance": "Deoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010525/202004",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010525-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carvedilol / ivabradine",
            "active_substance": "carvedilol;ivabradine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010586/201904",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010586-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carteolol",
            "active_substance": "carteolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000574/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000574-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carvedilol / ivabradine",
            "active_substance": "carvedilol;ivabradine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010586/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010586-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carvedilol",
            "active_substance": "carvedilol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000575/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000575-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ce (conjugated estrogens) / mpa (medroxyprogesterone acetate)",
            "active_substance": "conjugated estrogens;medroxyprogesterone acetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000582/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000582-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefadroxil",
            "active_substance": "cefadroxil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000584/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000584-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefazolin",
            "active_substance": "cefazolin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000589/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000589-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefazolin",
            "active_substance": "cefazolin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000589/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000589-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefepime",
            "active_substance": "cefepime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000593/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000593-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefepime",
            "active_substance": "cefepime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000593/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000593-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefepime",
            "active_substance": "cefepime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000593/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000593-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefodizime",
            "active_substance": "cefodizime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000595/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000595-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefoperazone",
            "active_substance": "cefoperazone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000597/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000597-202101"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "cefoperazone / sulbactam",
            "active_substance": "cefoperazone;sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000598/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000598-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "cefoperazone / sulbactam",
            "active_substance": "cefoperazone;sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000598/201601",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000598-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefoperazone",
            "active_substance": "cefoperazone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000597/201601",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000597-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefotaxime",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000599/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000599-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefotaxime",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000599/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000599-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefprozil",
            "active_substance": "cefprozil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000605/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000605-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ceftazidime",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000608/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000608-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ceftazidime",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000608/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000608-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ceftibuten",
            "active_substance": "ceftibuten",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000611/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000611-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ceftobiprole",
            "active_substance": "ceftobiprole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010734/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010734-202111-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ceftriaxone",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000613/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000613-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ceftriaxone",
            "active_substance": "cefotaxime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000613/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000613-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime axetil",
            "active_substance": "cefuroxime axetil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009099/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009099-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime sodium (except for intracameral use)",
            "active_substance": "cefuroxime sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000615/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000615-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime sodium (for intracameral use)",
            "active_substance": "cefuroxime sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010206/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime sodium (for intracameral use)",
            "active_substance": "cefuroxime sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010206/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime sodium (for intracameral use)",
            "active_substance": "cefuroxime sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010206/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime sodium (for intracameral use)",
            "active_substance": "cefuroxime sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010206/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010206-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Celecoxib",
            "active_substance": "celecoxib",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000616/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Celecoxib",
            "active_substance": "celecoxib",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000616/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Celecoxib",
            "active_substance": "celecoxib",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000616/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000616-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Celiprolol",
            "active_substance": "celiprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000617/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000617-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cetirizine / pseudoephedrine",
            "active_substance": "cetirizine;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000629/201608",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000629-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cetirizine pseudoephedrine",
            "active_substance": "cetirizine pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000629/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000629-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cetirizine",
            "active_substance": "cetirizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000628/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000628-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlormadinone acetate / ethinylestradiol",
            "active_substance": "chlormadinone acetate;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000679/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000679-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlormadinone",
            "active_substance": "chlormadinone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000677/201611",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000677-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chloroprocaine hydrochloride",
            "active_substance": "chloroprocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010078/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010078-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chloroquine",
            "active_substance": "chloroquine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000685/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000685-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chloroquine phosphate / proguanil hydrochloride",
            "active_substance": "chloroquine phosphate;proguanil hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010207/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010207-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chloroquine phosphate / proguanil hydrochloride",
            "active_substance": "chloroquine phosphate;proguanil hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010207/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010207-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chloroquine",
            "active_substance": "chloroquine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000685/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000685-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorphenoxamine hydrochloride",
            "active_substance": "chlorphenoxamine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010361/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010361-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorpromazine",
            "active_substance": "chlorpromazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000715/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000715-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorpromazine",
            "active_substance": "chlorpromazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000715/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000715-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorpromazine",
            "active_substance": "chlorpromazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000717/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000717-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorquinadol (vaginal tablet) / promestriene",
            "active_substance": "chlorquinaldol;promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009272/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009272-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorquinadol (vaginal tablet) / promestriene",
            "active_substance": "chlorquinaldol;promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009272/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009272-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chlorquinadol (vaginal tablet) / promestriene",
            "active_substance": "chlorquinaldol;promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009272/201609",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009272-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciclesonide",
            "active_substance": "ciclesonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000742/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciclesonide",
            "active_substance": "ciclesonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000742/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciclesonide",
            "active_substance": "ciclesonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000742/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000742-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beclometasone",
            "active_substance": "beclometasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000306/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000306-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: betula verrucosa (sublingual use)",
            "active_substance": "allergen for therapy: betula verrucosa (sublingual use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010815/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alitretinoin (oral use)",
            "active_substance": "alitretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010710/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010710-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciclosporin (systemic use)",
            "active_substance": "ciclosporin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000745/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciclosporin (systemic use)",
            "active_substance": "ciclosporin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000745/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cidofovir",
            "active_substance": "cidofovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010558/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cidofovir",
            "active_substance": "cidofovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010558/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cidofovir",
            "active_substance": "cidofovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010558/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cidofovir",
            "active_substance": "cidofovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010558/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cidofovir",
            "active_substance": "cidofovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010558/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010558-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilastatin / Imipenem",
            "active_substance": "cilastatin;imipenem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000748/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000748-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilazapril, cilazapril / hydrochlorothiazide",
            "active_substance": "cilazapril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000749/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilazapril, cilazapril / hydrochlorothiazide",
            "active_substance": "cilazapril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000749/201802",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilazapril, cilazapril / hydrochlorothiazide",
            "active_substance": "cilazapril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000749/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000749-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/201502",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilostazol",
            "active_substance": "cilostazol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010209/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010209-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cimicifuga racemosa (L.) nutt., rhizome",
            "active_substance": "cimicifuga racemosa (L.) nutt., rhizoma",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000755/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000755-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cinolazepam",
            "active_substance": "cinolazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000769/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000769-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofibrate",
            "active_substance": "ciprofibrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000771/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000771-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofibrate",
            "active_substance": "ciprofibrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000771/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000771-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin (systemic use)",
            "active_substance": "ciprofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000775/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000775-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin (topical use)",
            "active_substance": "ciprofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000775/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000775-201801-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin (topical use)",
            "active_substance": "ciprofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000776/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000776-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin hydrochloride / dexamethasone acetate (ear drops, suspension)",
            "active_substance": "ciprofloxacin hydrochloride;dexamethasone acetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010012/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010012-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin hydrochloride / hydrocortisone",
            "active_substance": "ciprofloxacin hydrochloride;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000774/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000774-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin hydrochloride / hydrocortisone",
            "active_substance": "ciprofloxacin hydrochloride;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000774/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000774-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin hydrochloride, dexamethasone acetate (ear drops, suspension)",
            "active_substance": "ciprofloxacin hydrochloride;dexamethasone acetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010012/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010012-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin hydrochloride, hydrocortisone",
            "active_substance": "ciprofloxacin hydrochloride;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000774/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000774-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cisatracurium",
            "active_substance": "cisatracurium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000777/202007",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000777-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cisatracurium",
            "active_substance": "cisatracurium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000777/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000777-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cisplatin",
            "active_substance": "cisplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000778/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000778-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Citalopram",
            "active_substance": "citalopram",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000779/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000779-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Citrulline malate",
            "active_substance": "citrulline malate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010579/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010579-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Citrulline malate",
            "active_substance": "citrulline malate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010579/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010579-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clarithromycin",
            "active_substance": "clarithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000788/202004",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000788-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clarithromycin",
            "active_substance": "clarithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000788/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000788-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clebopride",
            "active_substance": "clebopride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000789/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000789-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clenbuterol",
            "active_substance": "clenbuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000794/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000794-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clenbuterol",
            "active_substance": "clenbuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000794/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000794-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "botulinum toxin a - haemagglutinin complex",
            "active_substance": "botulinum toxin a - haemagglutinin complex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000427/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000427-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "niflumic acid",
            "active_substance": "niflumic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002157/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "bendamustine hydrochloride",
            "active_substance": "bendamustine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003162/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003162-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "hydromorphone",
            "active_substance": "hydromorphone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001686/202111",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "flunitrazepam",
            "active_substance": "flunitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001418/202201",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "citalopram",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000779/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000779-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clindamycin",
            "active_substance": "clindamycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000795/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clindamycin phosphate / tretinoin",
            "active_substance": "clindamycin phosphate;tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010080/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010080-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clindamycin",
            "active_substance": "clindamycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000795/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clindamycin",
            "active_substance": "clindamycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000795/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000795-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clobazam",
            "active_substance": "clobazam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000798/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000798-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clobetasol",
            "active_substance": "clobetasol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000799/202002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000799-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clobetasol",
            "active_substance": "clobetasol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000799/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000799-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clodronic acid",
            "active_substance": "clodronic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000804/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000804-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "clonazepam (56718)",
            "active_substance": "clonazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000812/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000812-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "clonazepam (56718)",
            "active_substance": "clonazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000812/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000812-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clotiazepam",
            "active_substance": "clotiazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000827/202005",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000827-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clotiazepam",
            "active_substance": "clotiazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000827/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000827-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract",
            "active_substance": "codeine camphosulphonate;sodium benzoate;sulfogaiacol;grindelia soft extract",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010542/201912",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010542-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Colchicine",
            "active_substance": "colchicine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000858/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000858-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Corticorelin",
            "active_substance": "corticorelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000876/201410",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000876-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Corticorelin",
            "active_substance": "corticorelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000876/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000876-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flumazenil",
            "active_substance": "flumazenil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001413/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001413-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "pilocarpine (ophthalmic formulation)",
            "active_substance": "pilocarpine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002410/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002410-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dermatophagoides pteronyssinus / dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)",
            "active_substance": "Dermatophagoides pteronyssinus;Dermatophagoides farina",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010582/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desfluran",
            "active_substance": "desfluran",
            "related_medicines": "",
            "procedure_number": "PSUSA/0000958/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0000958-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desflurane",
            "active_substance": "desflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000958/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000958-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desflurane",
            "active_substance": "desflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000958/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000958-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desmopressin",
            "active_substance": "desmopressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000964/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000964-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desmopressin",
            "active_substance": "desmopressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000964/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000964-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desmopressin",
            "active_substance": "desmopressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000964/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000964-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desogestrel / ethinylestradiol",
            "active_substance": "desogestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000967/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000967-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desogestrel / ethinylestradiol",
            "active_substance": "desogestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000967/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000967-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desogestrel",
            "active_substance": "desogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000966/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000966-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Desogestrel",
            "active_substance": "desogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000966/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000966-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamethasone (apart from centrally authorised products)",
            "active_substance": "dexamethasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000973/201601",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000973-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamethasone (apart from centrally authorised products)",
            "active_substance": "dexamethasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000973/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000973-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamethasone / netilmicin",
            "active_substance": "dexamethasone;netilmicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010854/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010854-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamethasone / tobramycin",
            "active_substance": "dexamethasone;tobramycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000979/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000979-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamethasone / tobramycin",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/202109",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0028",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0028"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0029",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0029"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/201709",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/201909",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexchlorpheniramine",
            "active_substance": "dexchlorpheniramine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000989/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexchlorpheniramine",
            "active_substance": "dexchlorpheniramine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000989/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexchlorpheniramine",
            "active_substance": "dexchlorpheniramine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000989/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000989-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexibuprofen",
            "active_substance": "dexibuprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000996/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000996-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexibuprofen",
            "active_substance": "dexibuprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000996/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000996-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexketoprofen / tramadol",
            "active_substance": "dexketoprofen;tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010468/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010468-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexketoprofen",
            "active_substance": "dexketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000997/202110",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000997-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexketoprofen / tramadol",
            "active_substance": "dexketoprofen;tramadol",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0035",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0035"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexketoprofen",
            "active_substance": "dexketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000997/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000997-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexlansoprazole / lansoprazole",
            "active_substance": "dexlansoprazole;lansoprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001827/201612",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001827-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexpanthenol xylometazoline",
            "active_substance": "dexpanthenol xylometazoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010030/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010030-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dextromethorphan",
            "active_substance": "dextromethorphan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001009/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001009-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dextromethorphan",
            "active_substance": "dextromethorphan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001009/201511",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001009-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dextromethorphan",
            "active_substance": "dextromethorphan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001009/201811",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001009-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dhydroergocryptine",
            "active_substance": "dihydroergocryptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001074/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001074-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diacerein",
            "active_substance": "Diacerein",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001026/201612",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001026-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diacerein",
            "active_substance": "Diacerein",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001026/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001026-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diacerein",
            "active_substance": "Diacerein",
            "related_medicines": "",
            "procedure_number": "PSUSA/0001026/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0001026-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diacerin",
            "active_substance": "diacerin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001026/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001026-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "methohexital",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010656/202201",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010656-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Esketamine",
            "active_substance": "Esketamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001266/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001266-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001048/202109",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "exemestane",
            "active_substance": "exemestane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001345/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001345-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ezetimibe / rosuvastatin",
            "active_substance": "ezetimibe;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010271/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010271-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ezetimibe / rosuvastatin",
            "active_substance": "ezetimibe;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010271/202007",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010271-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Domperidone",
            "active_substance": "domperidone",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0015",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0015"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dornase alpha",
            "active_substance": "dornase alpha",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001164/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001164-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac (systemic formulations)",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001048/201509",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dorzolamide / timolol",
            "active_substance": "dorzolamide;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001166/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001166-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/202004",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "13/09/2022",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dorzolamide / timolol",
            "active_substance": "dorzolamide;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001166/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001166-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Erdosteine",
            "active_substance": "Erdosteine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001248/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001248-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ezetimibe / simvastatin",
            "active_substance": "ezetimibe;simvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001347/201903",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001347-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ezetimibe",
            "active_substance": "ezetimibe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001346/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001346-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "F(ab’)2 fragments of equine antirabies immunoglobulin",
            "active_substance": "F(ab’)2 fragments of equine antirabies immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001348/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001348-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Famciclovir",
            "active_substance": "famciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001349/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001349-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Famciclovir",
            "active_substance": "famciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001349/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001349-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Famotidine",
            "active_substance": "Famotidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001350/201709",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001350-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Felbamate",
            "active_substance": "felbamate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010155/201609",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010155-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Felbamate",
            "active_substance": "felbamate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010155/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010155-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Felodipine / metoprolol",
            "active_substance": "felodipine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001357/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001357-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Felodipine / ramipril",
            "active_substance": "felodipine;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001358/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001358-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Felodipine",
            "active_substance": "felodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001356/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001356-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenofibrate",
            "active_substance": "fenofibrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001362/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001362-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenofibrate",
            "active_substance": "fenofibrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001362/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001362-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenoterol (obstetric indications)",
            "active_substance": "fenoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010001/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010001-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenoterol (respiratory indications)",
            "active_substance": "fenoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001366/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001366-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac (systemic formulations)",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001048/201809",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001048-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenspiride",
            "active_substance": "fenspiride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001368/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001368-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenoterol / ipratropium",
            "active_substance": "fenoterol;ipratropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001367/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001367-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenspiride",
            "active_substance": "fenspiride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001368/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001368-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "active_substance": "fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001370/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "active_substance": "fentanyl",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001370/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dorzolamide",
            "active_substance": "dorzolamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003168/201602",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fentanyl (transdermal patches, solution for injection)",
            "active_substance": "fentanyl",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001370/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fexofenadine",
            "active_substance": "fexofenadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001388/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001388-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/201608",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dorzolamide",
            "active_substance": "dorzolamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003168/201902",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac (topical formulations)",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010342/201809",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010342-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Finasteride",
            "active_substance": "Finasteride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001392/201708",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001392-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac (topical formulations)",
            "active_substance": "diclofenac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010342/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010342-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fish oil/olive oil/soybean oil/triglycerides medium-chain",
            "active_substance": "triglycerides medium-chain;olive oil;Fish oil;soya bean oil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010223/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010223-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Doxazosin",
            "active_substance": "doxazosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001169/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001169-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flecainide",
            "active_substance": "flecainide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001396/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001396-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac / misoprostol",
            "active_substance": "diclofenac;misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001040/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flubendazole",
            "active_substance": "flubendazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001400/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001400-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flucloxacillin",
            "active_substance": "flucloxacillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001402/202003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001402-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Doxazosin",
            "active_substance": "doxazosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001169/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001169-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluconazole",
            "active_substance": "fluconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001404/202003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001404-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac / omeprazole",
            "active_substance": "diclofenac;omeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010461/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010461-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Doxylamine",
            "active_substance": "doxylamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001174/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001174-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluconazole",
            "active_substance": "fluconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001404/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001404-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fludarabine",
            "active_substance": "fludarabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001406/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001406-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fludeoxyglucose (18f)",
            "active_substance": "fludeoxyglucose (18F)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001437/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001437-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac / omeprazole: List of nationally authorised medicinal products - PSUSA/00010461/201809",
            "active_substance": "diclofenac;omeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010461/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010461-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flumazenil",
            "active_substance": "flumazenil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001413/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001413-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flunarizine",
            "active_substance": "flunarizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001416/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flunarizine",
            "active_substance": "flunarizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001416/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Didanosine",
            "active_substance": "didanosine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001054/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001054-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flunarizine",
            "active_substance": "flunarizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001416/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001416-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Drospirenone / estradiol",
            "active_substance": "drospirenone;estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001184/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001184-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Didanosine",
            "active_substance": "didanosine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001054/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001054-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flunitrazepam",
            "active_substance": "flunitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001418/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest / estradiol (contraception indication)",
            "active_substance": "Dienogest;estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010444/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010444-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flunitrazepam",
            "active_substance": "flunitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001418/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001418-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest / estradiol (HRT indication)",
            "active_substance": "Dienogest;estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010443/201606",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010443-201606"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Drospirenone / ethinylestradiol",
            "active_substance": "drospirenone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010217/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010217-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest / estradiol (HRT indication)",
            "active_substance": "Dienogest;estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010443/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010443-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluorodopa (18F)",
            "active_substance": "fluorodopa (18F)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010002/201803",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010002-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide (intravitreal implant in applicator)",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest / ethinylestradiol",
            "active_substance": "Dienogest;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001057/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001057-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Drospirenone / ethinylestradiol",
            "active_substance": "drospirenone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010217/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010217-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluocinolone acetonide",
            "active_substance": "Fluocinolone acetonide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010224/202008",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010224-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Drospirenone",
            "active_substance": "drospirenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010853/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010853-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest",
            "active_substance": "Dienogest",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003167/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003167-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest",
            "active_substance": "Dienogest",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003167/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003167-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergocristine",
            "active_substance": "dihydroergocristine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001071/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001071-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergotamine",
            "active_substance": "dihydroergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001075/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergotamine",
            "active_substance": "dihydroergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001075/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergotamine",
            "active_substance": "dihydroergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001075/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001075-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergotoxine",
            "active_substance": "dihydroergotoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/0001079/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0001079-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Drospirenone/estradiol",
            "active_substance": "drospirenone;estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001184/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001184-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dihydroergotoxine",
            "active_substance": "dihydroergotoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001079/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001079-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dutasteride, dutasteride / tamsulosin",
            "active_substance": "dutasteride;tamsulosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010506/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010506-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diltiazem",
            "active_substance": "diltiazem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001084/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001084-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diltiazem",
            "active_substance": "diltiazem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001084/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001084-201705-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ebastine",
            "active_substance": "ebastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001191/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001191-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Corticorelin",
            "active_substance": "corticorelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000876/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000876-201910-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cromoglicic acid",
            "active_substance": "cromoglicic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000883/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000883-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyanocobalamin / diclofenac / pyridoxine / thiamine",
            "active_substance": "cyanocobalamin;diclofenac;pyridoxine;thiamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001041/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001041-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dinoprostone",
            "active_substance": "dinoprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001104/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001104-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Econazole, econazole nitrate / triamcinolone acetonide,  econazole nitrate / zinc oxide",
            "active_substance": "econazole;econazole nitrate;triamcinolone acetonide;zinc oxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001195/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001195-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproheptadine",
            "active_substance": "cyproheptadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000902/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproheptadine",
            "active_substance": "cyproheptadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000902/201412",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dinoprostone",
            "active_substance": "dinoprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001104/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001104-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivabradine / metoprolol",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/202004",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproheptadine",
            "active_substance": "cyproheptadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000902/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000902-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eletriptan",
            "active_substance": "eletriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001204/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001204-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproterone / ethinylestradiol",
            "active_substance": "cyproterone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000906/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000906-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproterone / ethinylestradiol",
            "active_substance": "cyproterone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000906/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000906-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eletriptan",
            "active_substance": "eletriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001204/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001204-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproterone / ethinylestradiol",
            "active_substance": "cyproterone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproterone / ethinylestradiol",
            "active_substance": "cyproterone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0005",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cyproterone / ethinylestradiol",
            "active_substance": "cyproterone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0006",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cytarabine",
            "active_substance": "cytarabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000911/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000911-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cytomegalovirus immunoglobulin",
            "active_substance": "cytomegalovirus immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000914/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000914-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cytomegalovirus immunoglobulin",
            "active_substance": "cytomegalovirus immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000914/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000914-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Enalapril / hydrochlorothiazide",
            "active_substance": "enalapril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001212/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001212-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Enalapril / nitrendipine",
            "active_substance": "enalapril;nitrendipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001213/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001213-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Enalapril, nitrendipine",
            "active_substance": "enalapril;nitrendipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001213/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001213-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Enalapril",
            "active_substance": "enalapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001211/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001211-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / pertussis (acellular, component) / haemophilus type b conjugate vaccine (adsorbed)",
            "active_substance": "haemophilus type b conjugate vaccine;pertussis (acellular, component);tetanus;diphtheria vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001121/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001121-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Enoxaparin (except for biosimilars)",
            "active_substance": "enoxaparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010560/201904",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010560-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)",
            "active_substance": "diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001124/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Enoxaparin (except for biosimilars)",
            "active_substance": "enoxaparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010560/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010560-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epinastine",
            "active_substance": "epinastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001231/201710",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001231-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epinephrine / lidocaine",
            "active_substance": "epinephrine;lidocaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001233/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001233-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / pertussis (acellular, component) / poliomyelitis (inactivated) / haemophilus type b conjugate vaccine (adsorbed)",
            "active_substance": "haemophilus type b conjugate vaccine (adsorbed);poliomyelitis (inactivated);pertussis (acellular, component);diphtheria vaccine;tetanus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001124/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) reduce antigens content",
            "active_substance": "diphtheria tetanus pertussis and poliomyelitis inactivated vaccine;diphtheria tetanus pertussis and poliomyelitis inactivated vaccine reduce antigens content",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001126/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001126-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivabradine / metoprolol",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/202004",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004-1"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria/tetanus/pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed), diphtheria/tetanus/pertussis (acellular, component) and poliomyelitis",
            "active_substance": "diphtheria tetanus pertussis and poliomyelitis inactivated vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001126/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001126-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivabradine / metoprolol",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-202004-2"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents",
            "active_substance": "pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents;tetanus;pertussis (acellular, component) vaccine (adsorbed), diphtheria;diphtheria vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001125/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001125-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)",
            "active_substance": "poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content);tetanus;diphtheria vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001127/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001127-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus vaccines (adsorbed), diphtheria vaccines (adsorbed)",
            "active_substance": "diphtheria vaccine;tetanus vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001128/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol (except cream/balm/emulsion for application in female genital area)",
            "active_substance": "estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010440/202108",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010440-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria tetanus vaccines (adsorbed)",
            "active_substance": "diphtheria tetanus vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001128/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria tetanus vaccines (adsorbed)",
            "active_substance": "diphtheria tetanus vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001128/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001128-201505-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate vaccine: List of nationally authorised medicinal products - PSUSA/00001124/201411",
            "active_substance": "diphtheria vaccine;tetanus;pertussis;poliomyelitis;haemophilus type b conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001124/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate vaccine",
            "active_substance": "diphtheria vaccine;tetanus;pertussis;poliomyelitis;haemophilus type b conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001124/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001124-201411-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Esketamine",
            "active_substance": "Esketamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001266/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001266-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Donepezil",
            "active_substance": "donepezil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001160/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001160-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol (17-beta) / Trimegestone",
            "active_substance": "17 beta-estradiol;trimegestone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001275/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001275-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Domperidone",
            "active_substance": "domperidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001158/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Domperidone",
            "active_substance": "domperidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001158/201611",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Esomeprazole / Naproxen",
            "active_substance": "esomeprazole;naproxen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001270/201704",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001270-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Domperidone",
            "active_substance": "domperidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001158/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001158-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dobutamine",
            "active_substance": "Dobutamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001151/202103",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001151-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dobutamine",
            "active_substance": "Dobutamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001151/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001151-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dobutamine",
            "active_substance": "Dobutamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001151/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001151-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Docosanol",
            "active_substance": "docosanol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010092/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010092-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Docosanol",
            "active_substance": "docosanol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010092/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010092-202104-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol (except cream/balm/emulsion for application in female genital area)",
            "active_substance": "estradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010440/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010440-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epinephrine / mepivacaine hydrochloride, mepivacaine /  norepinephrine, mepivacaine",
            "active_substance": "epinephrine;mepivacaine hydrochloride;mepivacaine;norepinephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001979/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001979-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluoxetine",
            "active_substance": "fluoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001442/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001442-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flupirtine",
            "active_substance": "flupirtine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010225/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010225-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epinephrine",
            "active_substance": "epinephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001232/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001232-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flupirtine",
            "active_substance": "flupirtine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010225/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010225-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flurbiprofen",
            "active_substance": "flurbiprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001450/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001450-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epirubicin",
            "active_substance": "epirubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001234/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001234-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flurbiprofen",
            "active_substance": "flurbiprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001450/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001450-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flutamide",
            "active_substance": "flutamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001453/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001453-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluticasone / salmeterol",
            "active_substance": "fluticasone;salmeterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001455/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001455-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluticasone propionate / formoterol fumarate dehydrate",
            "active_substance": "formoterol fumarate dihydrate;fluticasone propionate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010339/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epirubicin",
            "active_substance": "epirubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001234/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001234-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluticasone propionate / formoterol fumarate dihydrate",
            "active_substance": "fluticasone propionate;formoterol fumarate dihydrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010339/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluticasone propionate / formoterol fumarate dihydrate",
            "active_substance": "fluticasone propionate;formoterol fumarate dihydrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010339/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluticasone propionate / formoterol fumarate dihydrate",
            "active_substance": "formoterol fumarate dihydrate;fluticasone propionate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010339/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epoprostenol",
            "active_substance": "epoprostenol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001242/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001242-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eplerenone",
            "active_substance": "eplerenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001236/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001236-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eprosartan / hydrochlorothiazide",
            "active_substance": "hydrochlorothiazide;eprosartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001244/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001244-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eprosartan",
            "active_substance": "eprosartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001243/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001243-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Erythromycin / isotretinoin, isotretinoin (topical  formulations)",
            "active_substance": "erythromycin;isotretinoin;isotretinoin (topical formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010487/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010487-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Erythromycin / isotretinoin",
            "active_substance": "erythromycin;isotretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001796/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001796-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluticasone propionate",
            "active_substance": "fluticasone propionate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001454/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001454-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluvastatin",
            "active_substance": "fluvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA-00001457-201708",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001457-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluvoxamine",
            "active_substance": "fluvoxamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001458/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001458-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Folic acid",
            "active_substance": "folic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001459/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001459-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Formoterol",
            "active_substance": "formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001469/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001469-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Formoterol",
            "active_substance": "formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001469/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001469-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Foscarnet",
            "active_substance": "foscarnet",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001472/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001472-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosfomycin",
            "active_substance": "fosfomycin",
            "related_medicines": "",
            "procedure_number": "EMA/235643/2017",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/ema-235643-2017"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosfomycin",
            "active_substance": "fosfomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010336/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010336-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosfomycin",
            "active_substance": "fosfomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010326/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010326-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Erythromycin / tretinoin",
            "active_substance": "erythromycin;tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001259/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001259-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosfomycin",
            "active_substance": "fosfomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010326/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010326-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Erythromycin / tretinoin",
            "active_substance": "erythromycin;tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001259/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001259-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Erythromycin",
            "active_substance": "erythromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001257/201903",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001257-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Escherichia coli lysate",
            "active_substance": "escherichia coli lysate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001263/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001263-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Escherichia coli lysate",
            "active_substance": "escherichia coli lysate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001263/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001263-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Escitalopram",
            "active_substance": "escitalopram",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001265/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001265-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluorescein (systemic use)",
            "active_substance": "fluorescein",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009153/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009153-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluorescein (systemic use)",
            "active_substance": "fluorescein",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009153/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009153-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluorodopa (18F)",
            "active_substance": "fluorodopa (18F)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010002/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010002-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosinopril / hydrochlorothiazide",
            "active_substance": "fosinopril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001475/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001475-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosinopril, fosinopril / hydrochlorothiazide",
            "active_substance": "fosinopril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010463/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010463-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosinopril, fosinopril / hydrochlorothiazide",
            "active_substance": "fosinopril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010463/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010463-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosinopril",
            "active_substance": "fosinopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001474/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001474-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosphenytoin",
            "active_substance": "fosphenytoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001476/202008",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001476-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Frovatriptan",
            "active_substance": "frovatriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001484/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001484-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Furosemide / spironolactone",
            "active_substance": "furosemide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001493/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001493-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Furosemide / spironolactone",
            "active_substance": "furosemide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001493/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001493-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Furosemide",
            "active_substance": "furosemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001491/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001491-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Furosemide",
            "active_substance": "furosemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001491/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001491-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fusidic acid (systemic use)",
            "active_substance": "fusidic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010226/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fusidic acid (systemic use)",
            "active_substance": "fusidic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010226/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gabapentin",
            "active_substance": "gabapentin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001499/201602",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gabapentin",
            "active_substance": "gabapentin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001499/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadobenic acid",
            "active_substance": "gadobenic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001500/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadobenic acid",
            "active_substance": "gadobenic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001500/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadobenic acid",
            "active_substance": "gadobenic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001500/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001500-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadobutrol",
            "active_substance": "Gadobutrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001502/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadobutrol",
            "active_substance": "Gadobutrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001502/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001502-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadodiamide",
            "active_substance": "gadodiamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001503/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001503-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadodiamide",
            "active_substance": "gadodiamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001503/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001503-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadopentetic acid",
            "active_substance": "gadopentetic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001504/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadopentetic acid",
            "active_substance": "gadopentetic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001504/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadopentetic acid",
            "active_substance": "gadopentetic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001504/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001504-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteric acid (intra articular formulation)",
            "active_substance": "gadoteric acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001505/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001505-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteric acid (IV and intravascular formulations)",
            "active_substance": "gadoteric acid (IV and intravascular formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001506/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteric acid (IV and intravascular formulations)",
            "active_substance": "gadoteric acid (IV and intravascular formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001506/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteric acid (IV and intravascular formulations)",
            "active_substance": "gadoteric acid (IV and intravascular formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001506/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001506-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteridol",
            "active_substance": "gadoteridol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001507/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteridol",
            "active_substance": "gadoteridol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001507/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoteridol",
            "active_substance": "gadoteridol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001507/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001507-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoxetic acid disodium",
            "active_substance": "gadoxetic acid disodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001509/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoxetic acid disodium",
            "active_substance": "gadoxetic acid disodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001509/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gadoxetic acid disodium",
            "active_substance": "gadoxetic acid disodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001509/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001509-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Galantamine",
            "active_substance": "galantamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001512/202003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001512-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Galantamine",
            "active_substance": "galantamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001512/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001512-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ganciclovir",
            "active_substance": "ganciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001516/201606",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-201606"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ganciclovir",
            "active_substance": "ganciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001516/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gasiloxe",
            "active_substance": "gasiloxe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010283/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gasiloxe",
            "active_substance": "gasiloxe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010283/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gasiloxe",
            "active_substance": "gasiloxe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010283/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gasiloxe",
            "active_substance": "gasiloxe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010283/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gasiloxe",
            "active_substance": "gasiloxe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010283/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010283-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gemcitabine",
            "active_substance": "gemcitabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001519/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001519-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gentamicin (systemic use)",
            "active_substance": "gentamicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009159/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009159-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gentamicin",
            "active_substance": "gentamicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009159/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009159-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "gallium (68Ga) chloride;germanium (68Ge) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "gallium (68Ga) chloride;germanium (68Ge) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "gallium (68Ga) chloride;germanium (68Ge) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "gallium (68Ga) chloride;germanium (68Ge) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "gallium (68Ga) chloride;germanium (68Ge) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "gallium (68Ga) chloride;germanium (68Ge) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glatiramer",
            "active_substance": "glatiramer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001529/202011",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glatiramer",
            "active_substance": "glatiramer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001529/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glatiramer",
            "active_substance": "glatiramer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001529/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001529-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glibenclamide / metformin hydrochloride",
            "active_substance": "glibenclamide;metformin hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002002/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002002-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glibenclamide / metformin hydrochloride",
            "active_substance": "glibenclamide;metformin hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002002/201506",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002002-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glibenclamide / metformin hydrochloride",
            "active_substance": "glibenclamide;metformin hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002002/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002002-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gliclazide",
            "active_substance": "gliclazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001532/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001532-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gliclazide",
            "active_substance": "gliclazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001532/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001532-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glimepiride",
            "active_substance": "glimepiride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001534/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001534-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glipizide",
            "active_substance": "glipizide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001535/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glipizide",
            "active_substance": "glipizide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001535/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-201901-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glucosamine",
            "active_substance": "glucosamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001539/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001539-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glyceryl trinitrate",
            "active_substance": "glyceryl trinitrate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001552/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001552-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glycopyrronium / neostigmine",
            "active_substance": "glycopyrronium;neostigmine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001557/201509",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001557-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glycopyrronium bromide (all indications except for chronic obstructive pulmonary disease)",
            "active_substance": "glycopyrronium bromide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001556/201509",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001556-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Goserelin",
            "active_substance": "goserelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001562/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001562-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Goserelin",
            "active_substance": "goserelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001562/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001562-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Granisetron (other formulations except for transdermal patch)",
            "active_substance": "granisetron (other formulations except for transdermal patch)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001568/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001568-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Granisetron",
            "active_substance": "granisetron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001568/201602",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001568-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus influenzae / klebsiella ozaenae / klebsiella pneumoniae / moraxella catarrhalis / staphylococcus aureus / streptococcus pneumoniae / streptococcus pyogenes / streptococcus viridans vaccine",
            "active_substance": "streptococcus viridans vaccine;streptococcus pyogenes;streptococcus pneumoniae;staphylococcus aureus;moraxella catarrhalis;klebsiella pneumoniae;klebsiella ozaenae;haemophilus influenzae",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001582/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001582-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus type b and meningococcal group c conjugate vaccine",
            "active_substance": "haemophilus type b and meningococcal group c conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001583/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001583-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus type b and meningococcal group c conjugate vaccine",
            "active_substance": "haemophilus type b conjugate vaccine;meningococcal group c conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001583/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001583-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus type b conjugate vaccines",
            "active_substance": "haemophilus type b conjugate vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001584/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001584-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus type b conjugate vaccines",
            "active_substance": "haemophilus type b conjugate vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001584/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001584-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Halofantrine",
            "active_substance": "halofantrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001586/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001586-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)",
            "active_substance": "typhoid polysaccharide vaccine;hepatitis a",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001594/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001594-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)",
            "active_substance": "hepatitis A virus (inactivated);typhoid polysaccharide vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001594/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001594-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hepatitis A vaccines (inactivated, adsorbed)",
            "active_substance": "hepatitis A vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001596/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001596-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hexaminolevulinate hydrochloride",
            "active_substance": "hexaminolevulinate hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001606/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001606-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hexoprenaline sulfate",
            "active_substance": "hexoprenaline sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003170/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003170-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hexoprenaline sulphate",
            "active_substance": "hexoprenaline sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003170/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003170-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human alpha1-proteinase inhibitor (apart from the centrally authorised product)",
            "active_substance": "human alpha1-proteinase inhibitor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000108/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human alpha1-proteinase inhibitor (apart from the centrally authorised product)",
            "active_substance": "human alpha1-proteinase inhibitor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000108/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000108-201912-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human anti-d immunoglobulin",
            "active_substance": "human anti-d immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001614/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001614-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / levomenthol",
            "active_substance": "Ibuprofen;Levomenthol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001708/202007",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001708-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/202107",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/201907",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus), ibuprofen / caffeine",
            "active_substance": "Ibuprofen;ibuprofen lysine;Caffeine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010649/202002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010649-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen, ibuprofen lysine (not indicated in ductus arteriosus)",
            "active_substance": "Ibuprofen;ibuprofen lysine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010345/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010345-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibutilide",
            "active_substance": "ibutilide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001713/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001713-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Idarubicin",
            "active_substance": "idarubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001720/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001720-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Idebenone (non centrally authorised products)",
            "active_substance": "idebenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001721/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001721-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Idebenone (non centrally authorised products)",
            "active_substance": "idebenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001721/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001721-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Idebenone (non centrally authorised products)",
            "active_substance": "idebenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001721/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001721-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII (inhibitor bypassing fraction)",
            "active_substance": "human coagulation factor VIII (inhibitor bypassing fraction)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009174/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII (inhibitor bypassing fraction)",
            "active_substance": "human coagulation factor VIII (inhibitor bypassing fraction)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009174/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII (inhibitor bypassing fraction)",
            "active_substance": "human coagulation factor VIII (inhibitor bypassing fraction)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009174/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII (inhibitor bypassing fraction)",
            "active_substance": "human coagulation factor VIII (inhibitor bypassing fraction)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009174/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009174-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor viii / human von willebrand factor",
            "active_substance": "human coagulation factor VIII;human von willebrand factor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001621/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001621-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII / human von Willebrand factor",
            "active_substance": "human coagulation factor VIII;human von willebrand factor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001621/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001621-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human fibrinogen",
            "active_substance": "human fibrinogen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001624/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001624-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human hemin",
            "active_substance": "human hemin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001629/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human hemin",
            "active_substance": "human hemin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001629/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human hemin",
            "active_substance": "human hemin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001629/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human hemin",
            "active_substance": "human hemin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001629/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human hemin",
            "active_substance": "human hemin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001629/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human hemin",
            "active_substance": "human hemin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001629/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001629-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human plasma (pooled and treated for virus inactivation)",
            "active_substance": "human plasma (pooled and treated for virus inactivation)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001635/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001635-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human plasma protease C1 inhibitor (nationally authorised products)",
            "active_substance": "human plasma protease C1 inhibitor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010163/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human plasma protease C1 inhibitor",
            "active_substance": "human plasma protease C1 inhibitor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010163/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010163-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human plasma proteins with not less than 95% albumin",
            "active_substance": "Human plasma proteins",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010605/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010605-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human prothrombin complex",
            "active_substance": "human prothrombin complex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001638/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001638-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human prothrombin complex",
            "active_substance": "human prothrombin complex",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001638/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001638-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human rabies immunoglobulin",
            "active_substance": "human rabies immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001639/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001639-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human tetanus immunoglobulin",
            "active_substance": "human tetanus immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002909/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002909-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human von willebrand factor",
            "active_substance": "human von willebrand factor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001642/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human von willebrand factor",
            "active_substance": "human von willebrand factor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001642/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human von willebrand factor",
            "active_substance": "human von willebrand factor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001642/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001642-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / lisinopril",
            "active_substance": "hydrochlorothiazide;lisinopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001654/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001654-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / losartan",
            "active_substance": "hydrochlorothiazide;losartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001655/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001655-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / olmesartan",
            "active_substance": "hydrochlorothiazide;olmesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002209/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002209-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / olmesartan",
            "active_substance": "hydrochlorothiazide;olmesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002209/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002209-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / quinapril",
            "active_substance": "hydrochlorothiazide;quinapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002592/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002592-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / quinapril",
            "active_substance": "hydrochlorothiazide;quinapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002592/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002592-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / ramipril",
            "active_substance": "hydrochlorothiazide;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001660/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001660-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / spironolactone",
            "active_substance": "hydrochlorothiazide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001662/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide / spironolactone",
            "active_substance": "hydrochlorothiazide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001662/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ifosfamide",
            "active_substance": "ifosfamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001723/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001723-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iloprost (i.v. solution only)",
            "active_substance": "iloprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009190/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009190-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iloprost (iv solution)",
            "active_substance": "iloprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009190/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009190-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iloprost (iv solution)",
            "active_substance": "iloprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009190/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009190-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Imipramine",
            "active_substance": "imipramine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001728/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001728-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indapamide",
            "active_substance": "Indapamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001731/202011",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001731-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indapamide / perindopril",
            "active_substance": "Indapamide;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010230/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010230-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indapamide / perindopril",
            "active_substance": "Indapamide;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010230/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010230-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indapamide / perindopril",
            "active_substance": "Indapamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001731/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001731-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide moexipril",
            "active_substance": "hydrochlorothiazide moexipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002082/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002082-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide, ramipril",
            "active_substance": "hydrochlorothiazide;ramipril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001660/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001660-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrochlorothiazide, spironolactone",
            "active_substance": "hydrochlorothiazide;spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001662/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001662-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydrocortisone (except for products indicated in adrenal insufficiency in a modified release tablet formulation)",
            "active_substance": "hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010328/201908",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010328-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydromorphone",
            "active_substance": "hydromorphone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001686/201511",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydromorphone",
            "active_substance": "hydromorphone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001686/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001686-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroquinidine",
            "active_substance": "hydroquinidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001688/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001688-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxycarbamide (except for centrally authorised  product)",
            "active_substance": "hydroxycarbamide",
            "related_medicines": "",
            "procedure_number": "PSUSA-00009182-201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxycarbamide (except for centrally authorised product)",
            "active_substance": "hydroxycarbamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009182/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxycarbamide (except for centrally authorised  product)",
            "active_substance": "hydroxycarbamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009182/202012",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxycarbamide (except for centrally authorised  product)",
            "active_substance": "hydroxycarbamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009182/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxychloroquine",
            "active_substance": "hydroxychloroquine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001693/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001693-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA-00001694-202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0031",
            "regulatory_outcome": "Suspension",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0031"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyzine chloride / hydroxyzine pamoate and all fixed  combination, hydroxyzine",
            "active_substance": "hydroxyzine chloride;hydroxyzine pamoate;hydroxyzine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001696/202011",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyzine chloride / hydroxyzine pamoate and all fixed  combination, hydroxyzine",
            "active_substance": "hydroxyzine chloride;hydroxyzine pamoate;hydroxyzine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001696/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyzine chloride / hydroxyzine pamoate and all fixed combination, hydroxyzine",
            "active_substance": "hydroxyzine;hydroxyzine pamoate;hydroxyzine chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001696/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "hydroxyzine chloride, hydroxyzine pamoate and all fixed  combination/ hydroxyzine",
            "active_substance": "hydroxyzine chloride;hydroxyzine pamoate;hydroxyzine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001696/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001696-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hypericum perforatum L., herba",
            "active_substance": "hypericum perforatum L., herba",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001701/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001701-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iodine (131i) iobenguane",
            "active_substance": "Iodine (131I) iobenguane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001764/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001764-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iodine (131i) iobenguane",
            "active_substance": "Iodine (131I) iobenguane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001764/201505",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001764-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iodixanol",
            "active_substance": "iodixanol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001766/202004",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001766-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iohexol",
            "active_substance": "iohexol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001768/202006",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001768-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iomeprol",
            "active_substance": "iomeprol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001769/202004",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001769-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human anti-d immunoglobulin",
            "active_substance": "human anti-d immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001614/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001614-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor IX",
            "active_substance": "human coagulation factor IX",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001617/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001617-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VII",
            "active_substance": "human coagulation factor VII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001619/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001619-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII",
            "active_substance": "human coagulation factor VIII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001620/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001620-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iopamidol",
            "active_substance": "iopamidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001771/201912",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001771-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VIII (antihemophilic factor A)",
            "active_substance": "human coagulation factor VIII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001620/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001620-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iopromide",
            "active_substance": "iopromide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001773/202006",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001773-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ioxaglic acid",
            "active_substance": "ioxaglic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001777/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001777-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ipratropium salbutamol",
            "active_substance": "ipratropium salbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001781/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001781-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iron (parenteral preparations, except for iron dextran)",
            "active_substance": "iron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010236/201901",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "iron",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010236/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ipratropium / salbutamol",
            "active_substance": "ipratropium;salbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA-00001781-201701",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001781-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ipratropium",
            "active_substance": "ipratropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001780/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001780-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iron / parenteral preparations",
            "active_substance": "iron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010236/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Irinotecan (except for liposomal formulations)",
            "active_substance": "irinotecan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001783/201705",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001783-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Irinotecan (except for liposomal formulations)",
            "active_substance": "irinotecan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001783/202005",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001783-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivabradine/metoprolol",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivabradine / metoprolol",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/10381/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-10381-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "PSUSA/00010381/201604",
            "active_substance": "ivabradine;metoprolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010381/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010381-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (systemic use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010377/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (systemic use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010377/201904",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/201510",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/201604",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lenograstim",
            "active_substance": "lenograstim",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001839/201610",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001839-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Letrozole",
            "active_substance": "letrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001842/201610",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lenograstim",
            "active_substance": "lenograstim",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001839/201910",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001839-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Letrozole",
            "active_substance": "letrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001842/201810",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Leuprorelin (depot formulations)",
            "active_substance": "leuprorelin (depot formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010877/202107",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010877-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lercanidipine",
            "active_substance": "lercanidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001841/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001841-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Letrozole",
            "active_substance": "letrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001842/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Letrozole",
            "active_substance": "letrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001437/201410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001437-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Letrozole",
            "active_substance": "letrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001842/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001842-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Leuprorelin",
            "active_substance": "leuprorelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001844/201707",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001844-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Iron dextran",
            "active_substance": "iron dextran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010696/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010696-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levobunolol",
            "active_substance": "levobunolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010109/201701",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010109-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levobupivacaine",
            "active_substance": "levobupivacaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001848/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001848-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levocabastine",
            "active_substance": "levocabastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001849/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001849-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levocetirizine",
            "active_substance": "levocetirizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001850/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001850-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levofloxacin",
            "active_substance": "levofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001854/201810",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001854-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levofloxacin/dexamethasone (ocular use)",
            "active_substance": "levofloxacin/dexamethasone (ocular use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010881/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010881-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levofloxacin",
            "active_substance": "levofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001854/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001854-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levomethadone",
            "active_substance": "levomethadone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001855/201905",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001855-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel",
            "active_substance": "levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010828/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010828-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel,  Ethinylestradiol",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel,  Ethinylestradiol",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel,  Ethinylestradiol",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel,  Ethinylestradiol",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel,  Ethinylestradiol",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "levonorgestrel / ethinylestradiol, ethinylestradiol (combination pack)",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel,  Ethinylestradiol",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "levonorgestrel / ethinylestradiol, ethinylestradiol (combination pack)",
            "active_substance": "levonorgestrel;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010442/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010442-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel",
            "active_substance": "levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001856/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001856-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel",
            "active_substance": "levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001856/201905",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001856-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel",
            "active_substance": "levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001856/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001856-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levosalbutamol, salbutamol",
            "active_substance": "salbutamol;levosalbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010330/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010330-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levosalbutamol, salbutamol",
            "active_substance": "levosalbutamol;salbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010330/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010330-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levosimendan",
            "active_substance": "Levosimendan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001858/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001858-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levosimendan",
            "active_substance": "Levosimendan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001858/201909",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001858-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levothyroxine",
            "active_substance": "levothyroxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001860/201901",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001860-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levothyroxine",
            "active_substance": "levothyroxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001860/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001860-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine, phenazone",
            "active_substance": "lidocaine;phenazone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002359/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002359-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "ofloxacin (topical use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002204/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "iron sucrose (parenteral preparations)",
            "active_substance": "iron sucrose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010864/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010864-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "iron parenteral preparations",
            "active_substance": "iron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010236/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010236-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine, prilocaine (not centrally authorised product)",
            "active_substance": "lidocaine;prilocaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001867/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001867-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine",
            "active_substance": "lidocaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001861/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001861-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isoflurane",
            "active_substance": "Isoflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001786/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001786-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isoflurane",
            "active_substance": "Isoflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001786/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001786-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/202007",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isoniazid",
            "active_substance": "isoniazid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001789/201411",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001789-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isoniazid",
            "active_substance": "isoniazid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001789/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001789-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isoniazide / rifampicin",
            "active_substance": "isoniazid;rifampicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001792/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001792-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isoniazide / rifampicin",
            "active_substance": "isoniazid;rifampicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001792/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001792-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/201611",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/201905",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/2018",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-2018"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Isotretinoin",
            "active_substance": "isotretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001795/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001795-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/201904",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "tropicamide;phenylephrine hydrochloride;lidocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride/methylprednisolone acetate",
            "active_substance": "lidocaine hydrochloride;methylprednisolone acetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001879/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001879-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide",
            "active_substance": "lidocaine hydrochloride;phenylephrine hydrochloride;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010390/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010390-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine, tetracaine",
            "active_substance": "tetracaine;lidocaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001868/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001868-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Llinezolid",
            "active_substance": "linezolid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001888/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001888-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/202002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine dimesylate",
            "active_substance": "lisdexamfetamine dimesylate",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0033",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0033"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/201902",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisinopril, lisinopril / hydrochlorothiazide",
            "active_substance": "lisinopril;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010532/202009",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010532-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisinopril",
            "active_substance": "lisinopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001894/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001894-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loperamide, loperamide / simeticone",
            "active_substance": "loperamide;simeticone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010665/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010665-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisuride",
            "active_substance": "lisuride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001896/201411",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001896-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lomustine",
            "active_substance": "lomustine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001902/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001902-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loperamide, loperamide / simeticone",
            "active_substance": "loperamide;simeticone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010665/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010665-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketamine",
            "active_substance": "ketamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001804/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketamine",
            "active_substance": "ketamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001804/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketamine",
            "active_substance": "ketamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001804/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001804-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketobemidone",
            "active_substance": "ketobemidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001807/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001807-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loperamide",
            "active_substance": "loperamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001903/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001903-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketoprofen (all formulations except topical)",
            "active_substance": "ketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001809/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001809-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketoprofen (topical use only)",
            "active_substance": "ketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009205/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketoprofen (topical use only)",
            "active_substance": "ketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009205/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketoprofen (topical use only)",
            "active_substance": "ketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009205/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loratadine / pseudoephedrine",
            "active_substance": "pseudoephedrine;loratadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001908/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001908-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loratadine",
            "active_substance": "loratadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001907/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001907-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lorazepam",
            "active_substance": "lorazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001909/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lorazepam",
            "active_substance": "lorazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001909/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lorazepam",
            "active_substance": "lorazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001909/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lormetazepam",
            "active_substance": "lormetazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001910/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lormetazepam",
            "active_substance": "lormetazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001910/201412",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lormetazepam",
            "active_substance": "lormetazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001910/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001910-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Losartan",
            "active_substance": "losartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001912/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001912-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketorolac (ophthalmic formulations)",
            "active_substance": "ketorolac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001810/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001810-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketorolac (systemic formulations)",
            "active_substance": "ketorolac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001811/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001811-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketotifen (ophthalmic formulations)",
            "active_substance": "ketotifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001812/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001812-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketotifen (oral formulations)",
            "active_substance": "ketotifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001813/201410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketotifen (oral formulations)",
            "active_substance": "ketotifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001813/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketotifen (oral formulations)",
            "active_substance": "ketotifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001813/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001813-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lovastatin",
            "active_substance": "lovastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010051/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010051-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lovastatin",
            "active_substance": "lovastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010051/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010051-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lubiprostone",
            "active_substance": "Lubiprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010290/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lubiprostone",
            "active_substance": "Lubiprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/000010290/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-000010290-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alverine / simeticone",
            "active_substance": "alverine;simeticone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000125/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000125-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lubiprostone",
            "active_substance": "Lubiprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010290/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201601"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Alverine",
            "active_substance": "alverine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000124/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000124-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lubiprostone",
            "active_substance": "Lubiprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010290/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lubiprostone",
            "active_substance": "Lubiprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010290/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010290-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lysine acetylsalicylate",
            "active_substance": "lysine acetylsalicylate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001921/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001921-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Macrogol 3350",
            "active_substance": "Macrogol 3350",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001924/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001924-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Macrogol 3350",
            "active_substance": "Macrogol 3350",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001924/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001924-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Macrogol 4000, macrogol 4000 combinations (oral use)",
            "active_substance": "macrogol 4000",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010392/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010392-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Macrogol 4000",
            "active_substance": "macrogol 4000",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010392/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010392-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "magnesium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001926/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001926-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium hydroxide",
            "active_substance": "magnesium hydroxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001926/201610",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001926-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulfate",
            "active_substance": "magnesium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009225/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009225-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulfate",
            "active_substance": "magnesium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009225/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009225-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate / sodium sulphate / potassium sulphate",
            "active_substance": "sodium sulfate;magnesium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate / sodium sulphate / potassium sulphate",
            "active_substance": "sodium sulfate;magnesium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate / sodium sulphate / potassium sulphate",
            "active_substance": "sodium sulfate;magnesium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate / sodium sulphate / potassium sulphate",
            "active_substance": "sodium sulfate;magnesium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate / sodium sulphate / potassium sulphate",
            "active_substance": "sodium sulfate;magnesium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate heptahydrate, sodium sulphate anhydrous, potassium sulphate",
            "active_substance": "magnesium sulfate heptahydrate (BLI800);sodium sulfate anhydrous;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0016",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0016"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Magnesium sulfate, sodium sulfate, potassium sulfate",
            "active_substance": "magnesium sulfate;sodium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA 00010239202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Magnesium sulphate, sodium sulphate, potassium sulphate",
            "active_substance": "sodium sulfate;magnesium sulfate;potassium sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010239/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010239-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mefloquine",
            "active_substance": "mefloquine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001955/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001955-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meloxicam",
            "active_substance": "meloxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010474/201607",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010474-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mequitazine",
            "active_substance": "mequitazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001986/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001986-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meropenem",
            "active_substance": "Meropenem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001989/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zanamivir (except for centrally authorised products)",
            "active_substance": "zanamivir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003141/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003141-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loratadine",
            "active_substance": "loratadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001907/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001907-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cromoglicic acid",
            "active_substance": "cromoglicic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000883/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000883-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Loratadine / pseudoephedrine",
            "active_substance": "loratadine;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001908/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001908-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Manidipine",
            "active_substance": "manidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001932/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001932-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Manidipine",
            "active_substance": "manidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001932/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001932-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mannitol",
            "active_substance": "mannitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010005/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010005-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mannitol",
            "active_substance": "mannitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010005/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010005-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Measles vaccine (live attenuated)",
            "active_substance": "measles vaccine (live attenuated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001938/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001938-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mefloquine",
            "active_substance": "mefloquine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001955/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001955-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meningococcal group a and c polysaccharide vaccine",
            "active_substance": "meningococcal group a and c polysaccharide vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001970/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001970-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meningococcal group a, c, w135, y polysaccharide vaccine",
            "active_substance": "meningococcal group A, C, W-135 and Y conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010602/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010602-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meningococcal group c polysaccharide conjugate vaccine",
            "active_substance": "meningococcal group c polysaccharide conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001971/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001971-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meningococcal group c polysaccharide conjugate vaccine",
            "active_substance": "meningococcal group c polysaccharide conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001971/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001971-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meningococcal group c polysaccharide conjugate vaccine",
            "active_substance": "meningococcal group c polysaccharide conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001971/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001971-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meropenem",
            "active_substance": "Meropenem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001989/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001989-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methadone",
            "active_substance": "methadone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002004/201905",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002004-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metamizole",
            "active_substance": "metamizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001997/202003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mesalazine",
            "active_substance": "Mesalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001990/202002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mesalazine",
            "active_substance": "Mesalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001990/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mesterolone",
            "active_substance": "mesterolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010551/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010551-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metamizole",
            "active_substance": "metamizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001997/202103",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metamizole sodium / triacetonamine tosilate",
            "active_substance": "metamizole sodium;triacetonamine tosilate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001999/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001999-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metamizole",
            "active_substance": "metamizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001997/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metamizole",
            "active_substance": "metamizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001997/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001997-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metformin",
            "active_substance": "Metformin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002001/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metformin",
            "active_substance": "Metformin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002001/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metformin",
            "active_substance": "Metformin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002001/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002001-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methyl salicylate / levomenthol / DL-camphor",
            "active_substance": "methyl salicylate;Levomenthol;DL-camphor",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010117/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010117-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methyl salicylate / levomenthol",
            "active_substance": "Levomenthol;methyl salicylate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010241/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010241-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylaminolevulinate",
            "active_substance": "methylaminolevulinate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002019/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002019-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylphenidate",
            "active_substance": "methylphenidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002024/202110",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylphenidate",
            "active_substance": "methylphenidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002024/201810",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylphenidate",
            "active_substance": "methylphenidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002024/201910",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylprednisolone",
            "active_substance": "methylprednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002026/201411",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylphenidate",
            "active_substance": "methylphenidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002024/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylphenidate",
            "active_substance": "methylphenidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002024/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002024-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylphenobarbital",
            "active_substance": "methylphenobarbital",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002025/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002025-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylprednisolone",
            "active_substance": "methylprednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002026/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylprednisolone",
            "active_substance": "methylprednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002026/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002026-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methysergide",
            "active_substance": "methysergide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002030/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002030-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metoclopramide",
            "active_substance": "metoclopramide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002036/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metoclopramide",
            "active_substance": "metoclopramide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002036/201510",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metoclopramide",
            "active_substance": "metoclopramide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002036/201811",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002036-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metronidazole / neomycin / nystatin",
            "active_substance": "nystatin;neomycin;Metronidazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010508/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010508-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metronidazole / neomycin / nystatin",
            "active_substance": "Metronidazole;neomycin;nystatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010508/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010508-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Metyrapone",
            "active_substance": "metyrapone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002046/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002046-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Miconazole / hydrocortisone, miconazole nitrate / miconazole nitrate, zinc oxide",
            "active_substance": "Miconazole;hydrocortisone;miconazole nitrate;zinc oxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002052/201410",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002052-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Midazolam (all pharmaceutical forms and indications apart from oromucosal solution indicated for the treatment of prolonged, acute, convulsive seizures)",
            "active_substance": "midazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002057/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002057-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mifepristone / misoprostol",
            "active_substance": "mifepristone;misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010378/201705",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010378-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Midodrine",
            "active_substance": "midodrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003178/201606",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003178-201606"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mifepristone / misoprostol",
            "active_substance": "mifepristone;misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010378/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010378-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mifepristone",
            "active_substance": "mifepristone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002060/202005",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002060-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mifepristone",
            "active_substance": "mifepristone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002060/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002060-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Miglitol",
            "active_substance": "Miglitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002061/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002061-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Milnacipran",
            "active_substance": "milnacipran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002063/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002063-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Milnacipran",
            "active_substance": "milnacipran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002063/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002063-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Milnacipran",
            "active_substance": "milnacipran",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002063/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002063-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Milrinone",
            "active_substance": "milrinone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002064/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Milrinone",
            "active_substance": "milrinone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002064/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Milrinone",
            "active_substance": "milrinone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002064/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002064-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minocycline",
            "active_substance": "minocycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002065/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002065-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minoxidil",
            "active_substance": "minoxidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/0002066/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-0002066-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minoxidil",
            "active_substance": "minoxidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002066/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002066-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minoxidil",
            "active_substance": "minoxidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002067/201510",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minoxidil (topical formulation)",
            "active_substance": "minoxidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002067/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minoxidil (topical formulation)",
            "active_substance": "minoxidil",
            "related_medicines": "",
            "procedure_number": "PSUSA-00002067-202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002067-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mirtazapine",
            "active_substance": "mirtazapine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002068/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002068-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/201606",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201606"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gastrointestinal indication)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010291/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010291-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - labor induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - labour induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - labour induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/201605",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - termination of pregnancy)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010354/201705",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA00010291202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa00010291202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - termination of pregnancy)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010354/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - labour induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - labour induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - labour induction)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010353/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010353-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Misoprostol (gynaecological indication - termination of pregnancy)",
            "active_substance": "misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010354/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010354-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mitoxantrone",
            "active_substance": "mitoxantrone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002076/201606",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-201606"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mitoxantrone",
            "active_substance": "mitoxantrone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002076/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mivacurium",
            "active_substance": "mivacurium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002077/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002077-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mizolastine",
            "active_substance": "mizolastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002078/201711",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002078-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moclobemide",
            "active_substance": "moclobemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002079/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002079-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Modafinil",
            "active_substance": "modafinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010242/202108",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Modafinil",
            "active_substance": "modafinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010242/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moxifloxacin (systemic use)",
            "active_substance": "moxifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009231/201905",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009231-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moxifloxacin (systemic use)",
            "active_substance": "moxifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009231/201605",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009231-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Morphine morphine-cyclizine",
            "active_substance": "morphine;cyclizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010549/201710",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010549-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Montelukast",
            "active_substance": "montelukast",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002087/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Montelukast",
            "active_substance": "montelukast",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002087/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Montelukast",
            "active_substance": "montelukast",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002087/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002087-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Modafinil",
            "active_substance": "modafinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010242/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010242-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mometasone",
            "active_substance": "mometasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002085/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002085-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mometasone",
            "active_substance": "mometasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002085/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002085-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nefopam",
            "active_substance": "nefopam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002131/201603",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naproxen",
            "active_substance": "naproxen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002125/201708",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002125-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naftifine",
            "active_substance": "naftifine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002109/202008",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002109-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nafarelin",
            "active_substance": "nafarelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002105/202102",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002105-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nadroparin",
            "active_substance": "nadroparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002104/201803",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002104-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nadroparin",
            "active_substance": "nadroparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002104/202103",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002104-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nadifloxacin",
            "active_substance": "nadifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002102/201605",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002102-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moxifloxacin (topical ophthalmic use)",
            "active_substance": "moxifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002094/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002094-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moxonidine",
            "active_substance": "moxonidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002095/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002095-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mupirocin",
            "active_substance": "mupirocin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002096/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002096-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mxifloxacin (topical ophthalmic use)",
            "active_substance": "moxifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002094/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002094-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mycophenolic acid (apart from mycophenolate mofetil)",
            "active_substance": "mycophenolic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010243/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010243-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mycophenolic acid (apart from mycophenolate mofetil)",
            "active_substance": "mycophenolic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010243/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010243-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "N(2)-L-alanyl-L-glutamine",
            "active_substance": "N(2)-L-alanyl-L-glutamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003158/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003158-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "N(2)-L-alanyl-L-glutamine",
            "active_substance": "N(2)-L-alanyl-L-glutamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003158/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003158-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nabumetone",
            "active_substance": "nabumetone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002101/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002101-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nadifloxacin",
            "active_substance": "nadifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002102/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002102-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nadroparin",
            "active_substance": "nadroparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002104/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002104-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nafarelin",
            "active_substance": "nafarelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002105/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002105-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nafarelin",
            "active_substance": "nafarelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002105/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002105-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naltrexone",
            "active_substance": "naltrexone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002117/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002117-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naltrexone",
            "active_substance": "naltrexone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002117/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002117-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naratriptan",
            "active_substance": "naratriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002126/201702",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002126-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naproxen",
            "active_substance": "naproxen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002125/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002125-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nebivolol",
            "active_substance": "nebivolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002129/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002129-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nicardipine",
            "active_substance": "nicardipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002149/201605",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002149-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nefopam",
            "active_substance": "nefopam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002131/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nifedipine",
            "active_substance": "nifedipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002156/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002156-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nifuroxazide",
            "active_substance": "nifuroxazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002160/202108",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002160-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nifuroxazide",
            "active_substance": "nifuroxazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002160/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002160-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nicergoline",
            "active_substance": "nicergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002150/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002150-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nicergoline",
            "active_substance": "nicergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002150/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002150-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Niclosamide",
            "active_substance": "niclosamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002151/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002151-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nicorandil",
            "active_substance": "nicorandil",
            "related_medicines": "",
            "procedure_number": "PSUSA-00002152-201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002152-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nicorandil",
            "active_substance": "nicorandil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002152/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002152-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lorazepam",
            "active_substance": "lorazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001909/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001909-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nifedipine",
            "active_substance": "nifedipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002156/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002156-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Niflumic acid",
            "active_substance": "niflumic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002157/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Niflumic",
            "active_substance": "niflumic",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002157/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002157-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Donepezil",
            "active_substance": "donepezil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001160/202111",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001160-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acetylsalicylic acid",
            "active_substance": "acetylsalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000039/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000039-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nilutamide",
            "active_substance": "nilutamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002163/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002163-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nimesulide (systemic formulations)",
            "active_substance": "nimesulide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009236/202106",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nimesulide (systemic formulations)",
            "active_substance": "nimesulide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009236/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-201506"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Nimesulide (systemic formulations)",
            "active_substance": "nimesulide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009236/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009236-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nimesulide (topical formulations)",
            "active_substance": "nimesulide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002165/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002165-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "nitrofurantoin;nifurtoinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002174/201802",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002174-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrous oxide, nitrous oxide / oxygen",
            "active_substance": "nitrous oxide;oxygen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010572/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrous oxide, nitrous oxide / oxygen",
            "active_substance": "nitrous oxide;oxygen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010572/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nomegestrol",
            "active_substance": "nomegestrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002181/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nomegestrol",
            "active_substance": "nomegestrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002181/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lisdexamfetamine",
            "active_substance": "lisdexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010289/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010289-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nimodipine",
            "active_substance": "nimodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002166/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002166-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrazepam",
            "active_substance": "nitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002170/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002170-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrazepam",
            "active_substance": "nitrazepam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002170/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002170-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrendipine",
            "active_substance": "nitrendipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002171/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002171-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrendipine",
            "active_substance": "nitrendipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002171/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002171-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrendipine",
            "active_substance": "nitrendipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002171/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002171-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrofurantoin / nifurtoinol",
            "active_substance": "nitrofurantoin;nifurtoinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002174/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002174-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrofurantoin, nifurtoinol",
            "active_substance": "nitrofurantoin;nifurtoinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002174/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002174-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrous oxide, nitrous oxide / oxygen",
            "active_substance": "nitrous oxide;oxygen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010572/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nomegestrol",
            "active_substance": "nomegestrol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002181/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002181-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Norethisterone",
            "active_substance": "norethisterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002188/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002188-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nortriptyline",
            "active_substance": "nortriptyline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002192/201803",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002192-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Numeta",
            "active_substance": "alanine;arginine;aspartic acid;cysteine;glucose;glutamic acid;glycine;histidine;isoleucine;leucine;lysine monohydrate;methionine;ornithine hydrochloride;phenylalanine;proline;serine;taurine;threonine;tryptophan;tyrosine;valine;calcium chloride;magnesium acetate;potassium acetate;sodium chloride;sodium glycerophosphate;olive oil;soya bean oil",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0017",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0017"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Octenidine dihydrochloride / phenoxyethanol",
            "active_substance": "phenoxyethanol;octenidine dihydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002199/201701",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002199-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / atorvastatin",
            "active_substance": "amlodipine;atorvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000177/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000177-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moxonidine",
            "active_substance": "moxonidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002095/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002095-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketoprofen (all formulations except topical)",
            "active_substance": "ketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001809/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001809-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glipizide",
            "active_substance": "glipizide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001535/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001535-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Octenidine dihydrochloride 1-propanol 2-propanol",
            "active_substance": "octenidine dihydrochloride;1-propanol;2-propanol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010417/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010417-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Octenidine",
            "active_substance": "octenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010748/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010748-201907"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "octenidine",
            "active_substance": "octenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010748/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010748-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Octreotide",
            "active_substance": "octreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002201/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002201-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Octreotide",
            "active_substance": "octreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002201/202006",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002201-202006"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Ofloxacin (systemic use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002203/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ofloxacin (systemic use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002203/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ofloxacin (systemic use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002203/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002203-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ofloxacin (topical use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002204/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-201504"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Ofloxacin (topical use)",
            "active_substance": "ofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002204/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002204-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olmesartan",
            "active_substance": "olmesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002207/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002207-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olmesartan",
            "active_substance": "olmesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002207/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002207-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "olodaterol;tiotropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010489/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol / tiotropium",
            "active_substance": "olodaterol;tiotropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010489/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol/tiotropium",
            "active_substance": "olodaterol;tiotropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010489/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010489-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Omega-3-acid-ethyl esters",
            "active_substance": "omega-3-acid-ethyl esters",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010312/201701",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Omeprazole",
            "active_substance": "omeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002215/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002215-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Opium",
            "active_substance": "opium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010670/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Opium",
            "active_substance": "opium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010670/201909",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Opium",
            "active_substance": "opium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010670/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ondansetron",
            "active_substance": "ondansetron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002217/202102",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ondansetron",
            "active_substance": "ondansetron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002217/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ondansetron",
            "active_substance": "ondansetron",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002217/201502",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002217-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Omega-3-acid ethyl esters",
            "active_substance": "omega-3-acid-ethyl esters",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010312/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olodaterol",
            "active_substance": "olodaterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010245/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010245-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olsalazine",
            "active_substance": "olsalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002213/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002213-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Opium",
            "active_substance": "opium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010670/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010670-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxcarbazepine",
            "active_substance": "oxcarbazepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002235/202108",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Labetalol",
            "active_substance": "labetalol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001814/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001814-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lacidipine",
            "active_substance": "lacidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001815/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001815-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lacidipine",
            "active_substance": "lacidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001815/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001815-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lactitol",
            "active_substance": "lactitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001819/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001819-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxcarbazepine",
            "active_substance": "oxcarbazepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002235/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxcarbazepine",
            "active_substance": "oxcarbazepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002235/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxatomide",
            "active_substance": "oxatomide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002233/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002233-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lactulose",
            "active_substance": "lactulose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001821/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001821-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lactulose",
            "active_substance": "lactulose",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001821/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001821-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lamotrigine",
            "active_substance": "lamotrigine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001825/201711",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001825-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxaliplatin",
            "active_substance": "oxaliplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002229/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxaliplatin",
            "active_substance": "oxaliplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002229/201504",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Landiolol",
            "active_substance": "landiolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010570/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Landiolol",
            "active_substance": "landiolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010570/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Landiolol",
            "active_substance": "landiolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010570/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Landiolol",
            "active_substance": "landiolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010570/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Landiolol",
            "active_substance": "landiolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010570/202002",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lanreotide",
            "active_substance": "lanreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001826/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lanreotide",
            "active_substance": "lanreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001826/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lanreotide",
            "active_substance": "lanreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001826/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lanthanum",
            "active_substance": "lanthanum",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003175/202103",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003175-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxaliplatin",
            "active_substance": "oxaliplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002229/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002229-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lanthanum",
            "active_substance": "lanthanum",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003175/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003175-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxcarbazepinexcarbazepine",
            "active_substance": "oxcarbazepine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002235/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002235-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (except for products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001832/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001832-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (except for products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001832/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001832-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxycodone",
            "active_substance": "oxycodone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002254/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxycodone",
            "active_substance": "oxycodone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002254/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxymetazoline",
            "active_substance": "oxymetazoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002258/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002258-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxytocin",
            "active_substance": "Oxytocin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002263/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002263-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxytocin",
            "active_substance": "Oxytocin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002263/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002263-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost (products with paediatric indication)",
            "active_substance": "Latanoprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001834/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001834-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Latanoprost / timolol",
            "active_substance": "Latanoprost;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001833/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001833-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paclitaxel",
            "active_substance": "paclitaxel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002264/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002264-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pamidronate",
            "active_substance": "pamidronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002269/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002269-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pamidronate",
            "active_substance": "pamidronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002269/201505",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002269-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pamidronate",
            "active_substance": "pamidronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002269/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002269-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pancuronium",
            "active_substance": "pancuronium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002275/201912",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002275-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol (IV formulation)",
            "active_substance": "paracetamol (IV formulation)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002311/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quetiapine",
            "active_substance": "quetiapine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002589/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002589-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quetiapine",
            "active_substance": "quetiapine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002589/202006",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002589-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quinagolide",
            "active_substance": "quinagolide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002590/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002590-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quinapril",
            "active_substance": "quinapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002591/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002591-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quinapril",
            "active_substance": "quinapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002591/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002591-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quinine",
            "active_substance": "quinine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002598/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002598-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Quinine",
            "active_substance": "quinine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002598/201611",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002598-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabbit anti-human thymocyte (powder for solution for infusion)",
            "active_substance": "rabbit anti-human thymocyte",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010184/201412",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010184-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabbit anti-human thymocyte (powder for solution for infusion)",
            "active_substance": "rabbit anti-human thymocyte",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010184/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010184-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabbit anti-human T-lymphocyte immunoglobulin",
            "active_substance": "rabbit anti-humanT-lymphocyte immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010252/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010252-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabbit anti-human T-lymphocyte immunoglobulin",
            "active_substance": "rabbit anti-humanT-lymphocyte immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010252/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010252-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabeprazole",
            "active_substance": "rabeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002601/202110",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002601-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabeprazole",
            "active_substance": "rabeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002601/201610",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002601-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabeprazole",
            "active_substance": "rabeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002601/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002601-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabies vaccine",
            "active_substance": "rabies vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009277/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009277-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rabies vaccine",
            "active_substance": "rabies vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009277/201603",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009277-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Racecadotril",
            "active_substance": "racecadotril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002602/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002602-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Racecadotril",
            "active_substance": "racecadotril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002602/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002602-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ranitidine",
            "active_substance": "ranitidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002610/202105",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ranitidine",
            "active_substance": "ranitidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002610/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ranitidine",
            "active_substance": "ranitidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002610/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002610-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Reboxetine",
            "active_substance": "reboxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002615/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002615-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Reboxetine",
            "active_substance": "reboxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002615/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002615-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Reviparin",
            "active_substance": "reviparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002634/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002634-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ribavirin (aerosol application)",
            "active_substance": "ribavirin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010003/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010003-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rilmenidine",
            "active_substance": "rilmenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002643/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rilmenidine",
            "active_substance": "rilmenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002643/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rilmenidine",
            "active_substance": "rilmenidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002643/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002643-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rimexolone",
            "active_substance": "rimexolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002647/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002647-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Risedronate",
            "active_substance": "risedronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002648/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002648-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Risedronate",
            "active_substance": "risedronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002648/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002648-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Risperidone",
            "active_substance": "risperidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002649/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002649-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rizatriptan",
            "active_substance": "rizatriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002655/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002655-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rocuronium",
            "active_substance": "rocuronium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002656/201902",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rocuronium",
            "active_substance": "rocuronium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002656/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ropinirole",
            "active_substance": "ropinirole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002661/201607",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ropinirole",
            "active_substance": "ropinirole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002661/201907",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ropivacaine",
            "active_substance": "ropivacaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002662/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002662-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rosuvastatin",
            "active_substance": "rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002664/201711",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002664-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Roxithromycin",
            "active_substance": "roxithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002669/201612",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Roxithromycin",
            "active_substance": "roxithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002669/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Roxithromycin",
            "active_substance": "roxithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002669/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rubella vaccine (live, attenuated)",
            "active_substance": "rubella vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002670/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002670-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rubidium chloride RB-82",
            "active_substance": "rubidium (82Rb) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010806/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rubidium chloride RB-82",
            "active_substance": "rubidium (82Rb) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010806/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rupatadine",
            "active_substance": "rupatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002673/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rupatadine",
            "active_substance": "rupatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002673/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rupatadine",
            "active_substance": "rupatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002673/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rupatadine",
            "active_substance": "rupatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002673/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rupatadine",
            "active_substance": "rupatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002673/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002673-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Roxithromycin",
            "active_substance": "roxithromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002669/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002669-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Permethrin",
            "active_substance": "permethrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002355/201707",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002355-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Permethrin",
            "active_substance": "permethrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002355/201808",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002355-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Perindopril",
            "active_substance": "perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002354/201510",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002354-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Perindopril",
            "active_substance": "perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002354/202010",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002354-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pergolide",
            "active_substance": "pergolide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002351/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002351-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Saccharomyces boulardii",
            "active_substance": "saccharomyces boulardii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009284/202002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009284-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Saccharomyces boulardii",
            "active_substance": "saccharomyces boulardii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009284/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009284-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "peppermint oil (63557)",
            "active_substance": "peppermint oil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010436/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010436-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Salmeterol",
            "active_substance": "salmeterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002681/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002681-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Salmeterol/fluticasone propionate",
            "active_substance": "salmeterol;fluticasone propionate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001455/201410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001455-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pentoxyverine",
            "active_substance": "pentoxyverine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002345/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002345-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Salmeterol",
            "active_substance": "salmeterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002681/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002681-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pentamidine",
            "active_substance": "pentamidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002338/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002338-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Penciclovir",
            "active_substance": "penciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002333/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002333-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Penciclovir",
            "active_substance": "penciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002333/202108",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002333-202108"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pelargonium sidoides dc and/or pelargonium reniforme curt. / radix",
            "active_substance": "pelargonium sidoides dc;pelargonium reniforme curt. / radix",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002329/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002329-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pefloxacin",
            "active_substance": "pefloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002322/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002322-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Patent blue V sodium",
            "active_substance": "patent blue V sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002320/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002320-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertraline",
            "active_substance": "sertraline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002696/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002696-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paroxetine",
            "active_substance": "paroxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002319/201712",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002319-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sevoflurane",
            "active_substance": "sevoflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002698/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002698-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paricalcitol",
            "active_substance": "paricalcitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002316/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002316-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sevoflurane",
            "active_substance": "sevoflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002698/202001",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002698-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paricalcitol",
            "active_substance": "paricalcitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002316/201908",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002316-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Silver sulfadiazine",
            "active_substance": "silver sulfadiazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002702/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002702-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Simvastatin",
            "active_substance": "simvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002709/201704",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002709-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Simvastatin",
            "active_substance": "simvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002709/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002709-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paraffin liquid",
            "active_substance": "Paraffin liquid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009251/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009251-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium benzoate / grindelia tincture / polygala syrup",
            "active_substance": "sodium benzoate;grindelia tincture;polygala syrup",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010543/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010543-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium iodide (131i)",
            "active_substance": "sodium iodide (131I)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002753/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002753-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium iron gluconate (parenteral preparations)",
            "active_substance": "sodium iron gluconate (parenteral preparations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010867/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010867-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium oxybate (intravenous use)",
            "active_substance": "sodium oxybate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010613/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010613-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium oxybate (intravenous use)",
            "active_substance": "sodium oxybate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010613/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010613-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium oxybate (intravenous use)",
            "active_substance": "sodium oxybate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010613/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010613-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium tetradecyl sulphate",
            "active_substance": "sodium tetradecyl sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002767/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002767-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Solifenacin / tamsulosin",
            "active_substance": "solifenacin;tamsulosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010285/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010285-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol/pseudoephedrine",
            "active_substance": "paracetamol;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002307/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002307-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Solifenacin-tamsulosin",
            "active_substance": "solifenacin;tamsulosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010285/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010285-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Solifenacin/tamsulosin",
            "active_substance": "solifenacin;tamsulosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010285/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010285-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol / tramadol",
            "active_substance": "paracetamol;tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002310/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002310-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol / tramadol",
            "active_substance": "paracetamol;tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002310/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002310-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Solifenacin",
            "active_substance": "solifenacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002769/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002769-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Solifenacin",
            "active_substance": "solifenacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002769/202006",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002769-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol (IV formulation)",
            "active_substance": "paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002311/201805",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sotalol",
            "active_substance": "sotalol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002774/201908",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002774-201908"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Soybean phospholipids (oral use)",
            "active_substance": "soybean phospholipids (oral use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010707/202110",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010707-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Spironolactone",
            "active_substance": "spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002780/201503",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002780-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Spironolactone",
            "active_substance": "spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002780/202103",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002780-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Spironolactone",
            "active_substance": "spironolactone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002780/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002780-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Strontium [89sr] chloride",
            "active_substance": "strontium (89sr) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002795/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002795-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol (IV formulation)",
            "active_substance": "paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002311/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol (IV formulation)",
            "active_substance": "paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002311/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paracetamol (IV formulation)",
            "active_substance": "paracetamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002311/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002311-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenobarbital",
            "active_substance": "phenobarbital",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002370/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002370-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pethidine",
            "active_substance": "pethidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002357/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002357-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Permethrin",
            "active_substance": "permethrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002355/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002355-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenol",
            "active_substance": "phenol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009256/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009256-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenylephrine (ophthalmic formulations)",
            "active_substance": "phenylephrine (ophthalmic formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010402/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010402-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulbactam",
            "active_substance": "sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002800/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002800-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulbactam",
            "active_substance": "sulbactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002800/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002800-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulfamethizole",
            "active_substance": "sulfamethizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010561/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010561-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulfametrole / trimethoprim, sulfadiazine / trimethoprim, sulfamethoxazole / trimethoprim (co-trimoxazole)",
            "active_substance": "sulfametrole;trimethoprim;sulfadiazine;sulfamethoxazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010593/201903",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010593-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenylephrine / tropicamide",
            "active_substance": "phenylephrine;tropicamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010430/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010430-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulprostone",
            "active_substance": "sulprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002828/201604",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002828-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sultamicillin",
            "active_substance": "sultamicillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002829/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002829-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sultamicillin",
            "active_substance": "sultamicillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002829/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002829-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sumatriptan",
            "active_substance": "sumatriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002832/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002832-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sumatriptan",
            "active_substance": "sumatriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002832/201909",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002832-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Suxamethonium",
            "active_substance": "suxamethonium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002834/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002834-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Suxamethonium",
            "active_substance": "suxamethonium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002834/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002834-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Urapidil",
            "active_substance": "urapidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003078/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003078-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Urapidil",
            "active_substance": "urapidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003078/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003078-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Urapidil",
            "active_substance": "urapidil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003078/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003078-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Urofollitropin",
            "active_substance": "urofollitropin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003082/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003082-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ursodeoxycholic acid",
            "active_substance": "ursodeoxycholic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003084/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003084-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenylephrine hydrochloride / tropicamide",
            "active_substance": "tropicamide;phenylephrine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010430/201711",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010430-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Yellow fever vaccine (live)",
            "active_substance": "yellow fever vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003135/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Yellow fever vaccine (live)",
            "active_substance": "yellow fever vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003135/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Yellow fever vaccine (live)",
            "active_substance": "yellow fever vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003135/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zafirlukast",
            "active_substance": "zafirlukast",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003138/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003138-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zaleplon",
            "active_substance": "zaleplon",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003140/201907",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003140-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zanamivir",
            "active_substance": "zanamivir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003141/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003141-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zidovudine",
            "active_substance": "zidovudine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003143/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003143-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zidovudine",
            "active_substance": "zidovudine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003143/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003143-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ziprasidone",
            "active_substance": "ziprasidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003146/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003146-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ziprasidone",
            "active_substance": "ziprasidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003146/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003146-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Zolmitriptan",
            "active_substance": "zolmitriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003150/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003150-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenylephrine",
            "active_substance": "phenylephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002378/201501",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002378-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenylpropanolamine",
            "active_substance": "phenylpropanolamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010483/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010483-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenylpropanolamine",
            "active_substance": "phenylpropanolamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010483/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010483-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phenytoin",
            "active_substance": "phenytoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002392/202008",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002392-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phloroglucinol, phloroglucinol trimethylphloroglucinol",
            "active_substance": "phloroglucinol;phloroglucinol trimethylphloroglucinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010355/201809",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phloroglucinol, phloroglucinol / trimethylphloroglucinol",
            "active_substance": "phloroglucinol;trimethylphloroglucinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010355/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valaciclovir",
            "active_substance": "valaciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003086/201512",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003086-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valaciclovir",
            "active_substance": "valaciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003086/201812",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003086-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valganciclovir",
            "active_substance": "valganciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003089/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003089-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valganciclovir",
            "active_substance": "valganciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003089/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003089-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vinorelbine",
            "active_substance": "vinorelbine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003124/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003124-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vigabatrin",
            "active_substance": "vigabatrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003112/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003112-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vigabatrin",
            "active_substance": "vigabatrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003112/201409",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003112-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phloroglucinol, phloroglucinol/trimethylphloroglucinol",
            "active_substance": "phloroglucinol;trimethylphloroglucinol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010355/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010355-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pholcodine / biclotymol / chlorphenamine maleate",
            "active_substance": "Pholcodine;biclotymol;chlorphenamine maleate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010437/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010437-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pholcodine / biclotymol / chlorphenamine maleate",
            "active_substance": "Pholcodine;biclotymol;chlorphenamine maleate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010437/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010437-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pholcodine",
            "active_substance": "Pholcodine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002396/202105",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002396-202105"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pholcodine",
            "active_substance": "Pholcodine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002396/201905",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002396-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Verapamil",
            "active_substance": "verapamil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003105/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003105-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Venlafaxine",
            "active_substance": "venlafaxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003104/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003104-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vecuronium bromide",
            "active_substance": "vecuronium bromide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003102/202011",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003102-202011"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vecuronium bromide",
            "active_substance": "vecuronium bromide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003102/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003102-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Varicella zoster-immunoglobulin",
            "active_substance": "varicella zoster-immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010266/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010266-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Varicella zoster-immunoglobulin",
            "active_substance": "varicella zoster-immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010266/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010266-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Varicella vaccine (live)",
            "active_substance": "varicella vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010473/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vancomycin",
            "active_substance": "vancomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003097/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003097-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vancomycin",
            "active_substance": "vancomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003097/202001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003097-202001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valsartan, hydrochlorothiazide / valsartan",
            "active_substance": "valsartan;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010396/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valsartan, hydrochlorothiazide / valsartan",
            "active_substance": "valsartan;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010396/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valsartan / rosuvastatin",
            "active_substance": "valsartan;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010735/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010735-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valproic acid, sodium valproate, valproate pivoxil,  valproate semisodium, valpromide, valproate bismuth, calcium valproate, valproate magnesium",
            "active_substance": "valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpromide;valproate bismuth;calcium valproate;valproate magnesium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003090/201801",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valproic acid, sodium valproate, valproate pivoxil,  valproate semisodium, valpriomide, valproate bismuth, calcium valproate, valproate magnesium",
            "active_substance": "valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpriomide;valproate bismuth;calcium valproate;valproate magnesium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003090/202101",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valproic acid/sodium valproate/valproate pivoxil/valproate semisodium/valpromide/valproate bismuth/calcium valproate/valproate magnesium",
            "active_substance": "valproic acid;sodium valproate;valproate pivoxil;valproate semisodium;valpromide;valproate bismuth;calcium valproate;valproate magnesium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003090/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003090-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pholcodine",
            "active_substance": "Pholcodine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002396/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002396-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pilocarpine (non ophthalmic formulations)",
            "active_substance": "pilocarpine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002409/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002409-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pitavastatin",
            "active_substance": "pitavastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010502/201907",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-201907"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piroxicam",
            "active_substance": "piroxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002438/202004",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002438-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pitavastatin",
            "active_substance": "pitavastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010502/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pitavastatin",
            "active_substance": "pitavastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010502/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piribedil",
            "active_substance": "piribedil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002436/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002436-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piribedil",
            "active_substance": "piribedil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002436/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002436-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piretanide",
            "active_substance": "piretanide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002433/201810",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002433-201810"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piretanide",
            "active_substance": "piretanide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002433/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002433-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piretanide",
            "active_substance": "piretanide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002433/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002433-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piracetam",
            "active_substance": "piracetam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002429/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002429-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pipobroman",
            "active_substance": "pipobroman",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002427/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002427-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piperacillin / tazobactam",
            "active_substance": "tazobactam;piperacillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002425/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002425-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pimecrolimus",
            "active_substance": "pimecrolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002411/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pimecrolimus",
            "active_substance": "pimecrolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002411/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pimecrolimus",
            "active_substance": "pimecrolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002411/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pimecrolimus",
            "active_substance": "pimecrolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002411/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002411-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pilocarpine / timolol",
            "active_substance": "pilocarpine;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002408/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002408-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pilocarpine / timolol",
            "active_substance": "pilocarpine;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002408/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002408-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pilocarpine (ophthalmic formulation)",
            "active_substance": "pilocarpine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002410/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002410-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Primidone",
            "active_substance": "primidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002525/202006",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002525-202006"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Praziquantel",
            "active_substance": "praziquantel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002503/202104",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002503-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tafluprost / timolol",
            "active_substance": "tafluprost;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010324/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010324-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tafluprost / timolol",
            "active_substance": "tafluprost;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010324/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010324-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tafluprost",
            "active_substance": "tafluprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002843/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tafluprost",
            "active_substance": "tafluprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002843/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tafluprost",
            "active_substance": "tafluprost",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002843/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002843-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Praziquantel",
            "active_substance": "praziquantel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002503/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002503-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tamoxifen",
            "active_substance": "tamoxifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002846/202004",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002846-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pravastatin",
            "active_substance": "pravastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002500/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002500-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pravastatin",
            "active_substance": "pravastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002500/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002500-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tamoxifen",
            "active_substance": "tamoxifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002846/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002846-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pramiracetam",
            "active_substance": "pramiracetam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002492/201909",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002492-201909"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tamsulosin",
            "active_substance": "tamsulosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002847/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002847-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tamsulosin",
            "active_substance": "tamsulosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002847/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002847-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pramiracetam",
            "active_substance": "pramiracetam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002492/201409",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002492-201409"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Potassium para aminobenzoate",
            "active_substance": "potassium para aminobenzoate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010130/202002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010130-202002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Potassium para aminobenzoate",
            "active_substance": "potassium para aminobenzoate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010130/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010130-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Porfimer",
            "active_substance": "porfimer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010332/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010332-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tapentadol",
            "active_substance": "tapentadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002849/201711",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tapentadol",
            "active_substance": "tapentadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002849/201811",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Porfimer",
            "active_substance": "porfimer",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010332/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010332-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tapentadol",
            "active_substance": "tapentadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002849/202111",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002849-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Polystyrene sulfonate",
            "active_substance": "polystyrene sulfonate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002472/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002472-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Polystyrene sulfonate",
            "active_substance": "polystyrene sulfonate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002472/202010",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002472-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Poly (o-2-hydroxyethyl) starch",
            "active_substance": "poly (o-2-hydroxyethyl) starch",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0009",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tauroselcholic (75Se) acid",
            "active_substance": "tauroselcholic (75Se) acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010486/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010486-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine",
            "active_substance": "poliovirus type 1;poliovirus type 3 (oral, live, attenuated) vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010339/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010339-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine",
            "active_substance": "poliovirus type 1 vaccine;poliovirus type 3 vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002460/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002460-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine",
            "active_substance": "poliovirus type 1 / poliovirus type 3 (oral, live, attenuated) vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010642/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010642-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium (99mTc) bicisate",
            "active_substance": "technetium (99mTc) bicisate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002856/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002856-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated)",
            "active_substance": "poliovirus type 1;poliovirus type 2;poliovirus type 3",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002458/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002458-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Podophyllotoxin",
            "active_substance": "podophyllotoxin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002454/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002454-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium (99mTc) hynic-octeotide",
            "active_substance": "technetium (99mTc) hynic-octeotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010521/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010521-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Plasma protein fraction",
            "active_substance": "plasma protein fraction",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002449/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002449-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium (99mTc) pertechnetate",
            "active_substance": "technetium (99mTc) pertechnetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002866/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002866-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium (99mTc) pertechnetate",
            "active_substance": "technetium (99mTc) pertechnetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002866/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002866-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium (99mTc) tetrofosmin, tetrofosmin",
            "active_substance": "technetium (99mTc) tetrofosmin;tetrofosmin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002870/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002870-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium 99mtc sestamibi",
            "active_substance": "technetium (99mTc) sestamibi",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002868/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002868-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Technetium (99mtc) mebrofenin",
            "active_substance": "technetium (99mtc) mebrofenin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002861/201511",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002861-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Promestriene (cream and vaginal capsules)",
            "active_substance": "promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009271/202103",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Promestriene (cream and vaginal capsules)",
            "active_substance": "promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009271/201703",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Propofol",
            "active_substance": "propofol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002555/201711",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002555-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Prulifloxacin",
            "active_substance": "prulifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002569/201410",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Prulifloxacin",
            "active_substance": "prulifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002569/201710",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pseudoephedrine, acetylsalicylic acid / pseudoephedrine",
            "active_substance": "pseudoephedrine;acetylsalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010667/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010667-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pseudoephedrine, triprolidine",
            "active_substance": "pseudoephedrine;triprolidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003047/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pseudoephedrine / triprolidiner",
            "active_substance": "pseudoephedrine;triprolidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003047/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pseudoephedrine / triprolidine",
            "active_substance": "pseudoephedrine;triprolidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003047/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003047-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Prulifloxacin",
            "active_substance": "prulifloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002569/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002569-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Teicoplanin",
            "active_substance": "teicoplanin",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/S/0025",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-s-0025"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Teicoplanin",
            "active_substance": "teicoplanin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002878/202111",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002878-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Teicoplanin",
            "active_substance": "teicoplanin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002878/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002878-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tenonitrozole",
            "active_substance": "tenonitrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003185/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003185-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tenoxicam",
            "active_substance": "tenoxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002893/202102",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002893-202102"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tenoxicam",
            "active_substance": "tenoxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002893/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002893-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tenoxicam",
            "active_substance": "tenoxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002893/201502",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002893-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terazosin",
            "active_substance": "terazosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002895/201811",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002895-201811"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terazosin",
            "active_substance": "terazosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002895/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002895-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terbinafine",
            "active_substance": "terbinafine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002896/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002896-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terbutaline",
            "active_substance": "terbutaline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002897/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002897-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terlipressin",
            "active_substance": "terlipressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002905/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002905-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terlipressin",
            "active_substance": "terlipressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002905/201804",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002905-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terlipressin",
            "active_substance": "terlipressin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002905/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002905-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone (all formulations apart from topical use and testosterone undecanoate injection)",
            "active_substance": "testosterone;testosterone undecanoate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002907/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002907-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone (all formulations apart from topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010631/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010631-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone (all formulations apart from topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010631/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010631-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone (topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002908/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone (topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002908/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone (topical use)",
            "active_substance": "testosterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002908/201812",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002908-201812"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone undecanoate (injection)",
            "active_substance": "testosterone undecanoate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010161/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010161-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone undecanoate (injection)",
            "active_substance": "testosterone undecanoate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010161/201512",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010161-201512"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Testosterone undecylate (injection)",
            "active_substance": "testosterone undecylat",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010161/201411",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010161-201411"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetanus vaccines",
            "active_substance": "tetanus vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002910/201501",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002910-201501"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetanus vaccines",
            "active_substance": "tetanus vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002910/201801",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002910-201801"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetrabenazine",
            "active_substance": "tetrabenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002911/201410",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetrabenazine",
            "active_substance": "tetrabenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002911/201510",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-201510"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetrabenazine",
            "active_substance": "tetrabenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002911/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetrabenazine",
            "active_substance": "tetrabenazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002911/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002911-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Promestriene (cream and vaginal capsules)",
            "active_substance": "promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009271/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Promestriene (cream and vaginal capsules)",
            "active_substance": "promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009271/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Promestriene (cream and vaginal capsules)",
            "active_substance": "promestriene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009271/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009271-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Propafenone",
            "active_substance": "propafenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002550/202101",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002550-202101"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Propafenone",
            "active_substance": "propafenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002550/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002550-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tixocortol, chlorhexidine gluconate / tixocortol pivalate",
            "active_substance": "tixocortol pivalate;chlorhexidine gluconate;tixocortol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010333/201611",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010333-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tixocortol, chlorhexidine gluconate / tixocortol pivalate",
            "active_substance": "tixocortol;chlorhexidine gluconate;tixocortol pivalate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010333/201911",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010333-201911"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tizanidine",
            "active_substance": "tizanidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002977/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002977-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tizanidine",
            "active_substance": "tizanidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002977/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002977-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tobramycin (nebuliser solution) (apart from centrally authorised product)",
            "active_substance": "tobramycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009316/201712",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009316-201712"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tobramycin (nebuliser solution)",
            "active_substance": "tobramycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009316/202012",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009316-202012"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tobramycin (nebuliser solution)",
            "active_substance": "tobramycin",
            "related_medicines": "",
            "procedure_number": "SUSA/00009316/201412",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/susa-00009316-201412"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tobramycin (ophthalmic and otic use)",
            "active_substance": "tobramycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009317/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009317-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tobramycin (ophthalmic and otic use)",
            "active_substance": "tobramycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009317/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009317-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tobramycin (systemic use)",
            "active_substance": "tobramycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009318/202009",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009318-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tolperisone",
            "active_substance": "tolperisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002991/201906",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002991-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tolterodine",
            "active_substance": "tolterodine",
            "related_medicines": "",
            "procedure_number": "PSUSA-00002993-202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002993-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tolterodine",
            "active_substance": "tolterodine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002993/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002993-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Topiramate",
            "active_substance": "topiramate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002996/201701",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002996-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Topotecan",
            "active_substance": "topotecan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002997/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002997-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tramadol",
            "active_substance": "tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003002/201705",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003002-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tramadol",
            "active_substance": "tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003002/202005",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003002-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trandolapril / verapamil",
            "active_substance": "trandolapril;verapamil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003005/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003005-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trandolapril / verapamil",
            "active_substance": "trandolapril;verapamil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003005/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003005-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trandolapril",
            "active_substance": "trandolapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003004/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003004-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treosulfan",
            "active_substance": "treosulfan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009319/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009319-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiludronic acid",
            "active_substance": "tiludronic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002959/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002959-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Timolol (eye preparations)",
            "active_substance": "timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010439/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010439-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Timolol (eye preparations)",
            "active_substance": "timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010439/201607",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010439-201607"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Timolol (systemic use)",
            "active_substance": "timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010432/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010432-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Timolol (systemic use)",
            "active_substance": "timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010432/201910",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010432-201910"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tioconazole, tioconazole / hydrocortisone",
            "active_substance": "tioconazole;hydrocortisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010382/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010382-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiotropium",
            "active_substance": "tiotropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002972/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002972-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiotropium",
            "active_substance": "tiotropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002972/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002972-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tirofiban",
            "active_substance": "tirofiban",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002974/201605",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002974-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tirofiban",
            "active_substance": "tirofiban",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002974/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002974-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ticlopidine",
            "active_substance": "ticlopidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002952/202005",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002952-202005"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ticlopidine",
            "active_substance": "ticlopidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002952/201505",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002952-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Theophylline",
            "active_substance": "theophylline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002921/201706",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002921-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Thiamphenicol",
            "active_substance": "thiamphenicol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002925/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002925-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Thiamphenicol",
            "active_substance": "thiamphenicol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002925/201505",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002925-201505"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Thiocolchicoside",
            "active_substance": "thiocolchicoside",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002927/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002927-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Thiocolchicoside",
            "active_substance": "thiocolchicoside",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0008",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Thiocolchicoside",
            "active_substance": "thiocolchicoside",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0023",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0023"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Thiopental",
            "active_substance": "thiopental",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002929/201603",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002929-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiagabine",
            "active_substance": "tiagabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002942/202106",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiagabine",
            "active_substance": "tiagabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002942/201806",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiagabine",
            "active_substance": "tiagabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002942/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002942-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tianeptine",
            "active_substance": "tianeptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002943/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tianeptine",
            "active_substance": "tianeptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002943/201806",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-201806"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tianeptine",
            "active_substance": "tianeptine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002943/201506",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002943-201506"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiapride",
            "active_substance": "tiapride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002944/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiapride",
            "active_substance": "tiapride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002944/201807",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tiapride",
            "active_substance": "tiapride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002944/201507",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002944-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tibolone",
            "active_substance": "tibolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002947/201912",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002947-201912"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tibolone",
            "active_substance": "tibolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002947/201612",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002947-201612"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tick-borne encephalitis vaccine (inactivated)",
            "active_substance": "tick-borne encephalitis vaccine (inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002951/201701",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002951-201701"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treprostinil",
            "active_substance": "treprostinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003013/201711",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201711"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treprostinil",
            "active_substance": "treprostinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003013/201611",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201611"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treprostinil",
            "active_substance": "treprostinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003013/201511",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201511"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treprostinil",
            "active_substance": "treprostinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003013/201805",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201805"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treprostinil",
            "active_substance": "treprostinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003013/201905",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201905"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treprostinil",
            "active_substance": "treprostinil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003013/201605",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003013-201605"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Typhoid vaccine (live, attenuated)",
            "active_substance": "typhoid vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003067/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003067-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Typhoid vaccine (live, attenuated)",
            "active_substance": "typhoid vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003067/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003067-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Typhoid polysaccharide vaccine",
            "active_substance": "typhoid polysaccharide vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003065/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003065-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Typhoid polysaccharide vaccine",
            "active_substance": "typhoid polysaccharide vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003065/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003065-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tuberculin purified protein derivative",
            "active_substance": "tuberculin purified protein derivative",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003063/202109",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003063-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tuberculin purified protein derivative",
            "active_substance": "tuberculin purified protein derivative",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003063/201609",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003063-201609"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triptorelin",
            "active_substance": "triptorelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003048/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003048-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003043/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003043/201608",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003043/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003043/202008",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003043-202008"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/0001",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-0001"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0002",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0002"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trimetazidine",
            "active_substance": "trimetazidine",
            "related_medicines": "",
            "procedure_number": "EMEA/H/N/PSR/J/0003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/emea-h-n-psr-j-0003-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triglyceride combinations (e.g. olive oil, soya bean oil, fish oil)/ with or without mineral compounds/electrolytes (i.v. application)",
            "active_substance": "triglyceride combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010648/202106",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010648-202106"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triazolam",
            "active_substance": "triazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003023/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003023-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tretinoin (oral formulations)",
            "active_substance": "tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003015/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003015-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tretinoin (topical formulations)",
            "active_substance": "tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003016/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003016-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone (tablets and injectables)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010137/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010137-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone (topical and nasal formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003017/201707",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003017-201707"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/201603",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/201503",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-201503"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lamivudine / tenofovir disoproxil",
            "active_substance": "lamivudine;tenofovir disoproxil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010751/202003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010751-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lactitol",
            "active_substance": "lactitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001819/202009",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001819-202009"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/201804",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-201804"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (topical use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010376/202104",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010376-202104"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Itraconazole",
            "active_substance": "Itraconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001798/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001798-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Itopride",
            "active_substance": "itopride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010606/201906",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010606-201906"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol / norethisterone",
            "active_substance": "estradiol;norethisterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001278/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001278-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol, estradiol /prednisolone (only cream/balm/emulsion for application in the female genital area)",
            "active_substance": "estradiol;prednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010441/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010441-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol, estradiol /prednisolone (only cream/balm/emulsion for application in the female genital area)",
            "active_substance": "estradiol;prednisolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010441/202004",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010441-202004"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Exametazime/technetium (99mTc) exametazime",
            "active_substance": "exametazime;technetium (99mTc) exametazime",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001344/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001344-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Everolimus (indicated for rejection of transplanted organs)",
            "active_substance": "everolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010269/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Everolimus (indicated for rejection of transplanted organs)",
            "active_substance": "everolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010269/201807",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-201807"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Everolimus (indicated for rejection of transplanted organs)",
            "active_substance": "everolimus",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010269/201507",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010269-201507"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etoricoxib",
            "active_substance": "etoricoxib",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001334/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001334-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etoposide",
            "active_substance": "etoposide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001333/201602",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001333-201602"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etoposide",
            "active_substance": "etoposide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001333/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001333-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etonogestrel",
            "active_substance": "etonogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001331/202109",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-202109"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etonogestrel",
            "active_substance": "etonogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001331/201809",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-201809"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etonogestrel",
            "active_substance": "etonogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001331/201509",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001331-201509"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etomidate",
            "active_substance": "etomidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001330/201709",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001330-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etifoxine",
            "active_substance": "etifoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001321/202010",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-202010"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etifoxine",
            "active_substance": "etifoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001321/201710",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-201710"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etifoxine",
            "active_substance": "etifoxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001321/201410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001321-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etidronate",
            "active_substance": "etidronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001320/201709",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001320-201709"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethosuximide",
            "active_substance": "ethosuximide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001316/202003",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001316-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / norgestimate",
            "active_substance": "ethinylestradiol;norgestimate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001313/202110",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001313-202110"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / norgestimate",
            "active_substance": "ethinylestradiol;norgestimate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001313/201610",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001313-201610"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / norethisterone",
            "active_substance": "ethinylestradiol;norethisterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001312/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001312-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / levonorgestrel",
            "active_substance": "ethinylestradiol;levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001309/201604",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001309-201604"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / levonorgestrel",
            "active_substance": "ethinylestradiol;levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001309/201904",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001309-201904"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001308/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001308-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene (except for transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001308/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001308-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / etonogestrel",
            "active_substance": "ethinylestradiol;etonogestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001307/202007",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001307-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol, gestodene (transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010145/201502",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201502"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene (transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010145/201802",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201802"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene (transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010145/201708",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201708"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene (transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010145/201608",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201608"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene (transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010145/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / gestodene (transdermal application)",
            "active_substance": "ethinylestradiol;gestodene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010145/201702",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010145-201702"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethanol / orthophenylphenol",
            "active_substance": "Ethanol;orthophenylphenol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010416/201902",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010416-201902"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Interferon gamma",
            "active_substance": "Interferon gamma",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001760/201601",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001760-201601"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Interferon gamma",
            "active_substance": "Interferon gamma",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001760/201901",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001760-201901"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Interferon alpha-2a",
            "active_substance": "interferon alpha-2a",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009197/201706",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009197-201706"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Insulin porcine",
            "active_substance": "insulin porcine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001756/201410",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001756-201410"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Inosine dimepranol acedoben",
            "active_substance": "inosine dimepranol acedoben",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010425/201808",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010425-201808"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, virosome)",
            "active_substance": "influenza vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001746/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001746-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, virosome)",
            "active_substance": "influenza vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001746/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001746-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/201508",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "active_substance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010300/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010300-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "active_substance": "Influenza vaccine (split virion, inactivated, prepared in cell cultures)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010299/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010299-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/201504",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201504"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/201508",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201508"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/201603",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201603"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/201703",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201703"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/201803",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201803"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/201903",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-201903"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/202003",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202003"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/202103",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202103"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indoramin",
            "active_substance": "indoramin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001740/201809",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001740-201809"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "indometacin",
            "active_substance": "indometacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001738/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001738-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indobufen",
            "active_substance": "indobufen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001736/201705",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001736-201705"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indium (In-111) chloride, indium (In-111) oxine",
            "active_substance": "indium (In-111) chloride;indium (In-111) oxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001734/202107",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001734-202107"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Indium (111In) pentetate",
            "active_substance": "indium (111In) pentetate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009191/202007",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009191-202007"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piroxicam",
            "active_substance": "piroxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002438/201704",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002438-201704"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ciclosporin (systemic use)",
            "active_substance": "ciclosporin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000745/202112",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000745-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terbutaline",
            "active_substance": "terbutaline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002897/202112",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002897-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valaciclovir",
            "active_substance": "valaciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003086/202112",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003086-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum toxin a",
            "active_substance": "botulinum toxin a",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000426/202112",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000426-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bupropion",
            "active_substance": "bupropion",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000461/202112",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000461-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexketoprofen / tramadol",
            "active_substance": "dexketoprofen;tramadol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010468/202201",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010468-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Botulinum neurotoxin type a (150 kD) free from complexing proteins",
            "active_substance": "botulinum neurotoxin type a (150 kd) free from complexing proteins",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009084/202112",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009084-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexlansoprazole, lansoprazole",
            "active_substance": "dexlansoprazole;lansoprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001827/202112",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001827-202112"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbomers",
            "active_substance": "carbomers",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000557/202201",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000557-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rocuronium",
            "active_substance": "rocuronium",
            "related_medicines": "",
            "procedure_number": "PSUSA-00002656-202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002656-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aviptadil / phentolamine mesilate",
            "active_substance": "aviptadil;phentolamine mesilate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010814/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010814-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprazolam",
            "active_substance": "alprazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000109/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000109-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "fluticasone propionate",
            "active_substance": "fluticasone propionate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001454/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001454-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Phleum Pratense (oromucosal use, product authorised via mutually recognition procedure)",
            "active_substance": "allergen for therapy: Phleum Pratense",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010475/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010475-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "amlodipine",
            "active_substance": "amlodipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000174/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000174-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "cabergoline",
            "active_substance": "cabergoline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000477/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000477-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aprotinin",
            "active_substance": "aprotinin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000230/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000230-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nicorandil",
            "active_substance": "nicorandil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002152/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002152-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eplerenone",
            "active_substance": "eplerenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001236/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001236-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "clodronic acid, clodronic acid / lidocaine",
            "active_substance": "clodronic acid;lidocaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010650/202202",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010650-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Naratriptan",
            "active_substance": "naratriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002126/202202",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002126-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Chloroprocaine hydrochloride",
            "active_substance": "chloroprocaine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010078/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010078-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dorzolamide",
            "active_substance": "dorzolamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003168/202202",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003168-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketoprofen (topical use only)",
            "active_substance": "ketoprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009205/202201",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009205-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mesalazine",
            "active_substance": "Mesalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001990/202202",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001990-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carboplatin",
            "active_substance": "carboplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000559/202201",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000559-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Frovatriptan",
            "active_substance": "frovatriptan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001484/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001484-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gabapentin",
            "active_substance": "gabapentin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001499/202202",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001499-202202"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mesterolone",
            "active_substance": "mesterolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010551/202201",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010551-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levothyroxine",
            "active_substance": "levothyroxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001860/202201",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001860-202201"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human rabies immunoglobulin",
            "active_substance": "human rabies immunoglobulin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001639/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001639-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Itraconazole",
            "active_substance": "Itraconazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001798/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001798-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Linezolid",
            "active_substance": "linezolid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001888/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001888-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mupirocin",
            "active_substance": "mupirocin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002096/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002096-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Gentamicin (implant)",
            "active_substance": "gentamicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010628/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010628-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ozenoxacin",
            "active_substance": "Ozenoxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010651/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010651-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lidocaine / prilocaine (not centrally authorised product)",
            "active_substance": "lidocaine;prilocaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001867/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001867-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tretinoin (oral formulations)",
            "active_substance": "tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003015/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003015-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glucosamine",
            "active_substance": "glucosamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001539/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001539-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed), diphtheria / tetanus / pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents",
            "active_substance": "pertussis (acellular, component) vaccine (adsorbed), diphtheria;tetanus;pertussis (acellular, component) vaccine (adsorbed) reduced antigens contents;diphtheria vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001125/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001125-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Varicella vaccine (live)",
            "active_substance": "varicella vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010473/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010473-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methyl salicylate, menthol / methyl salicylate, menthol / methyl salicylate / camphor, methyl salicylate/ camphor, methyl salicylate / menthol / camphor / tocopherol, methyl salicylate / camphor / menthol / turpentine (essence, oil), methyl salicylate / menthol / camphor / hydroxyethyl salicylate, methyl salicylate / menthol / camphor / hydroxyethyl salicylate / benzyl nicotinate",
            "active_substance": "methyl salicylate;menthol;camphor;tocopherol;turpentine (essence oil);hydroxyethyl salicylate;benzyl nicotinate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010658/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010658-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etoricoxib",
            "active_substance": "etoricoxib",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001334/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001334-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mometasone furoate/olopatadine",
            "active_substance": "mometasone furoate;olopatadine hydrochloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010957/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010957-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nefopam",
            "active_substance": "nefopam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002131/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002131-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertraline",
            "active_substance": "sertraline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002696/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002696-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epoprostenol",
            "active_substance": "epoprostenol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001242/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001242-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Candesartan, candesartan / hydrochlorothiazide",
            "active_substance": "Candesartan;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000527/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000527-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carvedilol",
            "active_substance": "carvedilol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000575/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000575-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Certoparin",
            "active_substance": "certoparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000625/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000625-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / olmesartan",
            "active_substance": "amlodipine;olmesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002208/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002208-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / levonorgestrel",
            "active_substance": "ethinylestradiol;levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001309/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001309-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine besilate / hydrochlorothiazide / olmesartan medoxomil",
            "active_substance": "amlodipine besilate;hydrochlorothiazide;olmesartan medoxomil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002210/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002210-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulprostone",
            "active_substance": "sulprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002828/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002828-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / candesartan",
            "active_substance": "amlodipine;Candesartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010191/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010191-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carvedilol / ivabradine",
            "active_substance": "carvedilol;ivabradine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010883/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010883-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Estradiol / norethisterone",
            "active_substance": "estradiol;norethisterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001278/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001278-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Oxycodone",
            "active_substance": "oxycodone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002254/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002254-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fexofenadine",
            "active_substance": "fexofenadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001388/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001388-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amoxicillin/clavulanate",
            "active_substance": "amoxicillin;clavulanate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000188/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000188-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amoxicillin",
            "active_substance": "amoxicillin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000187/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000187-202203"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "erythromycin",
            "active_substance": "erythromycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010808/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010808-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Macrogol 3350",
            "active_substance": "Macrogol 3350",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001924/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001924-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Macrogol 4000, macrogol 4000 combinations (oral use)",
            "active_substance": "macrogol 4000;macrogol 4000 combinations",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010392/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010392-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fusidic acid (systemic use)",
            "active_substance": "fusidic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010226/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010226-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levofloxacin/dexamethasone (ocular use)",
            "active_substance": "levofloxacin;dexamethasone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010881/202206",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010881-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Risperidone",
            "active_substance": "risperidone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002649/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002649-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alteplase",
            "active_substance": "alteplase",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000112/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000112-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Calcifediol",
            "active_substance": "calcifediol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000491/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000491-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tirofiban",
            "active_substance": "tirofiban",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002974/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002974-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eprosartan hydrochlorothiazide",
            "active_substance": "eprosartan;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001244/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001244-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Eprosartan",
            "active_substance": "eprosartan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001243/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001243-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valsartan, hydrochlorothiazide / valsartan",
            "active_substance": "valsartan;hydrochlorothiazide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010396/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010396-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "latanoprost / timolol",
            "active_substance": "Latanoprost;timolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001833/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001833-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Olsalazine",
            "active_substance": "olsalazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002213/202205",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002213-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime axetil",
            "active_substance": "cefuroxime axetil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009099/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009099-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tolperisone",
            "active_substance": "tolperisone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002991/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002991-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefuroxime sodium (except for intracameral use)",
            "active_substance": "cefuroxime sodium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000615/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000615-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Omeprazole",
            "active_substance": "omeprazole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002215/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002215-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lamivudine / tenofovir disoproxil",
            "active_substance": "lamivudine;tenofovir disoproxil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010751/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010751-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ivermectin (systemic use)",
            "active_substance": "ivermectin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010377/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010377-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fentanyl (transdermal patches, solution for injection - nationally authorised product only)",
            "active_substance": "fentanyl",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001370/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001370-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Aprotinin / calcium chloride / human factor xiii / human  fibrinogen / human thrombin, aprotinin / fibrinogen / fibronectin / human  coagulation factor XIII / plasma protein fraction / plasminogen / thrombin,  aprotinin / human fibrinogen / thrombin / calcium chloride, aprotinin /  calcium chloride / factor xiii / human thrombin / human clottable protein  containing mainly fibrinogen and fibronectin, calcium chloride / human  fibrinogen / factor xiii / fibronectin / plasminogen / human thrombin",
            "active_substance": "aprotinin;calcium chloride;human factor xiii;human fibrinogen;human thrombin, aprotinin;fibrinogen;fibronectin;human coagulation factor XIII;plasma protein fraction;plasminogen;thrombin, aprotinin;human fibrinogen;thrombin;calcium chloride, aprotinin;calcium chloride;factor XIII;human thrombin;human clottable protein containing mainly fibrinogen and fibronectin, calcium chloride;human fibrinogen;factor XIII;bovine aprotinin, calcium chloride;bovine aprotinin, human fibrinogen;calcium chloride dihydrate;plasma fibronectin;bovine aprotinin;human coagulation factor XIII, human fibrinogen;calcium chloride dihydrate;plasma protein fraction;plasminogen;human thrombin;bovine aprotinin;human coagulation factor XIII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010346/202111",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010346-202111"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Vinorelbine",
            "active_substance": "vinorelbine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003124/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003124-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lanreotide",
            "active_substance": "lanreotide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001826/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001826-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triptorelin",
            "active_substance": "triptorelin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003048/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003048-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bleomycin",
            "active_substance": "bleomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000422/202203",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000422-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methoxyflurane",
            "active_substance": "Methoxyflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010484/202205",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010484-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Betaxolol",
            "active_substance": "betaxolol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000401/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000401-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levonorgestrel (for emergency contraception only)",
            "active_substance": "levonorgestrel",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010827/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010827-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Moclobemide",
            "active_substance": "moclobemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002079/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002079-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acamprosate",
            "active_substance": "acamprosate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000016/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000016-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amorolfine",
            "active_substance": "amorolfine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000185/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000185-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cilastatin / imipenem",
            "active_substance": "cilastatin;imipenem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000748/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000748-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ganciclovir",
            "active_substance": "ganciclovir",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001516/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001516-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pentamidine",
            "active_substance": "pentamidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002338/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002338-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for diagnostic and or therapy Vespula SPP. (802) (with or without adjuvant), Wasp venom",
            "active_substance": "Vespula SPP. (802);wasp venom",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010721/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010721-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Theophylline",
            "active_substance": "theophylline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002921/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002921-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methylaminolevulinate",
            "active_substance": "methylaminolevulinate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002019/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002019-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Apis mellifera (801) (with or without adjuvant), Apis mellifera venom",
            "active_substance": "Apis mellifera (801);Apis mellifera venom",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010722/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010722-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sulfamethizole",
            "active_substance": "sulfamethizole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010561/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010561-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Nitrous oxide, nitrous oxide / oxygen",
            "active_substance": "nitrous oxide;oxygen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010572/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010572-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor XIII",
            "active_substance": "human coagulation factor XIII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001622/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001622-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Germanium (68Ge) chloride / gallium (68Ga) chloride",
            "active_substance": "germanium (68Ge) chloride;gallium (68Ga) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010364/202203",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010364-202203"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ibuprofen / pseudoephedrine",
            "active_substance": "Ibuprofen;pseudoephedrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001711/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001711-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: betula verrucosa (sublingual use)",
            "active_substance": "allergen for therapy: betula verrucosa (sublingual use)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010815/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010815-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Phentermine/ topiramate",
            "active_substance": "phentermine;topiramate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010956/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010956-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Itopride",
            "active_substance": "itopride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010606/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010606-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flecainide",
            "active_substance": "flecainide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001396/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001396-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Glimepiride",
            "active_substance": "glimepiride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001534/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001534-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piracetam",
            "active_substance": "piracetam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002429/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002429-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Benserazide / levodopa",
            "active_substance": "benserazide;levodopa",
            "related_medicines": "",
            "procedure_number": "PSUSA/000000330/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-000000330-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketotifen (ophthalmic formulations)",
            "active_substance": "ketotifen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001812/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001812-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mitoxantrone",
            "active_substance": "mitoxantrone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002076/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002076-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Methadone",
            "active_substance": "methadone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002004/202205",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002004-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levomethadone",
            "active_substance": "levomethadone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001855/202205",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001855-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Esomeprazole / naproxen",
            "active_substance": "esomeprazole;naproxen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001270/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001270-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Venlafaxine",
            "active_substance": "venlafaxine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003104/202205",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003104-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bemiparin",
            "active_substance": "bemiparin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000312/202204",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000312-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefadroxil",
            "active_substance": "cefadroxil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000584/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000584-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diphtheria / tetanus / poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)",
            "active_substance": "diptheria;tetanus;poliomyelitis (inactivated) vaccine (adsorbed, reduced antigens(s) content)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001127/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001127-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosfomycin (oral formulation)",
            "active_substance": "fosfomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010326/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010326-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fosfomycin (IV formulation)",
            "active_substance": "fosfomycin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010336/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010336-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor IX",
            "active_substance": "human coagulation factor IX",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001617/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001617-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Poliovirus type 1 / poliovirus type 2 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 / poliovirus type 3 vaccine (oral, live, attenuated), poliovirus type 1 (oral, live, attenuated) vaccine, poliovirus type 2 (oral, live, attenuated) vaccine, poliovirus type 3 (oral, live, attenuated) vaccine",
            "active_substance": "poliovirus type 1 vaccine;poliovirus type 2 vaccine;poliovirus type 3 vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010801/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010801-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fludarabine",
            "active_substance": "fludarabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001406/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001406-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amikacin (except for centrally authorised products)",
            "active_substance": "amikacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000143/202206",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000143-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triazolam",
            "active_substance": "triazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003023/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003023-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluvoxamine",
            "active_substance": "fluvoxamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001458/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001458-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pilocarpine (non-ophthalmic formulations)",
            "active_substance": "pilocarpine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002409/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002409-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diclofenac / misoprostol",
            "active_substance": "diclofenac;misoprostol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001040/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001040-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Triamcinolone topical and nasal formulations",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003017/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003017-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Beclometasone formoterol (inhalative application)",
            "active_substance": "beclometasone;formoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010068/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010068-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alprostadil (indicated in peripheral arterial occlusive diseases)",
            "active_substance": "alprostadil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000111/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000111-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ethinylestradiol / norethisterone",
            "active_substance": "ethinylestradiol;norethisterone",
            "related_medicines": "",
            "procedure_number": "EMA/131957/2023",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/ema-131957-2023"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketorolac (ophthalmic formulations)",
            "active_substance": "ketorolac",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001810/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001810-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Diltiazem",
            "active_substance": "diltiazem",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001084/202205",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001084-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clindamycin phosphate / tretinoin",
            "active_substance": "clindamycin phosphate;tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010080/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010080-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Pitavastatin",
            "active_substance": "pitavastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010502/202207",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010502-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbetocin",
            "active_substance": "carbetocin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000546/202206",
            "regulatory_outcome": "",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000546-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Procyanidolic oligomers",
            "active_substance": "procyanidolic oligomers",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002537/202205",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002537-202205"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Norethisterone",
            "active_substance": "norethisterone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002188/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002188-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Delapril / manidipine, delapril / indapamide",
            "active_substance": "delapril;manidipine, delapril;Indapamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010496/202206",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010496-202206"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium tetradecyl sulphate",
            "active_substance": "sodium tetradecyl sulfate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002767/202204",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002767-202204"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ropinirole",
            "active_substance": "ropinirole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002661/202207",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002661-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Minocycline",
            "active_substance": "minocycline",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002065/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002065-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Piperacillin / tazobactam",
            "active_substance": "piperacillin;tazobactam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002425/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002425-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dornase alpha",
            "active_substance": "dornase alpha",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001164/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001164-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: dermatophagoides pteronyssinus / dermatophagoides farina (oromucosal use, products authorised via mutually recognition procedure and decentralised procedure)",
            "active_substance": "Dermatophagoides pteronyssinus;Dermatophagoides farina",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010582/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010582-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tretinoin (topical formulations)",
            "active_substance": "tretinoin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003016/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003016-202208-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Treosulfan (except for centrally authorised product)",
            "active_substance": "treosulfan",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009319/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009319-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Choline alfoscerate",
            "active_substance": "choline alfoscerate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010599/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010599-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dexamfetamine",
            "active_substance": "dexamfetamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000986/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000986-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Biperiden",
            "active_substance": "biperiden",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000415/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000415-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Paricalcitol",
            "active_substance": "paricalcitol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002316/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002316-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluoxetine",
            "active_substance": "fluoxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001442/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001442-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Drospirenone / ethinylestradiol",
            "active_substance": "drospirenone;ethinylestradiol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010217/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010217-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fluvastatin",
            "active_substance": "fluvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001457/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001457-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ketorolac (systemic formulations)",
            "active_substance": "ketorolac",
            "related_medicines": "",
            "procedure_number": "PSUSA-00001811-202207",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001811-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Meloxicam",
            "active_substance": "meloxicam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010474/202207",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010474-202207"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Artemether / lumefantrin (apart from the dispersible tablet)",
            "active_substance": "artemether;lumefantrin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000236/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000236-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Terbinafine",
            "active_substance": "terbinafine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002896/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002896-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromhexine",
            "active_substance": "bromhexine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000437/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000437-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Trifarotene",
            "active_substance": "trifarotene",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010929/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010929-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lysine acetylsalicylate",
            "active_substance": "lysine acetylsalicylate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001921/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001921-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambroxol",
            "active_substance": "ambroxol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000130/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000130-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ambroxol / clenbuterol",
            "active_substance": "ambroxol;clenbuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000131/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000131-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "EMA/223477/2023",
            "active_substance": "aminosalicylic acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000165/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000165-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Felbamate",
            "active_substance": "felbamate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010155/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010155-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etomidate",
            "active_substance": "etomidate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001330/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001330-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Etidronate",
            "active_substance": "etidronate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001320/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001320-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dinoprostone",
            "active_substance": "dinoprostone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001104/202209",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001104-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Midazolam (all pharmaceutical forms and indications apart from oromucosal solution indicated for the treatment of prolonged, acute, convulsive seizures)",
            "active_substance": "midazolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002057/202209",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002057-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Adenosine",
            "active_substance": "adenosine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000062/202208",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000062-202208"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tixocortol, chlorhexidine gluconate / tixocortol pivalate",
            "active_substance": "tixocortol;chlorhexidine gluconate;tixocortol pivalate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010333/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010333-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atovaquone / proguanil",
            "active_substance": "atovaquone;proguanil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000266/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000266-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Human coagulation factor VII",
            "active_substance": "human coagulation factor VII",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001619/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001619-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Epinastine",
            "active_substance": "epinastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001231/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001231-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Isoflurane",
            "active_substance": "Isoflurane",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001786/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001786-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Acitretin",
            "active_substance": "acitretin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000051/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000051-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clevidipine",
            "active_substance": "clevidipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010288/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010288-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Rubidium (82Rb) chloride",
            "active_substance": "rubidium (82Rb) chloride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010806/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010806-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lenograstim",
            "active_substance": "lenograstim",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001839/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001839-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Valsartan / rosuvastatin",
            "active_substance": "valsartan;rosuvastatin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010735/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010735-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ezetimibe",
            "active_substance": "ezetimibe",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001346/202210",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001346-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Clenbuterol",
            "active_substance": "clenbuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000794/202209",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000794-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Famotidine",
            "active_substance": "Famotidine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001350/202209",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001350-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Carbidopa / levodopa",
            "active_substance": "carbidopa;levodopa",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000548/202210",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000548-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenoterol (respiratory indications)",
            "active_substance": "fenoterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001366/202209",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001366-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ropivacaine",
            "active_substance": "ropivacaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002662/202209",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002662-202209"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Polystyrene sulfonate",
            "active_substance": "polystyrene sulfonate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002472/202210",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002472-202210"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Anti-T lymphocyte immunoglobulin for human use, horse",
            "active_substance": "anti-T lymphocyte immunoglobulin for human use, horse",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010433/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010433-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Propofol",
            "active_substance": "propofol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002555/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002555-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Econazole, econazole nitrate / triamcinolone acetonide, econazole nitrate / zinc oxide",
            "active_substance": "econazole;econazole nitrate;triamcinolone acetonide;econazole nitrate;zinc oxide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001195/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001195-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bambuterol",
            "active_substance": "bambuterol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000295/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000295-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bacillus clausii multi-antibioresistant spores",
            "active_substance": "bacillus clausii multi-antibioresistant spores",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000284/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000284-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Caffeine / ergotamine",
            "active_substance": "Caffeine;ergotamine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000485/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000485-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cetirizine",
            "active_substance": "cetirizine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000628/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000628-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Alfuzosin",
            "active_substance": "alfuzosin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000084/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000084-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "dutasteride, dutasteride / tamsulosine",
            "active_substance": "dutasteride;tamsulosine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010506/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010506-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Brotizolam",
            "active_substance": "brotizolam",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000444/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000444-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "naltrexone",
            "active_substance": "naltrexone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002117/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002117-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dienogest",
            "active_substance": "Dienogest",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003167/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "31/07/2023",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003167-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levocabastine",
            "active_substance": "levocabastine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001849/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001849-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sodium fluoride (18F)",
            "active_substance": "sodium fluoride (18F)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010706/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010706-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Bromperidol",
            "active_substance": "bromperidol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000439/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000439-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amlodipine / indapamide, amlodipine / indapamide / perindopril",
            "active_substance": "amlodipine;Indapamide;perindopril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010358/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010358-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hydroxycarbamide (except for centrally authorised product)",
            "active_substance": "hydroxycarbamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009182/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009182-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Yellow fever vaccine (live)",
            "active_substance": "yellow fever vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003135/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Inactivated leptospire vaccine",
            "active_substance": "inactivated leptospire vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010813/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010813-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Yellow fever vaccine (live)",
            "active_substance": "yellow fever vaccine (live)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00003135/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00003135-202212-0"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Apomorphine",
            "active_substance": "apomorphine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000227/202211",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000227-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cisplatin",
            "active_substance": "cisplatin",
            "related_medicines": "",
            "procedure_number": "PSUSA-00000778-202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000778-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Amisulpride",
            "active_substance": "amisulpride",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000167/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000167-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Hypericum perforatum L., herba",
            "active_substance": "hypericum perforatum L., herba",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001701/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001701-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Atracurium",
            "active_substance": "atracurium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000267/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000267-202212"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract",
            "active_substance": "codeine camphosulphonate;sodium benzoate;sulfogaiacol;grindelia soft extract",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010542/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010542-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)",
            "active_substance": "allergen for therapy: Dactylis Glomerata L., Phleum Pratense L., Anthoxanthum Odoratum L., Lolium Perenne L., Poa Pratensis L. (sublingual tablet)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010465/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010465-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Cefprozil",
            "active_substance": "cefprozil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000605/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000605-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Tetanus vaccines",
            "active_substance": "tetanus vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002910/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002910-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "5 fluorouracil (topical application)",
            "active_substance": "5 fluorouracil (topical application)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010000/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010000-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Flurbiprofen",
            "active_substance": "flurbiprofen",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001450/202211",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001450-202211"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Sertindole",
            "active_substance": "sertindole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002695/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002695-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Levobupivacaine",
            "active_substance": "levobupivacaine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001848/202212",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001848-202212"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Lamotrigine",
            "active_substance": "lamotrigine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001825/202211",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001825-202211"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Calcium chloride dihydrate / magnesium chloride hexahydrate / malic acid / sodium acetate trihydrate / sodium chloride / potassium chloride, calcium chloride dihydrate / sodium chloride / sodium lactate / potassium chloride, calcium chloride / sodium chloride / potassium chloride",
            "active_substance": "calcium chloride dihydrate;magnesium chloride hexahydrate;Malic acid;sodium acetate trihydrate;sodium chloride;potassium chloride;calcium chloride;sodium lactate",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010622/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010622-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Fenoterol / ipratropium",
            "active_substance": "fenoterol;ipratropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001367/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001367-202302"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (surface antigen, inactivated)",
            "active_substance": "influenza vaccine (surface antigen, inactivated)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001744/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001744-202303"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus type b and meningococcal group C conjugate vaccine",
            "active_substance": "haemophilus type b and meningococcal group c conjugate vaccine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001583/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001583-202302"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "active_substance": "influenza vaccine (split virion, inactivated) (non centrally authorised products)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010298/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010298-202303"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ipratropium",
            "active_substance": "ipratropium",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001780/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001780-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Ipratropium / salbutamol",
            "active_substance": "ipratropium;salbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001781/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001781-202301"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Haemophilus type b conjugate vaccines",
            "active_substance": "haemophilus type b conjugate vaccines",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001584/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001584-202302"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Saccharomyces boulardii",
            "active_substance": "saccharomyces boulardii",
            "related_medicines": "",
            "procedure_number": "PSUSA/00009284/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00009284-202302"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Mefloquine",
            "active_substance": "mefloquine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001955/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001955-202302"
        },
        {
            "category": "",
            "active_substances_in_scope_of_procedure": "Dacarbazine",
            "active_substance": "dacarbazine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000919/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000919-202302"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Tauroselcholic [75Se] acid",
            "active_substance": "tauroselcholic (75Se) acid",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010486/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010486-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "paroxetine",
            "active_substance": "paroxetine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002319/202212",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002319-202212"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "anastrozole",
            "active_substance": "anastrozole",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000210/202208",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000210-202208"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "idarubicin",
            "active_substance": "idarubicin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001720/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001720-202211"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "gemcitabine",
            "active_substance": "gemcitabine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001519/202301",
            "regulatory_outcome": "Variation",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001519-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "ethosuximide",
            "active_substance": "ethosuximide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001316/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001316-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Epinephrine / mepivacaine hydrochloride, mepivacaine / norepinephrine, mepivacaine",
            "active_substance": "epinephrine;mepivacaine hydrochloride;mepivacaine;norepinephrine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001979/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "05/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001979-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "",
            "active_substance": "enalapril",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001211/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001211-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Isotretinoin (oral formulations)",
            "active_substance": "isotretinoin (oral formulations)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010488/202305",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010488-202305"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Benzyl nicotinate / camphor / dimethyl sulfoxide / nonivamide / turpentine oil, Nicoboxil/ Nonivamide",
            "active_substance": "benzyl nicotinate;camphor;Dimethyl sulfoxide;nonivamide;turpentine oil;nicoboxil",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010584/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010584-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Methylphenobarbital",
            "active_substance": "methylphenobarbital",
            "related_medicines": "",
            "procedure_number": "PSUSA/00002025/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00002025-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Triamcinolone (intraocular formulations)",
            "active_substance": "triamcinolone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010292/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010292-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Mometasone furoate/olopatadine",
            "active_substance": "mometasone furoate;olopatadine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010957/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010957-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Human plasma (pooled and treated for virus inactivation)",
            "active_substance": "human plasma (pooled and treated for virus inactivation)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001635/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "04/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001635-202302"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Deproteinised hemoderivative of calf blood, deproteinised hemoderivative of calf blood / macrogol 400",
            "active_substance": "deproteinised hemoderivative of calf blood",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010600/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010600-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Hydroxyethyl starch",
            "active_substance": "hydroxyethyl starch",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001694/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001694-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Furosemide",
            "active_substance": "furosemide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001491/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001491-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Enalapril / nitrendipine",
            "active_substance": "enalapril;nitrendipine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001213/202301",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001213-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Drospirenone",
            "active_substance": "drospirenone",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010853/202211",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010853-202211"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Ciprofloxacin (systemic use)",
            "active_substance": "ciprofloxacin",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000775/202304",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000775-202304"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "BCG (bacillus calmette-guérin) for Immunotherapy",
            "active_substance": "bacillus calmette-guérin (BCG)",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000303/202303",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "01/12/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000303-202303"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "omega-3-acid ethyl esters",
            "active_substance": "omega-3-acid ethyl esters 90",
            "related_medicines": "",
            "procedure_number": "PSUSA-00010312-202301",
            "regulatory_outcome": "Variation",
            "first_published_date": "30/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010312-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "etoposide",
            "active_substance": "etoposide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001333/202302",
            "regulatory_outcome": "",
            "first_published_date": "29/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001333-202302"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "beta-alanine",
            "active_substance": "beta-alanine",
            "related_medicines": "",
            "procedure_number": "PSUSA/10510/202301",
            "regulatory_outcome": "Variation",
            "first_published_date": "29/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-10510-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "levosalbutamol, salbutamol",
            "active_substance": "levosalbutamol;salbutamol",
            "related_medicines": "",
            "procedure_number": "PSUSA/000010330/202301",
            "regulatory_outcome": "Variation",
            "first_published_date": "28/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-000010330-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "bicalutamide",
            "active_substance": "bicalutamide",
            "related_medicines": "",
            "procedure_number": "PSUSA/00000407/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "28/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00000407-202302"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "lomustine",
            "active_substance": "lomustine",
            "related_medicines": "",
            "procedure_number": "PSUSA/00001902/202301",
            "regulatory_outcome": "Variation",
            "first_published_date": "28/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00001902-202301"
        },
        {
            "category": "Human",
            "active_substances_in_scope_of_procedure": "Landiolol",
            "active_substance": "",
            "related_medicines": "",
            "procedure_number": "PSUSA/00010570/202302",
            "regulatory_outcome": "Maintenance",
            "first_published_date": "27/11/2023",
            "last_updated_date": "",
            "psusa_url": "https://www.ema.europa.eu/en/medicines/psusa/psusa-00010570-202302"
        }
    ]
}